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ii) Abstract 
Parkinson’s Disease (PD) is a common neurodegenerative condition characterised 
pathologically by progressive dopaminergic cell loss in the substantia nigra pars compacta, 
dopamine depletion and resulting cortico- basal ganglia circuit dysfunction.  There is a 
considerable variation in symptoms and treatment response between patients and therefore 
a need to individualise treatments, such as dopamine replacement therapy, and deep brain 
stimulation (DBS).  We therefore require a better understanding of how different motor and 
non-motor symptoms emerge from the cortico-basal ganglia dysfunction characteristic of PD.  
In this thesis, I investigated the hypothesis that distinct symptoms in PD may be due to the 
dysfunction of distinct cortico-basal ganglia circuits.  
I characterised cortico-basal ganglia coupling by simultaneously recording cortical activity 
with magnetoencephalography (MEG) and basal ganglia activity from intracranial electrodes 
placed during DBS surgery for PD. Coupling was measured in terms of coherence – a 
frequency specific measure of coupling.  
I found that resting cortico-basal ganglia networks had distinct cortical topographies at 
different frequencies. Frontal regions coupled to both the subthalamic nucleus (STN) and the 
pedunculopontine nucleus region (PPNR) in the beta frequency band whilst temporal, 
parietal and cerebellar areas coupled in the alpha range. I hypothesised that activity in the 
frontal beta network may relate to executive function, and found that local synchronisation in 
two frontal cortical hubs was related to stopping an on-going movement – a crucial executive 
function. In a related experiment in PD patients, transient frontal – basal ganglia coupling 
was again apparent during motor inhibition, but how this is related to behavioural 
performance needs further investigation.  
These results are useful in highlighting how cortico-basal ganglia networks can be separated 
both spatially and spectrally and how the function and dysfunction of these networks can be 
interrogated in PD patients. Future work should determine how different stimulation 
parameters differentially affect these distinct circuits. 
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1. Introduction 
 
1.1 Scope 
This thesis concerns the identification and functional interrogation of distributed neural 
activity in Parkinson’s Disease (PD).  In practice, such functional research has traditionally 
been hindered by several obstacles which may be useful to highlight at the start.  
Firstly, only humans get PD and accessing neural activity in vivo is difficult.  An ‘ideal’ 
experiment would involve the use of invasive neurophysiological recording devices in healthy 
humans and those that suffer from PD, but this is clearly unethical.  Researchers have 
therefore traditionally circumvented this obstacle in two ways: either by losing fidelity of the 
neurophysiological signal (by using non-invasive techniques such as PET, fMRI, EEG or 
MEG) or by approximating the diseased system (the use of animal models of PD). In this 
thesis, we rely on a small subgroup of PD patients who have high-fidelity recordings made 
possible via intracranial electrodes implanted for deep brain stimulation therapy.  
Secondly, some symptoms in PD can only be objectively measured indirectly. Classically, 
PD is thought of primarily as a movement disorder, and as such provides directly observable 
behavioural parameters with which brain activity can be correlated.  For example, motor 
physiologists have made great progress in associating pathological rhythmic activity in the 
basal ganglia with bradykinesia (the slowing and shrinking of movements) in humans, and 
representative behaviour in rodents (Hammond et al., 2007).  However, PD patients can also 
develop cognitive and psychiatric complications including distortion of their memory, mood 
and decision-making capabilities.  These are usually assessed subjectively, for example with 
questionnaires, and as such cannot be dynamically related to neurophysiological 
measurements in an experimental setting.  However, although cognitive processes cannot 
be measured directly, they can be inferred indirectly as hidden variables in an objective 
model of behaviour.  For example, although we cannot directly test the strength of a 
subject’s memory, we can assume that stronger memories are recalled quicker and more 
accurately. Therefore in an appropriate experimental design, the directly observed objective 
behavioural parameters of reaction time and error-rate can be used to infer the strength of a 
memory, given a model linking memory, reaction time and error-rate.  Such behavioural 
models fall within the realm of psychologists, who have successfully uncovered a range of 
insights into the diversity of human behaviour. However traditionally, and some may argue 
entirely appropriately, such researchers have regarded the brain as a ‘black box’,  
developing complex architectures of human behaviour with only brief regard to their neural 
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instantiation. In contrast, more recent developments in functional imaging have allowed such 
psychological models to be tested empirically in the field of cognitive neuroscience. In later 
chapters of this thesis, we will also depend on behavioural models, namely the horse-race 
model of response inhibition. The advantage of such models is that we can use them to 
translate the subjective cognitive symptoms of PD into objective measurable parameters 
appropriate to be related to neurophysiological measurements. However, we must always be 
aware that the hidden or inferred parameters that psychological models rely on may not in 
turn be the same parameters that the brain uses to generate that behaviour.  
Thirdly, the Parkinsonian brain is not a homunculus of symptoms.  If we want to correlate 
neural activity with behaviour, we would presumably start by identifying brain regions where 
behavioural modulations correlated with neural activity. This approach assumes that regions 
of the brain are functionally specialised to undertake different functions. Indeed we will rely 
on this sort of comparison in our introductory review. However, when trying to understand 
symptoms, rather than separately modelling different brain regions, we may be better served 
by modelling behaviour as an emergent property of the functional relations (i.e. connectivity) 
between regions (Friston, 2002).  Similarly dysfunctional brain circuitry may better 
correspond to behaviour if the activity of functionally connected compensatory regions is 
also taken into account. In this thesis, we weight our analyses towards measurement of 
cortico-basal ganglia coupling to address this issue.  
However, before proceeding, we will first carefully review the clinical features of PD, 
psychological models which may give insight into the cognitive symptoms of PD, and the 
anatomical and physiological basis of current neural models explaining these symptoms. 
 
1.2 Clinical aspects of Parkinson’s Disease 
 
1.2.1 Diagnostic Criteria 
Idiopathic PD is a common neurodegenerative condition characterised by basal ganglia 
dysfunction due to progressive dopamine depletion (Lees et al 2009).  The clinical syndrome 
was first described by the surgeon and apothecarist, James Parkinson in 1817 who saw 6 
patients (including some seen in the street, and not formally examined) with a ‘shaking palsy’ 
(Parkinson, 1817; Kempster et al., 2007). The condition was later named after Parkinson by 
Jean Martin Charcot.  Currently PD is viewed as a heterogeneous clinico-pathologically 
defined syndrome, the cause of which remains unknown. The clinical diagnosis is based on 
the presence of reduction in amplitude and speed of repeated alternating movements 
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(bradykinesia) in combination with either tremor, stiffness of passive movement around a 
joint (rigidity) or postural instability. Additionally, a good response to dopaminergic treatment 
is also supportive (Gibb and Lees, 1988).  Parkinsonism refers to idiopathic PD and other 
aetiologies which may mimic the symptoms of PD including Progressive Supranuclear Palsy 
(PSP), Multiple System Atrophy (MSA), and cerebrovascular disease. The most influential 
diagnostic criteria were formalised in 1986 as the Queen Square Brain Bank Criteria (see 
Table 1). In addition to the symptoms described above, these criteria list symptoms and 
signs (such as cerebellar signs) that effectively rule out idiopathic PD (Gibb and Lees, 1988). 
 
1.2.2 Epidemiology 
The lifetime risk of developing PD is 2% for men and 1.3% for women (Elbaz et al., 2002), 
with a median age of onset of 60 years (Lees et al., 2009). The age standardised prevalence 
of PD in the UK lies between 105-169 per 100000 (Wickremaratchi et al., 2009). This 
changes with age rising from 9.9 per 100000 in those aged 40-49, 272 per 100000 in those 
aged 60-69 and 1297 per 100000 in those aged over 80 years old (Wickremaratchi et al., 
2009).  A study from Rochester, USA found the overall incidence of PD to be 10.8 per 
100000 person-years. Incidence increased with age, with rates of 17.4, 52.5, 93.1 and 79.1 
per 100000 person-years in those aged 50-59, 60-69, 70-79 and 80-89 respectively (Bower 
et al., 1999). Incidence rates have been stable over time (arguing against an environmental 
aetiology) and men are consistently more affected than women (Bower et al., 1999; Rocca et 
al., 2001) with a male to female ratio around 1.5 (Wooten, 2004). However a recent meta-
analysis of incidence studies placed the overall incidence of PD higher than previously 
thought at 16-19 per 100000 person-years (Twelves et al., 2003). The death rate in those on 
dopaminergic replacement therapy is between 5.86 - 6.17 per 100 person-years 
(Katzenschlager et al., 2008), with a median duration from diagnosis to death of about 15 
years (Lees et al., 2009). 
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STEP 1: Diagnosis of PARKINSONIAN SYNDROME: 
BRADYKINESIA (slowness of initiation of voluntary movement with progressive reduction in 
speed and amplitude of repetitive actions). 
And at least one of the following: 
a. Muscular rigidity 
b. 4-6Hz rest tremor 
c. postural instability not caused by primary visual, vestibular, cerebellar or 
proprioceptive dysfunction. 
STEP 2. Exclusion criteria for Parkinson’s Disease 
History of repeated strokes with stepwise progression of Parkinsonian features 
History of repeated head injury 
History of definite encephalitis 
Oculogyric crises 
Neuroleptic treatment at onset of symptoms 
More than one affected relative 
Sustained remission 
Strictly unilateral features after three years 
Supranuclear gaze palsy 
Cerebellar signs 
Early severe autonomic involvement 
Early severe dementia with disturbances of memory, language and praxis 
Babinski sign 
Presence of cerebral tumour or communicating hydrocephalus on CT scan 
Negative response to large doses of levodopa (if malabsorption excluded) 
MPTP exposure 
STEP 3: Supportive prospective criteria for PARKINSON’S DISEASE.  
Three or more required for diagnosis of definite Parkinson’s disease. 
Unilateral onset 
Rest tremor 
Progressive disorder 
Persistent asymmetry affecting the side of onset most 
Excellent response (70-100%) to levodopa 
Severe levodopa-induced chorea 
Levodopa response for 5 years or more 
Clinical course of 10 years or more 
Table 1: UK Parkinson’s Disease Society Brain Bank clinical diagnostic criteria. 
Adapted from Gibb and Lees (1988) with permission from BMJ Publishing Group Ltd. 
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1.2.3 Genetic and environmental risk factors 
The underlying cause of PD is unknown, but many risk factors have been investigated. Of 
these, one of the most important is older age (Bower et al., 1999; Rocca et al., 2001). 
Evidence for other risk factors is less convincing. A systematic review determined that 
people who smoked tobacco were half as likely to get PD (Allam et al., 2004). Caffeine 
consumption also reduces PD risk in men but not, on average, in women. This later 
discrepancy may be confounded by the effect of oestrogens – for example if women on 
postmenopausal oestrogen replacement are excluded, then the remaining female coffee 
drinkers have a reduced incidence of PD, just like their male counterparts (Ascherio, 2004). 
But such risk factors may not cause PD per se – rather such behaviour may be a result of 
early subclinical disease. For example it is likely that the lower incidence of smoking and 
drinking coffee  may be explained by lower sensation-seeking rates in patients with PD 
(Evans, 2005). 
Risk from environmental causes is low. In 1983, four people developed chronic 
Parkinsonism after illicitly injecting a drug containing 1-methyl-4-phenyl-1,2,5,6-
tetrahydropyridine (MPTP) (Langston et al., 1983). MPTP has a molecular structure close to 
the herbicide paraquat and so these case reports prompted investigation into the risk of 
exposure to herbicides and pesticides (Elbaz and Tranchant, 2007). A meta-analysis 
revealed odds ratios for developing idiopathic PD were 1.56 for rural residence, 1.26 for well 
water use, 1.42 for farm exposure and 1.85 for pesticide exposure (Priyadarshi et al., 2001). 
Cyanide, carbon disulphide and toluene toxicity can also cause an extrapyramidal syndrome 
similar to PD (Lees et al., 2009). There is continued debate whether head injury is also a risk 
factor. Parkinsonism can also be iatrogenic (drug-induced Parkinsonism) usually due to 
long-term use of anti-psychotic drugs such as chlorpromazine as well as a miscellany of 
other drugs such as metoclopramide, sodium valproate, flunarizine and herbal remedies 
such as kava kava and Indian snake root (Lees et al., 2009). REM sleep behaviour disorder 
– the tendency to shout or kick out in one’s sleep – is also a strong predictor of PD. Although 
properly controlled cohort data are lacking, prospective studies have suggested that 5 years 
after diagnosis of REM sleep behaviour disorder, 19-38% of patients also develop PD or PD 
dementia, and at 10 years, this figure rises to 40-65% (Postuma et al., 2010). 
Several genetic mutations can cause a syndrome clinically indistinguishable from idiopathic 
PD (Table 2).  The commonest of these are leucine rich repeat kinase 2 (LRRK-2) 
mutations, which have a total frequency of 1% in sporadic PD and 4% in hereditary (with an 
affected first-degree relative) PD. However this is highly geographically variable, being most 
common in north African Arabs (hereditary 36%, sporadic 39%) and Ashkenazi Jews 
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(hereditary 28%, sporadic 10%) (Healy et al., 2008). These mutations are dominantly 
inherited and the commonest mutation (Gly2019Ser) confers a 28% risk of developing 
parkinsonism before the age of 60 years increasing to 74% by the age of 79 years (Healy et 
al., 2008). 
Recessive mutations in parkin, DJ-1, PINK1, and ATP13A2 genes cause Parkinsonism with 
an earlier onset, but more benign course, characteristically presenting with leg tremor, 
dystonia and early behavioural symptoms. Hyposmia is unusual in this cohort (Lees et al., 
2009). 
 
Gene Pathology Comments 
Parkinsonism 
Parkin Substantia-nigra 
degeneration but usually no 
Lewy bodies 
Recessive, young onset 
PINK1 Data on only one subject, 
showing Lewy bodies  
Recessive, young onset, 
psychiatric features 
DJ-1 No data Recessive, young onset 
ATP13A2 No data Recessive, young onset 
Parkinson’s Disease 
Alpha-synuclein Lewy bodies, sometimes 
GCIs and Tau inclusions. 
Dominant point mutations 
(PARK1) and 
duplications/triplications 
(PARK4). Rapid motor 
progression; frequent 
dementia. 
LRRK-2 Usually Lewy bodies in 
commonest mutation 
Dominant mutations, variable  
clinical features 
GBA Lewy bodies Dominant loss of function 
mutations increase risk 
Table 2: Genes associated to L-dopa-responsive parkinsonism. GCI: Glial cytoplasmic 
inclusions; GBA: Glucocerebrosidase mutations. Adapted from Lees et al. (2009) and  
Poulopoulos et al. (2012) with permission from Elsevier. 
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Additionally, genetic risk may be due to the combined effect of many mutations (rather than 
the monogenic forms discussed above). In such cases, several single nucleotide 
polymorphisms (SNPs) confer the genetic risk. A recent genome wide association study 
found 11 loci where polymorphisms were associated with PD (Nalls et al., 2011). However, 
the odds ratio of the highest at risk quintile of disease was only 2.51, suggesting that these 
genetic loci may not yet be useful as a clinical prediction tool (Klein and Ziegler, 2011). 
 
1.2.4 Pathology  
The pathological hallmark of PD is dopaminergic cell loss in the substantia nigra pars 
compacta (Hassler, 1938; Damier, 1999), progressively spreading more medially and 
rostrally as the disease progresses (Damier, 1999). However cell loss can also be found in 
the locus coeruleus, dorsal nuclei of the vagus, raphe nuclei, nucleus basalis of Meynert and 
the pedunculopontine nucleus. In addition to cell loss, intraneural 8-30 micrometre inclusions 
of hyaline can be seen can be seen and are termed Lewy bodies.  Lewy bodies stain 
strongly for alpha-synuclein, an abnormal post-translationally modified, aggregated protein 
(Spillantini et al., 1997).  Although very sensitive to the diagnosis of PD, Lewy bodies can 
also be found in other conditions, including those without extrapyramidal features and even 
in normal aging (Parkkinen et al., 2005). Much research has tried to relate the Lewy body 
burden in particular cases to their symptomatology. However, this is confounded by the 
observation that the number of nigral Lewy bodies does not change with disease length or 
severity (Greffard et al., 2010) suggesting rather that they are accumulated and degraded 
constantly.  Lewy bodies appear in the brainstem and cortex and similarly the topography of 
Lewy body spread has also been related to clinical features.  Braak and colleagues have 
suggested that Lewy Body pathology spreads from the olfactory nuclei and the gastric 
autonomic plexus of Meissner and the olfactory nerve endings through the brainstem to the 
cortex as the disease progresses (Braak et al., 2003). This theory has been partially 
confirmed in a subset of younger patients with PD, with slowly progressive disease, 
however, the same study characterised another group of older patients, with shorter survival 
and more immediately diffuse Lewy bodies pathology (Halliday et al., 2008). Indeed, 
although it remains highly influential, up to 15% of post-mortem examinations do not conform 
to the Braak progression (Kalaitzakis et al., 2008). Cortical Lewy bodies most commonly 
appear in the frontal, parietal, insular, cingulate and entorhinal areas, although work trying to 
correlate regional cortical Lewy body load and symptoms is unclear. Lewy bodies do not 
correlate with the degree of motor symptoms (Parkkinen et al., 2005) although one study did 
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find less Lewy bodies in a group of younger tremor-dominant subjects (Selikhova et al., 
2009). The relationship between cortical Lewy body load and frank dementia is also unclear 
although some reports suggest that cases with dementia have higher diffuse cortical loads of 
Lewy bodies (Hurtig et al., 2000; Apaydin, 2002; Halliday et al., 2008).   More promising 
clincopathological correlations occur between the presence of dementia in PD and cortical 
beta-amyloid deposition (Jellinger and Attems, 2008) and the correlation between cognitive 
function in life (as measured by the MMSE) and the degree of cortical B-amyloid deposition 
(Braak et al., 2005).  
 
1.2.5 Motor Symptoms 
The cardinal symptoms of PD are bradykinesia, rigidity, tremor and later on in the condition, 
postural instability. Symptoms are usually unilateral at onset. Bradykinesia and rigidity 
usually present with loss of hand dexterity or with dragging of a foot, although first 
recollections may be of finding it easier to sit still or tending to swim in circles (Lees et al., 
2009). Friends may notice that their facial expressions are less marked, their blink rate is 
reduced or that their writing has changed (becomes smaller as they write) or that their 
speech is quiet or monotonous. Bradykinesia, can be elicited on examination as a reduction 
in amplitude and speed of alternating hand movements. Some patients also develop more 
sustained, stereotyped and painful increases in tone, termed dystonia, often in their feet. 
A subgroup of patients also present with a 4-6Hz unilateral pill-rolling tremor of the upper 
limb, which is most apparent at rest. Older (>70 years old) patients may also present with 
jaw, chin, lip and tongue (but not usually head) tremor.  
Later in the disease, patients can develop slurred and accelerating (festinant) speech, 
sudden arrests of movement termed ‘freezing’ (especially triggered by visual cues such as 
doorways whilst walking) and falls. Patients can have difficulty turning in bed and eventually 
with chewing and swallowing food, sometimes needing feeding through percutaneous 
gastrostomy in the late stages (Chaudhuri et al., 2006; Lees et al., 2009). 
Progression of motor symptoms in PD can be assessed using part III of the Unified 
Parkinson’s Disease Rating Scale (UPDRS) - an objective motor score, administered by a 
trained physician or nurse (Goetz et al., 2008). UPDRS part III score increases on average  
by 2.24 points per year in successfully medicated patients (Evans et al., 2011).  
Although the Queen Square Brain Bank criteria are highly specific for the diagnosis of PD, 
they fail to convey the heterogeneity of PD symptoms in practice.  It is clear that not all 
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patients develop all symptoms and some patients undergo much more rapid progression 
than others. Zetusky reported that the presence of tremor resulted in more benign 
progression, whilst the presence of postural instability resulted in a more rapidly progressive 
disease (Zetusky et al., 2012). Lewis et al. used a data-driven approach to identify PD sub-
syndromes in 120 cases of PD.  Cases were segregated into four groups: those with earlier 
disease onset (25%), those that were tremor dominant (31%), those that had minimal tremor 
but cognitive impairment and depression (36%) and those with rapid disease progression 
without dementia (8%). This classification scheme was partially supported by a retrospective 
analysis of the symptoms of 242 pathologically proven cases of PD, which identified 
increased cortical Lewy body and amyloid deposition in the rapidly progressive group with 
dementia and no tremor (Selikhova et al., 2009). 
 
1.2.6 Non-Motor Symptoms 
Although motor symptoms have received the greatest interest from researchers into PD, 
non-motor symptoms such as depression and cognitive impairment contribute significantly to 
patients’ quality of life (Schrag, 2000) . A UK survey of 163 patients showed that in addition 
to difficulties with balance - sleep disturbance, memory symptoms and dribbling were rated 
as most disabling (Chaudhuri et al., 2006).  
The commonest symptoms later on in the condition are those related to autonomic 
dysfunction including constipation, postural hypotension, erectile dysfunction, urinary 
urgency and pain. All these may require appropriate pharmacological intervention, 
additionally sometimes needing urinary catheterisation (Chaudhuri et al., 2006; Lees et al., 
2009). 
Critically non-motor symptoms can predate motor symptoms by years, and close study could 
allow for earlier identification of Parkinson’s patients. Current opinion is that the earliest non-
motor sign is usually hyposmia, although it is rarely declared as a symptom without 
prompting. Although it is difficult to study the epidemiology of non-motor symptoms of PD, 
hyposmia in a relative of a PD patient conveys a 10% increased risk of that relative 
developing PD (Ponsen et al., 2004). Patients may also suffer from fatigue and stiffness 
years before the characteristic motor symptoms of PD become recognisable (Chaudhuri et 
al., 2006; Lees et al., 2009).   
Approximately one third of PD patients develop rapid eye movement (REM) sleep behaviour 
disorder (Gagnon et al., 2002) and sometimes years before the diagnosis of PD is made 
(Olson et al., 2000). In this condition, the patient suffers from vocalisations and sometimes 
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violent movements during sleep, occasionally waking up with scratches, or being 
unknowingly violent to a bed partner (Lees et al., 2009). Other difficulties with sleep are also 
common including sleep apnoea, difficulty turning in bed due to nocturnal stiffness and vivid 
dreams. Poor sleep at night, associated dementia and dopaminergic medications can all 
lead to daytime somnolence, sometimes with abrupt and unexpected episodes of sleep in 
the daytime (Chaudhuri et al., 2006). 
Depression occurs in 2.7 – 70% of patients with PD (Burn, 2002) again often before the 
diagnosis of PD has been made. It is thought to occur not only because of the effects of 
motor disability on quality of life, but also as the result of multiple neurotransmitter 
imbalances that occur in PD. Patients can also suffer from anxiety and apathy.  
Patients suffer from a degree of cognitive impairment which in some may lead to frank 
dementia, taking a mean of 6.2 years (Evans et al., 2011). PD dementia is characterised by 
fluctuating alertness, visuospatial difficulties and sometimes visual hallucinations, although 
up to 40% of patients have minor psychotic symptoms or visual hallucinations in the absence 
of formal dementia. Williams-Gray et al. used a 5 year longitudinal follow-up to disambiguate 
cognitive symptoms and the risk of developing dementia in 126 patients with PD. At the time 
of diagnosis, 62% of patients had some evidence of mild cognitive dysfunction on extensive 
neuropsychological testing. Five years after diagnosis, 10% of patients had developed 
dementia and a further 57% showed evidence of mild cognitive impairment. The authors 
suggested that cognitive impairment in PD could be subdivided into a rapidly progressive 
global syndrome, i.e. dementia, or a relatively stable frontal dysexecutive pattern of cognitive 
impairment. They identified three factors which predicted dementia at the time of diagnosis: 
age>72 years, semantic fluency <20 in 90s and inability to copy pentagons (Williams-Gray et 
al., 2007). 
 
1.2.7 Medical Treatments and side effects 
There is currently no cure for Parkinson’s Disease, and there are no disease modifying 
agents. However there are many available preparations to manage the motor symptoms 
(Lees et al., 2009; Fox et al., 2011). The most common and most effective treatment for PD 
remains dopamine replacement therapy with levodopa. It is administered in combination with 
a peripheral dopa decarboxylase inhibitor in order to reduce the systemic side-effects of the 
dopamine pro-drug. Most symptoms improve within weeks of starting treatment, although 
tremor can sometimes take much longer to improve. Side-effects include lightheadedness, 
hypomania, delirium, and daytime somnolence although it is well tolerated in the majority.  
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In addition it is thought that continued levodopa therapy precipitates periods of excessive 
choreiform movements that are known as dyskinesias, and rapidly fluctuating excessive and 
reduced movements which are known as motor fluctuations.  Evans et al. reported that the 
median time to develop dyskinesias was 6.6 years from disease onset, and 4.8 years from 
onset of levodopa therapy (Evans et al., 2011). Estimates of the prevalence of dyskinesias at 
10 years are up to 90% (Vlaar et al., 2011). It is speculated that this may be due to poor 
absorption of levodopa later in the disease, neuroplastic effects of continued, but pulsatile, 
levodopa therapy or the reduced capacity of middle to end-stage dopamine neurons.  As 
such, physicians and patients often delay starting levodopa to try to postpone these 
symptoms. However, there is no definitive evidence for this approach and the relationship 
between disease severity, levodopa treatment and dyskinesias remains unclear (Lees et al., 
2009; Seppi et al., 2011; Vlaar et al., 2011). Patients may also develop dopamine 
dysregulation syndrome (see next paragraph). 
Non-ergot dopamine agonists are also an effective treatment, some physicians preferring to 
use them first-line in younger patients. Side-effects include sleep attacks, ankle swelling and 
the development of addictive behavioural disorders such as impulse control disorders 
(ICDs), punding and other compulsive behaviours. Impulsive/compulsive behavioural 
phenomena have only recently described, first associated with taking large quantities of 
levodopa – dopamine dysregulation syndrome (DDS) (Giovannoni et al., 2000), and later 
associated with administration of dopamine agonists. The current rate of impulsive 
behaviours in UK and US PD clinics is 6% without and 17% with dopamine agonist therapy. 
Pathological behaviours can be highly significant and range from pathological gambling and 
punding to compulsive sexual behaviour, compulsive shopping and binge eating 
(Djamshidian et al., 2011). 
Additional, second-line medications include selective type B monoamine oxidase inhibitors, 
amantadine and entacapone (Fox et al., 2011).  
Non-motor symptoms have a wide range of medical management options although evidence 
exists for a limited few including Pramipexole and Venlafaxine for depression, Rivastigmine 
for dementia, clozapine for psychosis, melatonin for sleep disturbance, macrogol for 
constipation and botulinum toxin and glycopyrrolate for sialorrhea (Seppi et al., 2011). 
 
1.2.8 Deep Brain Stimulation 
Deep brain stimulation is a surgical therapy for PD. An electrode is stereotactically placed 
inside a basal ganglia target and chronically electrically stimulated via a pectorally placed 
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battery. The procedure derives from early lesioning of the basal ganglia structures which 
were noted to improve PD symptoms in the pre-levodopa era (Meyers, 1940; Cooper, 1953, 
1964). These procedures were originally high-risk and a stereotactic surgical technique 
greatly improved operative outcomes (Spiegel et al., 1952). During lesioning operations, 
electrical stimulation was often applied to the brain as a way of functionally localising brain 
areas. However Hassler et al. documented improvements in PD symptoms during intra-
operative electrical stimulation (Hassler et al., 1958). Following pioneers in movement 
disorder DBS surgery such as Mundinger (Mundinger, 1977) chronic electrical stimulation 
was applied to PD patients with tremor by Benabid in the 1980s (Benabid et al., 1987). A 
large European multi-centre study established the efficacy of thalamic DBS to improve 
tremor in 1999 (Limousin et al., 1999). In addition, results initially from primate, then human 
experiments suggested that stimulation of a new target, the subthalamic nucleus (STN), may 
help other symptoms in PD such as bradykinesia and rigidity (Limousin et al., 1998). 
Currently the commonest stimulation target is the STN although centres vary in their use of 
targeting techniques: some rely on entirely on pre-operative imaging (Foltynie et al., 2010), 
whilst others also rely on intra-operative electrophysiology (Gross et al., 2006). 
The indications for DBS are tremor and dopamine-responsive motor fluctuations. Motor 
fluctuations respond to stimulation of the STN or Globus Pallidus interna (GPi), whereas 
tremor responds to STN or thalamic stimulation. A recent expert review suggested that 
inclusion criteria include (1) an excellent response to levodopa, (2) younger age, (3) no or 
few axial non–levodopa-responsive motor symptoms, (4) no or very mild cognitive 
impairment, and (5) absence of or well-controlled psychiatric disease (Bronstein et al., 2011). 
However, these are probably more stringent than what is practiced.  More recently 
stimulation of a new target, the pedunculopontine nucleus (PPN), also shows promise as a 
therapy for gait freezing and postural instability.  
Multiple randomised controlled trials have confirmed the utility of DBS in improving motor 
symptoms (Deuschl et al., 2006; Kleiner-Fisman et al., 2006; Weaver et al., 2009; Follett et 
al., 2010; Williams et al., 2010). A meta-analysis of uncontrolled cohorts calculated that on 
average, DBS reduced OFF medication UPDRS part III motor scores by 27.55 points, and 
reduced the oral levodopa intake by 55.9%. Dyskinesias were reduced by 69.1%, and time 
spent OFF reduced by 68.2%. Quality of life, assessed by the PDQ-39 was also increased 
by 34.5% (Kleiner-Fisman et al., 2006). 
Controlled randomised trial data confirmed that STN stimulation improved motor UPDRS 
part III score in 71% of patients with a mean improvement of 19.6 points (Deuschl et al., 
2006) at 6 months. A larger trial confirmed that these findings could be generalised to 
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patients over 75 years old, and also to either STN or GPi (Weaver et al., 2009). Here 
stimulation increased daily ON time by 4.6 hours (vs. control) and improved the motor 
UPDRS part III score in 71% of patients (v 31% of controls) at 6 months (Weaver et al., 
2009). A UK based study compared any surgery (lesioning or DBS) with best medical 
treatment and found an increase in self-reported PDQ-39 of 5 points (0.3 points control) in 
the surgery group at 1 year (Williams et al., 2010). 
Randomised trials comparing STN to GPi DBS have been inconsistent: one trial finding that 
GPi stimulation had a better cognitive side-effect profile than STN stimulation (Follett et al., 
2010) and one lower powered trial finding that there was no difference (Okun et al., 2009).  
The current understanding is that STN stimulation results in improved motor outcomes when 
compared to GPI stimulation. This has been measured both directly in terms of rigidity (Okun 
et al., 2009) or indirectly inferred because GPi stimulation patients need more oral levodopa 
post-op to reach the same level of motor function (Follett et al., 2010). 
 The relationship between DBS and gait is more complex, with one uncontrolled study 
suggesting that STN, but not GPi, stimulation worsens gait after 2 years in spite of 
improvements in other parts of the UPDRS part III motor score (St George et al., 2010). 
However, although it is clear that DBS improves quality of life and motor function, it is also 
clear that it has a significant adverse event profile. Surgical adverse event rates are highly 
variable and include intracranial haemorrhage (0%-10%), stroke (0%-2%), infection (0%-
15%), lead erosion without infection (1%-2.5%), lead fracture (0%-15%), lead migration (0%-
19%), and death (0%-4.4%) (Bronstein et al., 2011).  Weaver reported that 49% of DBS 
patients experienced serious adverse events infection but the majority (83% of these) had 
resolved by 6 months (Weaver et al., 2009).  
The commonest non-surgical adverse events include falls, dystonia and neurobehavioural 
disorders and overall they were worse following STN DBS as compared to GPi DBS (Hariz 
et al., 2008). Cognitive function has also been reported to worsen with STN or GPi DBS: 
scores being worse on tests of working memory, visuospatial memory and phonemic 
fluency, with no change in scores on the Mattis dementia or Beck depression scales 
(Weaver et al., 2009). There is also a small but important increase in the rate of completed 
(0.45%) and attempted (0.9%) suicide, when STN stimulation is compared with background 
rates (not control groups). This difference persists for at least 4 years post-operatively (Voon 
et al., 2008). There is also a risk of weight gain following DBS, which cannot be completely 
explained by the reduction in dyskinesia score (Montaurier et al., 2007). Finally speech 
intelligibility and loudness may worsen with STN stimulation, especially with high voltages in 
the left STN (Tripoliti et al., 2011). 
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Although traditionally, subjects with active psychiatric disease have been deemed unsuitable 
for DBS, it is unknown whether DBS helps or worsens patients with dopaminergic 
medication related addictive behaviours such as impulse control disorders, pathological 
gambling and dopamine dysregulation syndrome. Symptoms theoretically may improve 
because oral levodopa levels decrease significantly after successful DBS stimulation. On the 
other hand, the increased cognitive and psychiatric complications of DBS may worsen these 
behaviours. Studies have also been divided, with some showing worsening, and some 
showing improvement (Mallet et al., 2002; Ardouin et al., 2006; Smeding et al., 2007). 
However a recent larger (n=63) prospective study is more promising: it found dramatic 
improvements in DDS and ICD, without impairment of cognitive function in 63 PD patients 
following STN DBS (Lhommée et al., 2012). Current Practice regarding DBS in the UK is 
summarised in Table 2. 
 Subthalamic nucleus Globus pallidus interna 
Indication and 
therapeutic effect 
Motor fluctuations, tremor. 
Directly improves 
bradykinesia/rigidity/tremor – 
dyskinesias reduced as the 
result of medication reduction 
Motor fluctuations. Directly 
abolishes dyskinesias – less 
effect of 
bradykinesia/rigidity/tremor 
Motor benefit Levodopa responsive motor 
deficits 
 
Potential motor 
adverse effects 
On medication axial deficits 
can worsen, as can speech 
On medication axial deficits can 
worsen, especially gait freezing 
Non-motor effects Greater risk of cognitive and 
psychiatric effects. Dopamine 
medication reductions may 
improve or worsen non-motor 
features (e.g. mood and 
impulse control disorders) 
Less likely to cause 
cognitive/psychiatric effects 
Typical candidate Younger patient Biologically ‘older’ patient and 
those with neuropsychological 
issues. 
Table 2: Summary of current practice for STN vs. GPi DBS. Neuropsychiatric effects are 
still debated. Adapted from Thevathasan and Gregory (2010) with permission from BMJ 
Publishing Group Ltd. 
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1.3 The pathophysiological basis of Parkinsonian symptoms: 
function and dysfunction of the cortico-basal ganglia network 
 
The heterogeneous nature of motor and non-motor symptoms in PD, and their differential 
response to treatments, suggests that different symptoms may have a different underlying 
pathophysiological basis. How can we reconcile the relatively specific neuronal degeneration 
associated with PD (loss of dopaminergic cells in the substantia nigra pars compacta) with 
the multiplicity of its symptoms? This may partially be explained by the multiple divergent 
projections of midbrain dopaminergic cells onto different cortico-basal ganglia circuits 
(Haber, 2003). Indeed pathophysiological models of PD primarily concern themselves with 
these circuits. In this section we will review the anatomical and physiological basis of these 
cortico- basal ganglia circuits before taking a look at the evidence of their dysfunction in PD. 
 
1.3.1 The firing rate model of cortico-basal ganglia connectivity 
The basal ganglia are an interconnected set of deep brain nuclei that were first thought to be 
linked to movement control by Ferrier in 1876 (Ferrier, 1876). This was further established 
by Wilson who characterised the predominantly motor impairment resulting from bilateral 
striatal copper deposition (Wilson, 1912). However, the first functional architecture of the 
basal ganglia was developed as late as the 1980s in a series of highly influential papers by 
Alexander and DeLong (Alexander et al., 1986; Albin et al., 1989; Alexander and Crutcher, 
1990; DeLong, 1990).  This model was mainly based on primate anatomical and 
electrophysiological data, and placed the basal ganglia in a partially closed circuit between 
the cortex and the thalamus. The overall function of the basal ganglia was proposed to be 
dependent on the balance of firing rate changes within different pathways through the basal 
ganglia, and therefore the model was also known as the firing rate model.  Although, the 
more dorsal motor circuits remain the best characterised (Alexander et al., 1986; Bolam et 
al., 2000), recent research has also begun to focus on the more ventral, cognitive and 
emotional, functions of what Wilson termed, “the dark basement of the mind” (Wilson, 1925). 
 
1.3.1.1 Parallel, partially segregated, partially closed circuits 
Virtually the entire cerebral cortex projects into the main input zone of the basal ganglia, the 
striatum. However, the output zones of the basal ganglia, the globus pallidus internal (GPi) 
and substantia nigra pars reticulata (SNr), project to relatively specific parts of the cortex via 
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a thalamic relay (Kemp and Powell, 1971; Alexander et al., 1986; Bolam et al., 2000). 
Alexander et al. (1986) crystallized the anatomical basis underlying this imbalance in terms 
of two opposing processes: segregation and integration. Firstly, the input from 
topographically distinct cortical areas remains broadly segregated in the striatum. This 
segregation is kept both in the relay stations within the basal ganglia, the subthalamic 
nucleus (STN) and globus pallidus externa (GPe), and the GPi/SNr output complex. This 
output remains segregated in the thalamus from where it projects back to limited and 
discrete areas of the cerebral cortex. Based on the passage through the basal ganglia and 
the cortical output areas, Alexander et al. (1986) identified at least five such circuits (see  
Figure 1, but also see section 1.4.5). The best characterised was the motor circuit, which 
received inputs from the primary motor, supplementary motor, arcuate premotor and 
somatosensory cortices. These inputs were then channelled through the posterior, dorsal 
aspect of the striatum (the putamen in primates) to the ventrolateral GPi and caudolateral 
SNr.  Motor output then projected to the ventralis lateralis pars medialis and pars oralis 
nuclei in the thalamus before returning to the supplementary motor area (Kunzle, 1975, 
1978; Alexander et al., 1986). In a similar fashion, segregated circuits were identified which 
projected to the frontal eye fields (the occulomotor circuit), the dorsolateral prefrontal cortex, 
the lateral orbitofrontal cortex and the anterior cingulate cortex. These circuits were only 
partially closed in that they had widespread cortical inputs, but projected back to only a 
subset of these areas. This implied that within each cortico-basal ganglia circuit there must 
be an integration or ‘funnelling’ of information. Crucially, integration was felt not to exist 
between different circuits leading to the description of parallel, partially segregated, partially 
closed circuits (Alexander et al., 1986).  A more detailed description of the processing within 
each circuit was developed by the same group and others and requires a closer examination 
of the synaptic organisation of the basal ganglia.  
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Figure 1: Simplified diagram of the basal ganglia circuit. Multiple such circuits involve 
different cortical regions and remain partially segregated throughout the basal ganglia. 
Pathway 1 is the direct pathway, pathway 2 is the indirect pathway and pathway 3 is the 
hyperdirect pathway. GPI: Globus Pallidus interna, SNr: Substantia Nigra pars reticulate, 
STN: subthalamic nucleus, GPe: Globus Pallidus externa. Adapted from Jha and Brown 
(2010) with permission from Cambridge University Press. 
38 
 
1.3.1.2 The striatum and the origin of the direct and indirect pathways 
The striatum can be divided into dorsal and ventral regions. In primates, the dorsal striatum 
can be divided further into the dorsal and lateral caudate and putamen. The ventral striatum 
is composed of the nucleus accumbens, the medial and ventral edges of the caudate and 
putamen and the striatal cells of the olfactory tubercle and anterior perforated substance 
(Bar-Gad et al., 2003).  
In addition to excitatory glutamatergic inputs from the cortex, the striatum receives inputs 
from the intralaminar thalamic nuclei, amygdala, hippocampus and dorsal raphe (Alexander 
et al., 1986; Bolam et al., 2000) making it ideally placed to integrate information from such 
different areas. Most cells in the striatum (>90%) project to other structures and are termed 
medium size densely spiny neurons (MSNs) because their spherically distributed dendritic 
branches are covered in spines (DiFiglia et al., 1976; Bolam et al., 2000).  The resting 
membrane potential of MSNs is characteristically low (a ‘down’ state) and increases during 
periods of cortical excitation (‘up’ states) (Wilson and Groves, 1981; Stern et al., 1998; 
Bolam et al., 2000; Murer et al., 2002).  At rest the MSNs do not fire, and therefore cortical 
input is thought to facilitate MSN firing during up states.   
MSNs can be further classified into two groups. The first group express receptors for γ-
aminobutyric acid (GABA), substance P, dynorphin and D1 dopamine receptors and 
preferentially projects directly to the GPi/SNr. This has been termed the ‘direct’ pathway. The 
second group express GABA, enkephalin and D2 dopamine receptors, projects to the 
GPI/SNr via the GPe and STN, and is known as the indirect pathway (Albin et al., 1989; 
Bolam et al., 2000; Bar-Gad et al., 2003).  In addition to downstream projections, MSNs also 
project symmetrically to neighbouring MSNs (Bolam et al., 2000).  All MSNs have inhibitory 
GABAergic output such that the net effect of cortical excitation of the striatum is inhibition of 
both downstream projection targets (GPi and GPe) and surrounding striatum. This property 
suggests that the striatum focuses or selects a range of cortical inputs. 
 
1.3.1.3 The rate model explains movement and movement disorders 
Based on the connections of the rate model, Albin et al. suggested a potential role for the 
basal ganglia in movement and movement disorders (Albin et al., 1989). Although 
substantial parts of this theory remain experimentally untested, it still forms the basis on 
which many current ideas about basal ganglia function are built.  
The thalamus, which has excitatory output to the cortex, is under tonic inhibitory control from 
the GPi/SNr. During a movement, motor cortical activity is passed via the direct pathway 
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through the basal ganglia. This inhibits the GPi/SNr, therefore suspending the tonic inhibition 
of the thalamus and allowing excitation of the cortex and movement. At the same time, 
cortical activity from undesired movements is topographically separated in the striatum and 
sent through the indirect pathway. This causes the opposite effect on the GPi/SNr, 
increasing tonic inhibition on the thalamus and suppressing undesired movements 
(Alexander et al., 1986; Albin et al., 1989; Alexander and Crutcher, 1990; DeLong, 1990).  
The imbalance between movement facilitating (direct) and inhibiting (indirect) pathways was 
also proposed to explain symptoms of movement disorders such as hemiballism, chorea and 
akinesia (Albin et al., 1989). In PD, for example, dopaminergic input from the substantia 
nigra pars compacta (SNc) to the striatum is reduced. This increases activity of D2 
expressing MSNs (the indirect pathway) whilst decreasing the activity of D1 expressing 
MSNs (the direct pathway). The net result is an overactive STN, increased tonic inhibition of 
the thalamus and reduced motor cortical activity (Alexander et al., 1986; Albin et al., 1989; 
Alexander and Crutcher, 1990; DeLong, 1990). This proposed a mechanism for akinesia, but 
didn’t explain symptoms and signs such as tremor or rigidity. 
 
1.3.2 Revisions to and limitations of the rate model 
 
1.3.2.1 The topography and organisation of cortical connections to the 
basal ganglia 
Alexander et al. (1986) suggested that there were at least five partially segregated circuits 
projecting to the supplementary motor area, frontal eye fields, dorsolateral prefrontal cortex, 
lateral orbitofrontal cortex and anterior cingulate cortex (Alexander et al., 1986). Since then 
these findings have been extended in animals using retrograde transneuronal tracers, and 
some of them have also been confirmed in humans using diffusion tensor imaging (DTI). 
Prefrontal connections are more extensive than previously thought, accounting for 27% of 
GPi and 45% of SNr output (Middleton and Strick, 2002).  Areas specifically tested by this 
study on non-human primates included the superior medial prefrontal area (equivalent to 
Brodmann area 9), the dorsolateral prefrontal area (equivalent to Brodmann area 46) and 
the lateral orbitofrontal area (equivalent to Brodmann area 12). Additionally, nearby 
prefrontal cortical areas remain segregated from each other, and also other e.g. motor loops, 
as they pass through the nuclei of the basal ganglia.  Closer examination of the 
supplementary motor complex, again reveals separate segregated loops. The GPi output to 
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the anterior pre-SMA is located in the rostral ‘associative’ part whilst the output to the SMA is 
located in the ventral ‘sensorimotor’ part (Akkal et al., 2007).  Both pre-SMA and SMA also 
have segregated inputs into the striatum and the STN [(Inase et al., 1999), see also section 
1.3.2.2].  
The basal ganglia also project to some areas outside of the frontal cortex. A non-human 
primate study established the closed loop architecture of basal ganglia connections with the 
inferior temporal area, which is thought to be involved in the recognition of visual objects 
(Middleton and Strick, 1996). Additional connections with the cerebellum and brainstem have 
now been characterised (see section1.4.4). 
Recent methodological advances in neuroimaging have allowed visualisation of segregated 
cortico-basal ganglia circuits in humans (Lehericy et al., 2004; Lehéricy et al., 2004; 
Draganski et al., 2008). Diffusion tensor imaging (DTI) allows non-invasive, three 
dimensional, tracking of axons in humans, although it does not have the ability to 
characterise directionality. DTI analysis of healthy volunteers revealed that striatal 
connections with the motor, associative and limbic parts of the cortex were also segregated 
at the striatal level (Lehéricy et al., 2004). However, compared with animal data, there was a 
paucity of parietal and cingulate connectivity with the striatum. Draganski et al. (2008) 
reproduced these findings in another cohort, and extended them to include thalamic circuits 
(Draganski et al., 2008). They used pre-specified cortical regions to parcellate the striatum, 
GPe and thalamus into characteristic but partially overlapping regions which were in keeping 
with prior data from animals.  
Based on anatomical connectivity, cortico-basal ganglia circuits are now seen as a 
continuum of somatotopically organised circuits broadly organised, by their cortical output, 
into limbic, associative and motor circuits. The topography of these different circuits, and the 
sub-circuits within them, is kept at all stages of basal ganglia processing (Haber, 2003).    
 
1.3.2.2 The subthalamic nucleus and the hyperdirect pathway 
Recent work has focused on the importance of the subthalamic nucleus (STN) identifying it 
as a second major input into basal ganglia circuitry in addition to the striatum. It is an 
almond-shaped ~175mm3 structure (Levesque and Parent, 2005) that lies between the zona 
incerta dorsally and the cerebral peduncle ventrally (Parent and Hazrati, 1995). Apart from 
medially merging into the lateral hypothalamus, it is separated from other grey matter 
structures by myelinated fibre tracts. It was originally thought to be a homogeneous structure 
with densely packed excitatory glutamatergic projection neurons (Parent and Hazrati, 1995; 
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Bar-Gad et al., 2003) but a recent post-mortem study of human STNs has revealed that at 
least 7.5% of cells stain positively for, glutamic acid decarboxylase (GAD),  the GABA 
synthesizing enzyme (Levesque and Parent, 2005). 
Afferent projections to the STN are mainly from the cerebral cortex and GPe but also the 
centeromedian-parafascicular complex of the thalamus (Feger et al., 1994), the substantia 
nigra, the dorsal raphe nucleus and the pedunculopontine tegmental nucleus (Parent and 
Hazrati, 1995; Mena-Segovia et al., 2004; Coizet et al., 2009). The direct cortical-
subthalamic connections are sometimes referred to as the ‘hyperdirect pathway.’ Direct 
cortical afferents to the STN in the rodent include the primary motor and somatosensory 
cortex, prefrontal cortex, anterior and medial cingulate cortex and the insular cortex 
(Monakow et al., 1978; Nambu et al., 2002).  Cortical afferents in the primate show similar 
afferents concentrated in the primary motor cortex (somatotopically to the dorsolateral STN) 
and the premotor cortex (Brodmann areas 6, 8 and 9) which terminates in the ventromedial 
STN (area 6 most ventral) (Parent and Hazrati, 1995; Nambu et al., 1996, 1997). 
 
Figure 2: Distribution of afferents into the STN. Reprinted from Nambu, (2011) in 
accordance with Frontiers Media SA.The vertical axis is in panel A is dorsal (top) to ventral 
(bottom), whilst the vertical axis in panel B is rostral (top) to caudal (bottom). Both panels 
have a horizontal axis which is lateral (left) to medial (right). Panel A shows that the SMA 
and M1 areas project to different but neighbouring regions of the STN.  From a different 
viewpoint, panel B confirms this and also shows that other neighbouring motor regions 
project onto neighbouring regions of the STN. SMA supplementary motor area; pre-SMA 
pre-supplementary motor area; M1 primary motor cortex; CMAr rostral cingulate motor area, 
PMdc dorsal premotor area; PMvc; ventral premotor area; CMAc caudal cingulate motor 
area. 
42 
 
Based on the distribution of cortical afferents to the STN, it has been divided into a 
dorsolateral sensorimotor region, a ventromedial associative territory and a medial limbic 
territory (Parent and Hazrati, 1995; Haber, 2003; Levesque and Parent, 2005). Further sub-
parcellation can be made of the dorsolateral sensorimotor region, from the distinctive 
distribution of afferent projections from different parts of the motor system (see Figure 2). In 
addition, there has been recent evidence for histological inhomogeneities within the STN 
such as the relatively increased concentration of, likely GABAergic, interneurons in the 
limbic/associative segments of the STN (Levesque and Parent, 2005). 
STN projection cells have sparsely spined dendrites arborizing along the main axis of the 
nucleus (Sato et al., 2000). Their predominant projection targets are the SNr, GPi and GPe 
(Sato et al., 2000), although projections to the striatum, the cerebral cortex, the substantia 
innominata, the pedunculopontine tegmental nucleus, and the mesencephalic and pontine 
reticular formation have been described (Parent and Hazrati, 1995). A recent systematic 
review of direct STN connections in mammals identified 130 papers and summarized them 
in an ideogram, although equal prominence was given to anatomical tracing and human 
diffusion tract imaging data (Lambert et al., 2011). 
The role of the STN and the hyperdirect pathway remains uncertain, but its importance does 
not. It conveys cortical signals to the GPi/SNr faster than the direct and indirect pathways 
(Nambu et al., 2002; Nambu, 2008) and it has been implicated in inhibiting and changing 
motor plans (Aron et al., 2007a; Isoda and Hikosaka, 2008) and impulsive behaviour (Frank 
et al., 2007) and is the current most popular target for deep brain stimulation (DBS) in PD 
(Limousin et al., 1995; Rezai et al., 2008; Thevathasan and Gregory, 2010). 
  
1.3.2.3 Complex connectivity between the striatum, GPe and GPi/SNr  
Are the direct and indirect pathways clearly distinct? Recent studies in transgenic mice have 
confirmed that MSNs projecting to the SNr (the direct pathway) express only D1 receptors 
(Matamales et al., 2009; Bertran-Gonzalez et al., 2010), and are electrophysiologically 
different (Bertran-Gonzalez et al., 2010).  On the other hand, anatomical tracing studies 
have shown that the vast majority of MSNs projecting to the GPi/SNr also send collaterals to 
the GPe (Wu et al., 2000). The most parsimonious explanation is that MSNs expressing D2 
receptors project to the GPe only (the old indirect pathway) whereas MSNs expressing D1 
receptors send collateral projections to a combination of GPi/SNr and GPe. However this 
hypothesis requires confirmation by a combined transgenic neurochemical and anatomical 
tracing study (Bertran-Gonzalez et al., 2010). 
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More extensive study of the GPe connections reveals that, in addition to the STN, it projects 
directly to the GPi/SNr and the dopaminergic cells of the SNc (Smith et al., 1998; Bolam et 
al., 2000), and also sends reciprocal projections back to the striatum and to itself (Bevan et 
al., 1998; Kita, 2001; Miwa et al., 2001; Nambu, 2008). Its connections suggest that the GPe 
plays a central role in basal ganglia processing and possibly in basal ganglia pathology 
(Magill et al., 2001). 
 
1.3.2.4 The pedunculopontine nucleus 
Preliminary work has identified a set of sub-cortical structures that input into the striatum via 
the midline intralaminar complex of the thalamus. These include the superior and inferior 
colliculi, the pedunculopontine nucleus (PPN), cuneiform area, periaquaductal grey 
parabrachial complex and other medullary and pontine reticular nuclei (McHaffie et al., 
2005). Perhaps the best characterised of these are the interactions between the superior 
colliculus and basal ganglia – framed as a partially closed circuit, similar to cortico-basal 
ganglia circuits, between the colliculus, thalamus, striatum and GPi (McHaffie et al., 2005). 
However, we will focus on the cortical and basal ganglia connections to the PPN as this may 
be more clinically relevant for PD. 
The PPN, located at the junction between the midbrain and pons, is bounded laterally by the 
medial leminiscus and medially by the superior cerebellar decussation.  The caudal pole of 
the PPN lies adjacent to the locus coeruleus, the cuneiform and subcuneiform nuclei, whilst 
rostrally it is adjacent to the substantia nigra and retrorubral field (Pahapill, 2000). It is part of 
the reticular activating system and comprises cholinergic, glutamatergic and GABAergic cells 
(Wang and Morales, 2009).  As a reticular nucleus, it has relatively indistinct boundaries and 
debate exists as to whether the extent of the nucleus should be defined histologically or 
immunochemically. It was first described histologically by Olszewski and Baxter (Olszewski 
and Baxter, 1982), who divided the nuclei into two regions based on cholinergic cell density: 
the dorsolateral caudal pars compacta, and the rostral pars dissipata. However Mesulam et 
al. recognized that cholinergic neurons within the PPN were part of a larger group of 
cholinergic neurons termed the Ch5 complex. The Ch5 complex also neighbours the 
cholinergic Ch6 complex, and so it is difficult to be certain of the boundaries of the PPN if 
one relies on cholinergic cells alone (Mesulam et al., 1989). However, a broad rostro-caudal 
distinction of the nucleus can be made based on the distribution of all cell types, and also 
provides a basis on which to categorise the heterogeneous anatomical connectivity of the 
nucleus (Martinez-Gonzalez et al., 2011).  
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The basal ganglia interact prominently with the PPN. The GABAergic output neurons from 
the substantia nigra pars reticulata and GPi (Semba and Fibiger, 1992; Parent et al., 2001) 
input into the predominantly GABAergic rostral PPN. Efferents from this region lead back to 
the substantia nigra pars compacta and reticulata, to the GPi and also to the hypothalamus, 
suggesting that this region may have a prominent role modulating basal ganglia processes 
(Martinez-Gonzalez et al., 2011). The caudal PPN receives afferents from the cortex and 
dorsal raphe onto its predominantly cholinergic and glutamatergic neurons. The efferents are 
to the thalamus (Lavoie and Parent, 1994), STN (Hammond et al., 1983; Lavoie and Parent, 
1994; Parent and Hazrati, 1995), VTA and superior and inferior colliculi. This suggests that 
the caudal PPN is involved in regulating arousal via thalamocortical networks and 
importantly that the same network is responsible for descending projections to brainstem 
and spinal locomotion centres, and also to the STN (Martinez-Gonzalez et al., 2011). 
Cortical regions projecting to the caudal PPN include the auditory cortex (Schofield and 
Motts, 2009)(Schofield et al., 2010), the medial prefrontal cortex (Sesack et al., 1989), motor 
and premotor areas, the amygdala and the hypothalamus (Semba and Fibiger, 1992; 
Matsumura et al., 2000). The entire axis of the PPN receives afferents from the cerebellum 
(Hazrati and Parent, 1992). 
Evidence of a similar functional distinction is minimal in humans. Low frequency stimulation 
of the PPN region alters resting cortical glucose metabolism and cerebral blood flow in a 
large network of areas that include the orbitofrontal cortex, cingulate, prefrontal areas, 
temporal lobe, thalamus and cerebellum (Ballanger et al., 2009; Ceravolo et al., 2011). 
However, functional magnetic resonance imaging (fMRI) and positron emission tomography 
(PET) have insufficient spatial resolution to reliably discern different areas of the PPN region 
(Ballanger et al., 2009; Snijders et al., 2011). Direct recordings of local field potentials (LFPs) 
from intracranial electrodes afford excellent spatial and temporal resolution: Thevathasan et 
al. recently demonstrated that oscillatory synchrony is topographically organized in the PPN 
region (Thevathasan et al., 2011).  
 
1.3.3 Developing concepts of basal ganglia function 
Many theories have been put forward regarding the computational processing performed by 
the basal ganglia (Alexander et al., 1986; Mink, 1996; Redgrave et al., 1999, 2010; Bar-Gad 
et al., 2003; Haber, 2003; Nambu, 2008), however, all remain largely speculative.  A 
common theme is information selection by the striatum, and rather appealingly, the repeating 
modular nature of the basal ganglia suggests that similar computational processing in 
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different cortico-basal ganglia circuits (e.g. motor versus associative) may be similar 
(Alexander et al., 1986; Redgrave et al., 2010).   
The somatotropic and interneuronal organisation of the striatum ensure that cortical signals 
associated with movement cause localised activation of MSNs within the striatum (Bolam et 
al., 2000; Nambu, 2008). Activated MSNs then inhibit surrounding MSNs via lateral 
projections or via inhibitory interneurons.  The largest striatal interneurons are called 
tonically active neurons (TANs) due to their spontaneous 3-10Hz firing activity which is 
mainly due to their membrane properties.  TANs require only a small cortical input to 
influence their firing pattern (Bolam et al., 2000; Bar-Gad et al., 2003). The striatum also 
contains GABAergic fast-spiking interneurons that stain positive for the calcium-binding 
protein parvalbumin. Although only representing 3-5% of the striatal neuronal population, 
these cells are coupled together via gap junctions and have a greater spatial spread than 
lateral MSN projections and,  therefore potentially have a strong inhibitory effect on 
surrounding MSNs (Parthasarathy and Graybiel, 1997; Bolam et al., 2000; Bar-Gad et al., 
2003).  
The spatial focusing of competing motor programs is passed onto the thalamus via the direct 
pathway, ensuring that the tonic inhibition of the thalamus is only interrupted for desired 
motor programs whilst unwanted motor programs are suppressed (Mink, 1996; Nambu, 
2008).  A further refinement to this idea is that motor programs are also focused in time. This 
is achieved by prior, spatially broad excitation of the GPi/SNr via the faster STN hyperdirect 
pathway, and subsequent similar excitation by the slower indirect pathway (Mink, 1996; 
Nambu, 2008). More complex theories of the selection mechanism have been put forward 
including the suggestion that the cortical information is re-coded by the striatum and that this 
can be modelled as a dimensionality reduction similar to principal component analysis (Bar-
Gad et al., 2003). However, most current theories agree that the each cortico-basal ganglia 
circuit outputs a selected subset of the data it receives. 
But how do we combine data from different circuits, such as motivational and associative, to 
select an action? Recently, in addition to the integration within each circuit, theories have 
tried to understand the integration of information between separate cortico- basal ganglia 
circuits (Redgrave et al., 1999, 2010; Haber, 2003). Haber summarised two mechanisms by 
which such integration could take place based on non-human primate data (Haber, 2003). 
Spiral striato-nigral-striatal and thalamo-cortical-thalamic connections feed information from 
limbic circuits forward into associative and motor circuits. Thereby motor circuit activity, i.e. 
actions, could be influenced by motivational and cognitive circuitry (Haber, 2003). 
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1.3.4 The pattern model of movement disorders 
 
1.3.4.1 Limitations of the rate model and emergence of the pattern model  
While the rate model is seminal in our understanding of the basal ganglia, it fails to explain 
why functional neurosurgery is a successful treatment for PD (Marsden and Obeso, 1994; 
Brown and Eusebio, 2008). For example, destruction of the thalamus (thalamotomy) or GPi 
(pallidotomy) improved PD symptoms, but why does this not make movements worse 
(Marsden and Obeso, 1994)? The model suggests that these two lesions should obliterate 
basal ganglia output to the cortex completely. Alternatively, how does a pallidotomy, improve 
opposing symptoms such as akinesia and dyskinesias? Finally, the model suggests that 
lesioning the STN, should also improve symptoms of PD. However, although therapeutic 
high frequency DBS of the STN is very effective for PD, we are still unclear whether in fact 
its effect would be best modelled as a ‘virtual lesion’ or stimulation.  These and other 
paradoxes were first summarized by Marsden & Obeso in 1994 (Marsden and Obeso, 1994). 
One of their postulates was that, in addition to firing rate, firing pattern may also be important 
in basal ganglia function. Abnormal patterns could act as a ‘noisy’ signal and disrupt basal 
ganglia function. The appeal of this idea was that it allowed multiple functional or 
dysfunctional networks, characterised by their firing pattern, to occupy the same anatomical 
circuit. Different patterns could be potentially associated with different symptoms.  
In the same year, a landmark paper by Bergman et al. established the abnormal patterning 
of neuronal firing in the STN and pallidum in the 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP) treated primate model of PD (Bergman et al., 1994; Brown and Eusebio, 2008). 
Since then building evidence from human and animal studies suggests that abnormal 
patterning is a characteristic feature of Parkinsonian symptoms.  Abnormal patterning can be 
revealed by either recording neuronal firing simultaneously at different sites or by measuring 
the synchronised local extracellular activity within a region. This later activity is thought to 
represent summed local dendritic currents due to excitatory and inhibitory post-synaptic 
potentials. This activity, called a local field potential (LFP), characteristically oscillates and 
can be characterised in terms of the frequency of oscillation (Buzsaki and Draguhn, 2004). 
The latter are especially convenient to record in humans as they are accessible temporarily 
via implanted DBS electrodes immediately post-operatively. 
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1.3.4.2 Beta oscillations and their relation to movement, dopamine and 
DBS 
The clearest link between neuronal synchronisation and PD lies in the 10-30Hz range, often 
termed the beta range for convenience (Brown, 2007). Post-operative recordings in humans 
with PD have consistently shown that beta oscillations in LFPs are locally generated in 
multiple basal ganglia structures including the STN and GPi (Brown et al., 2001; Brown and 
Williams, 2005; Gatev et al., 2006; Hammond et al., 2007). Local spiking neuronal activity 
also oscillates in the beta frequency range (Levy et al., 2000) and, in the STN, seems to be 
tightly linked to LFPs  recorded from the same region (Kuhn et al., 2005; Weinberger et al., 
2006) but may underestimate the extent of synchrony at the population level (Schneidman et 
al., 2006). Animal data also show synchrony but at a lower frequency in primate models of 
PD (Hammond et al., 2007), and at similar frequencies in rat models (Sharott et al., 2005b). 
Further evidence, linking beta synchronisation to movement dynamics and dopaminergic 
levels, is suggestive that beta synchronisation may be an anti-kinetic signal (Hammond et 
al., 2007; Brown and Eusebio, 2008). Dopamine suppresses beta synchronisation in the 
STN (Priori et al., 2004) and the degree of suppression correlates with improvement in 
akinesia (Silberstein et al., 2005; Kuhn et al., 2006b). In addition, beta synchronisation, in 
the STN and GPi, decreases just before and during movement (Amirnovin et al., 2004; 
Brown, 2007). Such oscillatory phenomena are known as event related desynchronisations 
(ERDs) and the timing of the beta ERD correlates with reaction time (Kuhn et al., 2004; 
Williams et al., 2005). Because the beta ERD occurs before movement, it presumably 
reflects motor preparation, rather than mere sensory re-afference. This is also consistent 
with retained beta desynchronisation, but not re-synchronisation (ERS), when subjects are 
asked to imagine a movement but not execute it (Kuhn et al., 2006a). As well as affecting 
resting levels of beta, dopamine also modulates the beta ERD with movement, and this 
modulation is inversely correlated to motor impairment (Doyle et al., 2005).  
Deep brain stimulation of the STN inhibits local beta oscillations (Wingeier et al., 2006; 
Eusebio et al., 2010) but not necessarily in everyone, and the effect may be separate from 
that of dopamine (Giannicola et al., 2010).  Additionally, stimulation of the STN reduces beta 
synchronisation in the downstream GPi (Brown et al., 2004), consistent with the idea that 
beta activity may be pathological in PD.  
Finally, one may expect different territories within the STN to have different levels of beta 
synchronisation given that this signal seems to best correlate with motor impairment. Indeed 
most beta synchronisation occurs in the dorsolateral or ‘motor’ part of the STN (Kuhn et al., 
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2005; Alonso-Frech et al., 2006; Weinberger et al., 2006) and the spatial spread of this 
synchronisation correlates with akinesia (Pogosyan et al., 2010; Zaidel et al., 2010). 
Although there is ample correlative evidence for the role of beta synchronisation, causal 
evidence remains incomplete. Standard square-wave pulse stimulation of the STN at 10-20 
Hz does worsen bradykinesia (Timmermann et al., 2004; Chen et al., 2007; Eusebio et al., 
2008) but only by 5 – 10%. Brown and colleagues suggested reasons why this effect was so 
limited, including aspects of the stimulation parameters (clinical single pulse stimulation 
failing to mimic the endogenous bursting pattern of beta) and presumed ceiling effects on the 
endogenous presumably saturated beta synchronisation (Brown, 2007; Brown and Eusebio, 
2008). A further study by the same group, using cortical alternating current stimulation at 
20Hz (more similar to the natural oscillations occurring in the brain) found a consistent but 
similarly small effect on movement in healthy controls (Pogosyan et al., 2009). However, 
similar alternating current interference during a go/ no-go task reduced peak force and peak 
rate of force development by a dramatic 35% specifically during partially responded no-go 
trials (Joundi et al., 2012). Similar changes were not apparent with gamma stimulation, 
providing strong evidence for the role of beta oscillations in the inhibition of motor responses. 
 
1.3.4.3 Theta-alpha oscillations and their relation to dystonia and 
dyskinesias 
Several studies have also suggested that there is excessive synchronisation at less than 
10Hz, in the alpha-theta range, in the pallidal LFP of patients with dystonia (Liu et al., 2002; 
Silberstein et al., 2003). Activity in this range in the basal ganglia has been implicated in the 
integration of sensory and motor signals (Bland and Oddie, 2001; Gengler et al., 2005) in 
keeping with the proposed abnormal mechanism behind dystonia.  
One quirk of dystonia is that patients often have a ‘sensory trick’.  The act of touching a 
specific part of the body (usually near the dystonic muscle) somehow temporarily 
suppresses dystonic movements.  As predicted, the theta signal transiently abates during a 
sensory trick (Tang et al., 2007).  It also seems that the specific frequency characteristics of 
this signal are linked to activity in the dystonic muscle itself (Chen et al., 2006a), and that 
activity appears in the pallidum before the dystonic muscle, suggesting a driving role for the 
theta activity (Foncke et al., 2007). 
A similar correlation between levodopa-induced dyskinesias and theta activity in the local 
field potential has also been noted, suggesting that this abnormality may be common to 
conditions associated with excessive movements (Silberstein et al., 2003; Alonso-Frech et 
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al., 2006). After receiving dopaminergic medication, beta activity in the basal ganglia is 
suppressed in patients with Parkinson’s disease, but as patients’ dyskinesias supervene, 
activity in the theta range increases, as does that at frequencies of 60 to 95 Hz, a range 
called high gamma (Silberstein et al., 2003; Alonso-Frech et al., 2006). However, so far 
there is little evidence that stimulation of components of the basal ganglia at these 
frequencies causes dystonia or dyskinesias. 
 
1.3.5 Characterising cortico- basal ganglia circuit activity in humans with 
PD 
Although neuronal activity in individual regions of the basal ganglia circuit can be linked to 
symptoms in PD, it may be more informative to compare symptoms to the simultaneous 
activity in multiple regions.  In this way, individual variation in symptoms can be accounted 
for not only by the degree of pathology in one region, but also by the compensatory activity 
of other parts of the network.  Put another way, PD symptoms and treatment effects may be 
more accurately explained by emergent properties of cortico - basal ganglia connectivity. 
However, characterisation of these networks requires the simultaneous acquisition of 
temporally precise data from multiple points in the brain.  This is difficult and so far human 
research has relied upon indirect measures, such as blood oxygenation, or measured distant 
neuronal activity at the cost of poor spatial resolution (i.e. electroencephalography).  
Additionally, computational models based on this data have focused on modelling single 
cortico - basal ganglia networks, and have not considered the role of separate limbic, 
associative and motor circuits and their presumably different roles in symptom generation 
(Bar-Gad et al., 2003; Humphries et al., 2006). 
  
1.3.5.2 Functionally distinct circuits are spatially segregated 
A large body of evidence has built up linking the function of segregated basal ganglia circuits 
to their anatomical underpinnings. Regions within the ventral circuits are involved in reward-
based, addictive and re-inforcement behaviours (Schultz, 1997; Everitt et al., 2001; McClure 
et al., 2003; Knutson and Cooper, 2005; Delgado, 2007). Central regions have been 
implicated in set-shifting, response inhibition and working memory (Postle and D’Esposito, 
2003; Crottaz-Herbette et al., 2004; Garavan et al., 2006; Monchi et al., 2006), whilst 
dorsolateral regions have been implicated in movement (Kuhn et al., 2005; Alonso-Frech et 
al., 2006).  In fact a meta-analysis of 126 functional magnetic resonance imaging (fMRI) 
studies in which task subtractions revealed peak activations in the basal ganglia was in 
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keeping with this anatomically suggested structure (Postuma and Dagher, 2006). In addition, 
parietal cortex and insula seemed to be activated more often than predicted by anatomical 
models, and orbitofrontal cortex and anterior cingulate cortex less, but this could be due to 
task - specific bias.  
However, these studies focused on regional activation during task and medication conditions 
and did not explicitly characterise network activity in different circuits. The latter can be 
characterised by calculating functional connectivity, which is the degree of correlation 
between spatially distant neuronal activity (Friston et al., 1993). A greater degree of 
correlation implies ‘shared information’ between the two regions i.e. a functional connection. 
Di Martino et al. examined functional connectivity between the striatum and cortex in healthy 
controls at rest using fMRI (Di Martino et al., 2008).  The results were consistent with 
preceding anatomical data on the striatum in that, approximately, ventromedial striatum 
connected to the orbitofrontal area, the ‘central’ striatum with the dorsolateral prefrontal 
cortex and the dorsolateral striatum with motor areas. However, functional correlation 
suggested that there was much greater overlap and therefore integration between these 
circuits than previously thought. Dopamine strengthened connections from the putamen to 
the cerebellum and brainstem, and from the ventral striatum to the cingulate in healthy 
controls, but weakened connectivity between the caudate and a more widely distributed 
cortical network (Kelly et al., 2009).  In keeping with and extending these findings, patients 
with PD had reduced posterior putamenal connectivity to the cingulate cortex, postcentral 
gyrus, parietal operculum, prefrontal cortex and temporal area (Helmich et al., 2010). 
Interestingly, cortical connectivity to the anterior putamen actually increased (Helmich et al., 
2010).  
In summary, as well as confirming previous anatomical data regarding fronto-striatal 
connections, functional studies in humans also point to the importance of other areas such 
as the brainstem, temporal and parietal lobes. Although, these spatially defined functional 
circuits may provide a substrate for different features of motor and cognitive processes, they 
rely on indirect measures of neural activity, have poor temporal resolution, and struggle to 
characterise connectivity from small, but important, structures such as the STN.  
 
1.3.5.3 Cortico - basal ganglia circuits are frequency specific and 
dopamine sensitive 
An alternative approach is to characterise the functional connections underlying basal 
ganglia-cortical circuits in terms of the degree of neuronal synchronisation between spatially 
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distributed neuronal populations (Fries, 2005). The oscillatory LFP activity of two brain 
regions can be correlated by the degree to which they share a consistent phase relationship 
(Buzsaki and Draguhn, 2004; Fries, 2005). This measure, called coherence, assumes that 
the two regions are synchronised at a specific frequency (Fries, 2005). Recordings from PD 
patients undergoing surgery for DBS demonstrate prominent coherence between different 
components of the cortico - basal ganglia circuit (Brown et al., 2001; Williams et al., 2002; 
Fogelson et al., 2006; Lalo et al., 2008).  These studies have shown that PD patients have 
coherence between STN and GPi in the beta band, and that this is reduced with dopamine 
(Brown et al., 2001). Coherence between cortical EEG and STN or GPi is present in different 
frequency bands, is differentially distributed over the cortex depending on frequency, and 
has different responses to dopamine. Alpha-theta (2-10Hz) and beta (10-30Hz) band 
coherence are strongest and beta frequencies are predominantly midline (Williams et al., 
2002; Fogelson et al., 2006). The role of dopamine is less clear at these frequencies 
although there is some suggestion that it may increase gamma (70-85Hz) coherence 
(Williams et al., 2002; Lalo et al., 2008). Whether this coherence is pathological, remains 
unclear, although animal data suggests there may be abnormally increased coherence in PD 
(Sharott et al., 2005b; Mallet et al., 2008).  Electrical stimulation of the STN has suggested 
that cortico –basal ganglia loops may have resonant frequencies (Eusebio et al., 2009) 
leading to the intriguing hypothesis that the abnormally synchronised beta activity may be 
due to the failure of normal dopaminergic activity to suppress the system’s resonant 
properties. However, significant coherence at different frequencies may not necessarily 
occur only through this mechanism.  Recently it has been shown that theta-alpha coherence 
occurs between cortical EEG and the STN, and that this coherence correlates with the 
presence of dyskinesias and impulse control disorders associated with PD (Rodriguez-Oroz 
et al., 2011). Interestingly, this paper suggested that coherence in spatially different motor 
and associative-limbic circuits was related to dyskinetic and impulse control symptoms 
respectively. 
In summary the spectral range, and cortical and subcortical distributions, of synchronised 
neuronal activity may be promising criteria by which distinct cortico-basal ganglia circuits 
may be disambiguated: the hope being that distinct circuits would correspond to distinct 
symptoms in PD. However, a clear relationship between the spectral range and cortical 
distribution of basal ganglia-cortical connections has proven difficult to establish in the EEG 
studies made to date.  This is because scalp recording sites are necessarily very limited in 
peri-operative patients and the scalp topography of the EEG is deranged by the presence of 
burr-holes (Benar and Gotman, 2002; Oostenveld and Oostendorp, 2002). We use 
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simultaneous subcortical LFP and high-density MEG recordings to overcome this limitation 
(see section 2). 
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1.4 Quantifying cognitive functions: a psychological perspective  
To identify the moment-to-moment cortico-basal ganglia activity underlying symptoms we 
must have an appropriate dynamic measure of the symptoms.  This is easier for motor 
symptoms such as tremor (where we can use tremor amplitude and frequency) and even 
bradykinesia (where we can use reaction time as a surrogate), but more difficult for cognitive 
symptoms in PD such as slowness of thought processes (bradyphrenia) and changes to the 
way patients make decisions. In addition, day-to-day behavioural symptoms that patients 
complain of (such as difficulty preparing meals) require many mental processes in parallel, 
and as a consequence, a similar behavioural symptom may be caused by different patterns 
of neuronal dysfunction.  However, psychologists and motor control theorists have, over the 
last century, attempted to fractionate day-to-day behaviours into a hierarchical structure of 
simpler ‘cognitive’ and motor sub-components. 
From the time of Sherrington, evidence existed that actions (in this case spinal reflexes) 
were modulated by descending projections in the nervous system (Sherrington, 1925). This 
lead to the development of the idea that more complex actions could also be explained in 
terms of a system of hierarchical modulations, in order to achieve goals (e.g.(Craik, 1947)).  
‘Higher levels’ in such a system would represent the cognitive processes that would ‘control’ 
lower level motor actions. The theoretical structure of such a system was formalised by 
Logan and Cowan in 1984 (Logan and Cowan, 1984). It consisted of an executive system 
that formed the behavioural, goal-directed intention and issued commands, and a 
subordinate system, that interpreted and carried out the commands. Postulated acts of 
executive control could include remembering things, predicting future events and redirecting 
attention. However Logan and Cowan focused on dynamically measuring the ability to inhibit 
actions. They formalised this measure using the stop-signal experimental paradigm, which 
crucially does provide trial-to-trial variation in behaviour that can be used to interrogate the 
function of neuronal networks (Logan and Cowan, 1984). Therefore in order to understand 
the neuronal network dysfunction responsible for the cognitive symptoms of PD, we need to 
rely on intermediary psychological models of behaviour, rather than focus on the symptoms 
themselves. 
 
1.4.1 Response interference and inhibition 
The terms ‘inhibition’, ‘interference’ and ‘suppression’ have been used by many 
psychological theorists and cover a broad range of behaviours (Harnishfeger, 1995). 
Mentioned by prominent psychologists such as James and Luria (James, 1890; Luria, 1961), 
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the term inhibition has been used to refer to the inhibition of motor behaviours, the inhibition 
or suppression of urges and the inhibition of other thoughts. 
In this thesis, we restrict the term ‘inhibition’ to mean the last-minute prevention of a 
prepared motor act, or the replacement of such an act with something else. Early 
behavioural evidence suggested that inhibition and interference were a dissociable 
component of cognitive control during experimental paradigms such as the psychological 
refractory period (PRP) or dual-task paradigm (Welford, 1952). In this paradigm, subjects are 
asked to perform two separate responses to two closely presented stimuli. The reaction time 
for the second stimulus is consistently increased compared to the first (called interference), 
and this increase is greater if the stimuli are close together. However, if subjects were asked 
to replace the response to the first stimulus with a response to the second, the reaction time 
of the second response was relatively reduced. Therefore, inhibition of the first response 
allowed performance of the second to be quicker.  Pioneering studies experimented with 
response inhibition by using a stop-signal (Vince, 1948; Lappin and Eriksen, 1966), but 
these stop-signal tasks was eventually mathematically formalised by Logan and Cowan in 
1984 as a horse-race model (Logan and Cowan, 1984). 
 
1.4.1.1 The stop –signal paradigm 
Logan and Cowan aimed to design an experimental system where one could measure the 
length of time it took to inhibit an action or thought (Logan and Cowan, 1984).  By comparing 
such times between subjects and experiment types, one could also infer the relative difficulty 
of inhibiting different behaviours – tasks that were more difficult to control, would require a 
longer period of time to inhibit. However, such a measurement is not trivial because 
successful inhibition necessarily has no behavioural marker, and therefore a straightforward 
measurement of the ‘inhibition reaction time’ is not possible.  However, given certain 
assumptions, it is possible to infer this measurement in the following way using the stop-
signal paradigm. 
In the classic stop-signal task, subjects are asked to respond to an intermittent visual cue by 
pressing a button with their right hand, as quickly and accurately as possible. This part of the 
experiment is termed the primary task.  During a randomly selected minority of trials (usually 
25 - 30%), an audible tone is heard at a specified delay after the initial primary task cue. This 
tone, called the stop-signal, instructs the subjects to abort the primary task (i.e. withhold 
pressing the button) if possible.  It follows that the ability to successfully inhibit the primary 
task depends on two crucial factors.  Firstly, it depends on the reaction time of the primary 
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task, and secondly it depends on the delay between the primary task cue and the stop-signal 
(called the stop signal delay (SSD) or the stimulus onset asynchrony (SOA) – we shall use 
the later term).  By repeating the task many times at a fixed SOA, the experimenter could 
empirically determine the percentage (and therefore probability) of stop-signal trials where 
the primary task was executed (i.e. inhibition failed).  Then, by varying the SOA 
systematically, the probability of inhibition failure (equal to 1-probability of inhibition success) 
could be determined as a function of SOA. This function is sigmoidal and termed the 
inhibition function (see Figure 3). 
 
Figure 3: The inhibition function. The empirically determined probability of response (i.e. 
inhibition failure) on stop-signal trials as a function of SOA (termed stop-signal delay here) in 
ms is displayed for 3 subjects. For all subjects, as the SOA increases (and therefore the time 
between the stop-signal and response decreases), the probability of failure increases in a 
sigmoid. This sigmoid function is the basic, non-normalised ‘inhibition function’. Reprinted 
from Logan and Cowan (1984) with permission from the American Psychological 
Association. 
Additionally, by examining the reaction times  of stop-signal trials with a response (failed 
inhibition trials), they were able to determine that such trials terminated quicker than the 
average primary task reaction time, and that such trials lengthened if the SOA lengthened.  
To explain these findings, Logan and Cowan proposed the horse-race model of inhibition, 
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and under the assumptions of such a model, more substantial inferences could be made 
from the same data (Logan and Cowan, 1984). 
 
1.4.1.2 The horse-race model 
This models reaction time data from the stop-signal experiment as resulting from two 
competing behavioural processes. The primary task (in this case pressing a button in 
response to the visual cue) and the stopping process race against each other. The outcome 
is determined by the winner of the horse-race i.e. whichever process is the first to finish. This 
idea is consistent with the behavioural findings – e.g. a short SOA, would mean that the 
primary task had had less time to progress and was therefore more likely to be inhibited.  
Under the assumptions of the horse-race model, we need only two parameters (the primary 
task reaction time distribution, and the probability of inhibiting a response at a certain SOA) 
to estimate a third parameter – the stop-signal reaction time (SSRT). The stop-signal 
reaction time is a measure of the time it takes to successfully inhibit the primary task. Tasks 
with longer SSRTs are more difficult to control, hence SSRT was originally designed to be 
able to determine how difficult a task is to control. 
The horse-race model, and therefore the estimate of SSRT, depends on a number of key 
assumptions hinging on the fact that the stop and go processes are independent. 
The first assumption is that the primary task reaction time distribution is contextually 
independent of the stop-signal. In other words, the primary task reaction time distribution 
would be the same during a stop-signal trial, and during a trial without a stop-signal.  
A second assumption, in some forms of analysis, is that the SSRT is a fixed value without a 
distribution. This is merely for convenience. A fuller model, where SSRT is modelled as a 
Gaussian distribution, is approximated reasonably well with this simplification (Logan and 
Cowan, 1984). 
Thirdly it is assumed that the SSRT does not vary with varying SOA. In practice this 
assumption is threatened by the idea that go and stop processes may share limited neural 
resources (so interfere with each other). However the implications of this idea are that when 
the stop-signal occurs, it would divert resources away from primary task, and so stop signal-
respond reaction times should be longer than no-signal reaction times, which is not the case. 
Additionally the longer the stop-signal delay, the longer the interference of the primary task, 
and therefore longer the predicted RT of signal-respond trials. Again this is not the case as 
stop signal-respond reaction time estimates increase with SOA. 
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Finally, in some methods of analysis, it is assumed that subjects do not guess. When 
guessing, the subjects decide to respond or not at the start of the trial. In this case, the 
probability of stopping on no-signal trials should be around ~50% which is not the case. A 
more subtle version of this is if they guess only on a certain proportion of the trials.  In this 
case, the proportion of guesses is the same for no-signal and signal trials and so the primary 
task and stop-signal respond reaction time distributions will be noisier. One can see if this is 
the case as the lower bound of the inhibition function (see later) will not be zero, even if the 
stop signal is sufficiently early. A proportion of zero SOA trials will be guessed and therefore 
will have a response. 
 
1.4.1.4 Different methods to estimate SSRT 
The stop-signal task was initially performed with the SOA varying by a fixed interval between 
blocks. However, this allows the subject to predict the presence of a stop-signal. More recent 
experiments vary the SOA on a trial-by-trial basis to reduce the predictability of the timing 
and presence of a stop-signal.  In addition, the SOA is varied according to a tracking 
staircase which aims to keep the probability of responding correctly at around 50%. This has 
several advantages: it efficiently samples an equal number of stop-fail and stop-success 
trials, it automatically adjusts for differences in SSRT between subjects, and it increases the 
difficulty of the task in subjects that strategically wait for the stop-signal. Different methods of 
mathematically determining the SSRT have been proposed and tested against each other 
(Logan and Cowan, 1984; Band et al., 2003; Boehler et al., 2012; Congdon et al., 2012). 
Although relatively robust as a measure, certain methods may poorly estimate the SSRT in 
certain conditions.  
The principles underlying the relationship between the primary task reaction time distribution, 
the SOA and the SSRT are shown in Figure 4. 
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Figure 4: The horse-race model. The probability of response (y axis) is plotted against time 
(x axis). The response distribution of the primary task can be seen as a skewed distribution. 
Overlaid onto this are the events during stop-signal trials with a fixed SOA (termed SSD 
here). Given a fixed primary task reaction time distribution, a fixed SSD and a fixed SSRT, 
the likelihood of successfully stopping can be calculated. In practice, the first and second 
parameters are empirically measured so the third can be calculated. Reprinted from Logan 
and Cowan (1984) with permission from the American Psychological Association. 
  
 The mathematical formalisation of the above model is shown in Equation 1. 
 
   (  )   ∫  ( )   
     
  
 
Equation 1: Mathematical Formalisation of the horse-race model. Where T=the mean 
primary task reaction time; f(t) = the distribution of primary task reaction time; Pr = the 
probability of response; Pr (td) is the probability of response at given SSD (td); ts = stop signal 
reaction time (internal stopping process and ballistic phase of response). In this case a 
response is a failure to stop. 
 
For a given stop-signal delay, and primary task reaction time distribution, the probability of a 
response (i.e. failure to stop)  is the integral of the primary task distribution with respect to 
time, from –infinity to the time point when stop process finishes. Therefore ts + td is the time 
point at which the cumulative integral of the primary task reaction time distribution is equal to 
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Pr (td). Because we empirically know Pr (td) for a range of td, then this provides a range of 
SSRTs (ts) as a function of stop-signal delay. Alternatively, the SSRT is equivalent to the 
rank ordered primary task reaction time that corresponds to Pr (td). For example if Pr (td) 
=0.3, ts + td is equivalent to the 30th percentile quickest trial.  
The integral method (or quintile method) of SSRT calculation uses the probability of 
inhibition and primary task RT to calculate an SSRT value at each SOA. These values can 
be used to determine the relationship between SOA and SSRT, or more commonly 
averaged to obtain a single SSRT estimate. This method assumes no variance in SSRT and 
needs lots of data at each SOA to estimate this (Band et al., 2003).  
Alternatively, the average method assumes that the SOA is sampled around its mean (e.g. 
from a tracking algorithm, or because skews in the data have been corrected by discarding a 
proportion of trials). Therefore the SSRT is simply the average SOA subtracted from the 
primary task RT.  Recent trends have acknowledged the non-gaussianity of reaction time 
data and have used the median rather than the mean. This method requires less data to 
estimate the SSRT but provides only one parameter per inhibition function (Band et al., 
2003). 
Band et al. suggested that 30-50 trials were needed to reliably estimate SSRT using 
tracking, and 50-100 without using tracking (Band et al., 2003). A more recent study has 
suggested that the quintile method is more accurate still, because it does not assume central 
sampling and is able to use more of the data (Congdon et al., 2012).  
 
1.4.2 Factors modulating the stop-signal reaction time 
 
1.4.2.1 The effect of stimulus characteristics 
Converging evidence suggests that the overall the SSRT is relatively resistant to variations 
in stimulus characteristics (Verbruggen and Logan, 2009a). Conflicting data suggest that 
either visual cues produce faster primary task reaction times and faster SSRTs (by over 
100ms) than auditory cues (Cabel et al., 2000) or that they produce SSRTs close to that 
associated with auditory stop signals (Colonius and Arndt, 2001; Ozyurt et al., 2003). 
However, this may be because of stimulus intensity rather than stimulus modality. Morein-
Zamir and Kingstone found that mean saccadic SSRT was faster in trials with high intensity 
(SSRT=87ms) as opposed to low intensity (SSRT=110ms) visual stop-signals and 
additionally saccadic SSRT was faster in high intensity (SSRT=121ms) as opposed to low 
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intensity (SSRT=154ms) auditory stop-signals (Morein-Zamir and Kingstone, 2006). Hence 
apparent differences between auditory and visual stop signals may be due to confounding 
mismatch between the auditory and visual stimuli used. This is consistent with another 
recent study in which the SSRT was faster with an auditory rather than a visual stop-signal, 
but even faster for a louder stimulus (Van der Schoot et al., 2005). Primary task latencies are 
also faster to more intense stimuli (Reuter-Lorenz et al., 1991; Kingstone and Klein, 1993). 
 
Placement of the stop-signal in the visual field has also been investigated. Armstrong and 
Munoz found shorter SSRTs if the stimulus was presented to the fovea, rather than in the 
peripheral visual field, but Asrress and Carpenter found no difference between these 
conditions (Asrress and Carpenter, 2001). One study found that SSRTs were quicker if the 
stop-signal was presented in the right, rather than left, visual field (Van der Schoot et al., 
2003) but this has not been repeated. 
 
The visual context, and the presence of distracters may have a non-specific lengthening 
effect on the primary task reaction time and also sometimes the SSRT. Morein-Zamir and 
Kingstone found that providing a gap between the presentation of the fixation cue and the 
presentation of the go cue (visual or auditory) resulted in ~10ms increase in saccade latency 
but not SSRT (Morein-Zamir and Kingstone, 2006). Co-presenting incongruent distractor 
information at the time of the go signal increased in primary task reaction time and also 
SSRT (Kramer et al., 1994; Ridderinkhof et al., 1999) .  Some authors conceptualised this as 
focal inhibition (distractor processing) and global inhibition (stop-signal processing) 
(Ridderinkhof et al., 1999). Verbruggen et al. did find a dissociation between the effects of 
flankers on primary task reaction time and on SSRT: flankers non-specifically caused 
slowing down of primary task whereas SSRT lengthened only after neutral or incongruous 
flankers, suggesting that the interference occurs early during processing of the flanker signal 
(Verbruggen et al., 2004, 2006). 
 
1.4.2.2 The effect of response characteristics 
Stop signal reaction time estimates are remarkably similar (mean ~200ms) for different tasks 
such as typewriting and button pressing (Logan and Cowan, 1984) and reaching arm 
movements (Mirabella et al., 2006), although they are notably lower for saccadic 
countermanding (Hanes and Carpenter, 1999; Cabel et al., 2000). Saccades have shorter 
61 
 
SSRTs, possibly because the a visual stop-stimulus directly activates fixation neurons in the 
superior colliculus  (Munoz and Wurtz, 1993). In addition, hand movements have a larger 
ballistic component (the time after which, if the response is initiated, it cannot be stopped) 
and there is greater ambiguity of hand responses (eyes just have to maintain fixation). 
However the idea of a ballistic phase has recently been challenged because EMG of arm 
movements have detected partial responses, not just instantaneous stops (McGarry and 
Franks, 1997). However both saccadic and hand response inhibition can be modelled by a 
horse-race (Logan and Irwin, 2000). 
SSRTs estimates from stop-signal experiments are also roughly similar to SSRTs estimated 
from tasks requiring the stopping of on-going activity, such as continuous target pursuit 
(Morein-Zamir et al., 2004) speech with nonsense words (150-200ms) and saying single 
letters (Xue et al., 2008). Response side also does not affect SSRT: the SSRT to a centrally 
presented cue, is the same for left and right hand movements, regardless of faster right hand 
reaction time (Mirabella et al., 2006). However consistently crossing the side of visual stop 
and go signals with the required arm response results in an increased primary task reaction 
time and also increased SSRT (Mirabella et al., 2006). 
 
1.4.2.3 The effect of subject characteristics 
The primary task reaction time and SSRT is the same in men and women, although one 
study suggested that, in spite of this, the underlying neural correlates are different (Li et al., 
2006). Initial studies failed to reveal differences in performance between children and adults 
(e.g. (Band et al., 2000)), however, studies using larger sample sizes and tracking 
algorithms have found a statistically significant elevated  SSRT in younger children (e.g. 
(Williams et al., 1999; van den Wildenberg and van der Molen, 2004), even when accounting 
for the faster primary task reaction times (Ridderinkhof et al., 1999; Williams et al., 1999). 
The mean SSRT has been reported to be 305 ms in 6-8yr olds and 188 ms in adults in the 
same study, although the differences in SSRT are correlated with global reaction time 
changes (Ridderinkhof et al., 1999). There is weaker evidence that SSRT lengthens in older 
age (Williams et al., 1999) as compared to other psychological tasks (Kramer et al., 1994). 
The stop-signal task has also been studied in people with impulsive personality traits (Logan, 
1997; Stahl and Gibbons, 2007) and patients with obsessive-compulsive disorder 
(Chamberlain, 2006; Penades et al., 2007). Most consistently, SSRT is lengthened in 
children with attention deficit/hyperactivity disorder (ADHD) compared to control groups 
(Lijffijt and Kenemans, 2005). Adults with ADHD also show longer SSRTs compared to 
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control groups (e.g., (Aron and Dowson, 2003; Ossmann and Mulligan, 2003). The effects of 
Parkinson’s Disease on SSRT will be discussed in section 1.5.4. 
 
1.4.3 Modifications to the stop-signal task 
 
1.4.3.1 The stop-change task 
The stop-change task (also called the change-of-plan task) is very similar to the stop-signal 
task except that in response to the stop-signal (now called the change signal), the subject is 
required to make an alternate response. For example, on a trial where the primary 
instruction is to press a button with the left hand, if a change signal occurs on the trial, the 
subject is required to withhold the left button press and then press a button with the right 
hand. 
 
Here, it will be helpful to make a distinction between the task-switching paradigm, the 
Psychological Refractory Period PRP paradigm, and the stop-change paradigm. The first 
important difference is temporal overlap: task-switching tasks (Jersild, 1927) present one 
stimulus on each trial and require switching tasks between trials. The PRP paradigm, 
(Telford, 1931; Welford, 1952), the stop-signal paradigm (Vince, 1948; Lappin and Eriksen, 
1966; Logan and Cowan, 1984), and the stop-change paradigm (Logan and Burkell, 1986; 
Brown and Braver, 2005; Nachev et al., 2007), require response switching within a trial, as 
instructed by closely placed go and stop/change stimuli.  Furthermore, there is a crucial 
difference between the PRP paradigm and the stop-signal paradigm: when the first and 
second stimuli (go1 and go2 in the PRP paradigm, go and stop in the stop-signal paradigm) 
are closer together, the go2 reaction time is longer in the PRP task, whereas the SSRT is 
shorter. This is consistent with the idea that in the PRP paradigm, because both responses 
are needed, the processing of the first response interferes with processing of the second 
response. Therefore if the stimuli for response one and response two are close together, 
there is greater temporal overlap, greater interference and a longer reaction time for 
response two. This is in contrast to the stop-signal paradigm, where the stop-signal inhibits 
the first response. If the go and stop signals are close together, the primary task response is 
less prepared, easier to cancel and therefore the SSRT is shorter. Therefore the stop-signal 
task can be modelled as a horse-race between two independent (as opposed to interfering) 
processes.  
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Logan and Burkell studied the stop-change task, and found that behaviour on this task was 
concordant with the stop-signal task (i.e. a horse-race) rather than the PRP task (Logan and 
Burkell, 1986). This raises a couple of questions: firstly whether changing a response is a 
unitary act of control (rather than separate acts for stopping and switching) and secondly, if  
separate, do the stop and switch processes occur in parallel or in series. Verbruggen et al. 
used a stop-signal followed by a change signal with two varying SOAs (go signal to stop 
signal and stop signal to change signal) to attempt to dissect out whether the changing is a 
unitary act, or put another way whether the primary task is simply stopped by preparation of 
the secondary task (Verbruggen et al., 2008b). They found that their data were the most 
consistent with a model that required a three part go-stop-change process with essentially a 
serial (or a weighted parallel model, with most of the weight of processing occupied by the 
stopping process) order of processing. However, in order to do this, they a priori assumed 
that the subjects strategically deferred stopping until after they had seen the change signal – 
therefore they biased the conclusions of their paper towards favouring models with three 
separate go-stop-change functions (Verbruggen and Logan, 2008, 2009b; Verbruggen et al., 
2008a). In addition, they found that the SSRTs estimated with the stop-signal task were 
slightly shorter (206ms) than those estimated by the stop-change task (250ms), although 
SSRT was collapsed across SOAs and tracking was not used to ensure the data were 
centrally sampled.  Similarly another study found that the SSRT was longer during the stop-
change task, although changing required the use of a different effector (the foot) to going 
(De Jong et al., 1995). Therefore any differences between SSRT from stop-change and 
stop-signal trials remain equivocal. This lead to the idea that the response to the stop-signal 
was privileged: it was relatively fast, automatic and it did not need to share neural processing 
resources with ‘go’ processes (i.e. did not suffer from dual task interference) (Verbruggen 
and Logan, 2009b). 
 
If both stop-change and stop-signal tasks share a similar underlying inhibition process, then 
why is the stop-change task needed? Indeed very little recent research has been undertaken 
with the stop-change task. However there is always a measurable response in the stop-
change task. This has potential benefit in patient populations who may struggle with the task 
or who may have significant lapses of concentration. A lapse of concentration may 
inappropriately translate into successful response inhibition in the stop-signal task, whereas 
these trials could be excluded if the subject were to perform a stop-change task. 
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1.4.3.2 The LATER model 
Attempts to relate behaviour and neuronal activity lead to fuller models of response 
inhibition. Aside from debates about the differences between the stop-change and stop-
signal task, it was clear that both could be modelled as two (or possibly three in the stop-
change task) competing processes in a horse-race. This race model was implemented more 
fully as the linear rise to threshold (LATER) model (Hanes and Carpenter, 1999). The 
original horse-race model was restricted to modelling the finishing times of the primary task 
and the inhibition process i.e. their latencies, and not the processes themselves. It had no 
memory of what happened on the previous trial and could not explain trial-to-trial variation in 
the probability of responding. The LATER model explicitly models the go and stop processes 
as linear functions. Crucially, the rate of rise, and the starting point of these functions varies 
between trials in a stochastic manner and can be used to explain the effects of prior beliefs 
(such as an increase in the frequency of the stop-signal would result in an increased starting 
point). Additional models which have been used include variants of stochastic accumulator 
models which have been developed by signal detection theorists. These models have three 
parameters that define competing go and stop processes: the onset of accumulation, the 
rate of accumulation, and the threshold of accumulation (Ratcliff and Smith, 2004). Control 
signals such as errors, response conflict, and stop-signal expectancy vary these parameters 
and alter primary task reaction time. For example delaying the onset increases primary task 
reaction time without affecting accuracy whilst reducing the rate increases reaction time 
whilst reducing accuracy. 
 
1.4.4 Strategic adjustments in reaction time 
In addition to the time taken to stop or cancel a response (the SSRT) recent research has 
also investigated how subjects strategically vary their behaviour on the primary task, during 
the stop-signal paradigm. Intuitively subjects have to balance against speed (going) and 
caution (stopping). Reaction time variation of the primary task has been categorised into 
strategic change (a change prescribed before the stop-signal is presented) and reactive 
change (the change in the primary task reaction time after a stop-signal has been 
presented). Strategic changes are thought to be partly due to expectation of the stop-signal. 
Therefore subjects tend to slow on the first few trials of the paradigm, even if they are all go 
only trials (Verbruggen and Logan, 2009b) and also if stop signals occur more frequently 
(Logan and Burkell, 1986; Emeric et al., 2007). 
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The characterisation of reactive changes has been more variable. Studies have reported 
greater post stop-signal slowing after successfully inhibited trials (Emeric et al., 2007), after 
failed inhibition trials (Schachar et al., 2004), or after both (Rieger and Gauggel, 1999).  This 
variation is partially explained by Nelson et al, who found that slow fluctuation in primary task 
reaction time contaminated estimates of post stop-signal changes in reaction time (Nelson et 
al., 2010). Depending on the reaction time changes, different hypotheses have been put 
forward to explain them including conflict detection, error detection, surprise detection etc. 
 
Bisset et al evaluated five different theories for strategic changes in primary task reaction 
time during variants of the stop-signal task (Bissett and Logan, 2011). They corrected slow 
fluctuations in the reaction time data by subtracting the reaction time of the previous go only 
trial from the post stop-signal trial.  They found stop-signal slowing after both successful and 
unsuccessful stop trials and were thus able to reject theories based on error detection 
(slowing only after stop-fail trials) and response conflict (slowing greater on successful trials, 
as by definition, successfully stopped trials must have the highest conflict).  Additionally, they 
confirmed that post-stop-signal slowing is greater if the frequency of stop-signal trials is 
increased, arguing against the surprise theory (the rarer the event, the greater the change in 
reaction time). Their results were compatible with two hypotheses which were not mutually 
exclusive. Firstly that after seeing any stop-signal, the subject is more cautious – the goal 
priority hypothesis. Here the goal priority varies between going and stopping after each trial. 
Secondly they found post stop-slowing after a repeated go cue only, and more so if the 
subject had successfully stopped. This suggested that the previous go stimulus – stop 
stimulus mapping was still partially active and interfered with the next trial, a hypothesis they 
called the memory hypothesis.  Finally a separate experiment suggested that the difficulty of 
the task as measured by the probability of failure also increased post stop-signal slowing. 
However, this study also had limitations, in that the hypotheses tested were not mutually 
exclusive and were not tested in combination. For example although the data could not have 
been explained by either conflict or error detection alone, it can be explained by both 
theories used in combination together (Bissett and Logan, 2011; Yamaguchi et al., 2011).   
 
However consistently across studies, changing goals, or switching stimulus-response 
mappings have been implicated in explaining primary task reaction time behaviour in the 
stop-signal task (Verbruggen and Logan, 2008; Leotti and Wager, 2010). 
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1.5 The neural correlates of response inhibition 
The stop-signal task is able to isolate a measure, the SSRT that corresponds to the time it 
takes to stop an action. If SSRT is relatively constant across tasks, then this raises a 
question: are different actions inhibited by a similar brain network?  Many studies have tried 
to address this issue, but there are significant methodological limitations to most:  correlating 
brain activity with behaviour is not straightforward.  
 
1.5.1 Lesion studies 
First we will review some of the most convincing data, which is from human lesion studies.  
Early reports suggested that the damage to the frontal lobes may result in apathy or 
impulsive behaviour (Damasio et al., 1994).  However, using the stop-signal paradigm in 
patients with frontal lesions, Aron et al. found that lengthening of the SSRT correlated most 
strongly with damage to the pars opercularis region (roughly BA 44), also termed the right 
inferior frontal gyrus (Aron et al., 2003).  Rieger et al similarly found that, relative to 
orthopaedic controls, patients with right frontal and bilateral frontal lesions showed inhibitory 
deficits (Rieger et al., 2003). Interestingly, patients with cerebrovascular lesions in the basal 
ganglia were also significantly slower in inhibiting their responses. However, the study also 
highlights some of the difficulties in making inferences from lesion studies. Firstly the primary 
task reaction time was globally increased in subjects with any lesion, suggesting that to 
perform the stop-signal paradigm a subject recruits a large network of brain regions. If one of 
these regions is damaged, activity of ‘healthy’ regions may become abnormal to 
compensate, and therefore behaviour may best be explained as activity across a network of 
areas. However, lesion studies do provide data that a brain region is necessary to perform a 
particular function. 
 
Similarly, Nachev et al. used a change-of-plan task to detect an increase in SSRT in a single 
subject with a unilateral pre-SMA lesion. They then performed fMRI to show that the non-
damaged pre-SMA was active during the change-of-plan task (Nachev et al., 2007). 
Additionally studies in rats have shown that lesions to the orbitofrontal cortex, the 
dorsomedial striatum and the STN all lengthen SSRT (Eagle et al., 2008; Eagle and Baunez, 
2010). 
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Human lesion studies are opportunistic by their nature, and effects of lesion size and 
subsequent neuronal plasticity make the data difficult to generalise to healthy populations. 
However temporary ‘virtual lesions’ of cortical areas can be induced in healthy control 
subjects by the application of repeated transient magnetic fields, i.e. with trans-cranial 
magnetic stimulation (TMS). In fact TMS over the right inferior frontal cortex, but not over the 
medial frontal cortex, or parietal cortex, increased SSRT and error rate (Chambers et al., 
2006; Verbruggen et al., 2010) whereas TMS over the pre-SMA has been less consistent. 
Cai et al found an increased SSRT with TMS (Cai et al., 2012), whereas Verbruggen and 
colleagues did not (Verbruggen et al., 2010). 
 
1.5.2 Single-cell activity 
Further evidence has been obtained from single cell recordings in non-human primates 
performing the stop-signal task. Hanes et al. used a saccadic stop-signal paradigm to 
identify cells in the frontal eye field that generated signals sufficient to control gaze (Hanes et 
al., 1998). Similar signals were also later seen in the superior colliculus (Paré and Hanes, 
2003). However, neurons in the supplementary eye field (Ito et al., 2003; Emeric et al., 2008) 
and anterior cingulate cortex (Ito et al., 2003), that fire specifically during stopping, fire too 
late to be causal, and have been postulated to monitor performance or to reflect error 
signals.  
In contrast, Isoda et al used a change-of-plan paradigm to detect switch-specific signals in 
the pre-SMA that were early enough to be causal to changing plan (see Figure 5). 
Furthermore, stimulation of the pre-SMA replaced fast incorrect responses with correct 
slower responses (Isoda and Hikosaka, 2007).  The same authors found a similar 
relationship between switching actions and activity in the subthalamic nucleus (Isoda and 
Hikosaka, 2008), and postulate a medial frontal – basal ganglia – superior colliculus network 
mediating stopping (Hikosaka and Isoda, 2010).   
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Figure 5: Spiking neurons in the pre-supplementary motor area (pre-SMA) of a rhesus 
monkey during switching. Reprinted from Isoda and Hikosaka, (2007) with permission 
from Nature Publishing Group. The vertical axis is spiking density, whilst the horizontal axis 
is time. This figure shows the average response of ‘switch sensitive’ neurons in the pre-SMA 
during three trial types in a switch task. The responses are aligned to the initial cue which 
may or may not be associated with a valid switch cue. In ‘go’ trials where no switch is 
required (blue, labelled cue-nonswitch trial) no spiking response is seen. However, if the 
monkey successfully switches to a switch signal (red line) there is an increase in spiking. A 
similar delayed response is seen if the monkey is instructed to switch but fails (grey line). 
1.5.3 Human neurophysiology 
Aron and colleagues have used fMRI in humans to consistently reveal a relationship 
between increased right inferior frontal activity and shorter SSRT (Aron and Poldrack, 2006; 
Aron et al., 2007a) although not with SSRT and pre-SMA activity. 
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Figure 6: Brain networks activated during the stop-signal task. Reprinted from Aron and 
Poldrack, (2006) with permission from the Society of Neuroscience. Activations are 
highlighted in red-yellow (according to their t score – colourbar not shown) and overlayed on 
a template image of the brain. C: The StopInhibit-Go contrast shows the effect of the stop-
signal on brain activation, even though in this case, the stop-signal was not followed. 
Activated areas include the pre-SMA, anterior cingulate (acc), right inferior frontal cortex 
(IFC), parietal cortex and a diencephalic region the authors claim is the STN. It is clear that 
the spatial resolution is too poor to be sure that this is actually the STN, rather than a 
neighbouring nucleus. Furthermore, the most interesting contrast is E: Stopinhibit-
StopRespond. However this contrast shows less convincing activation than other contrasts 
and is confounded by a movement present in the StopRespond condition which is not 
present in the StopInhibit condition. Contrast D: StopRespond-null shows all brain areas 
activated during movement preparation and successful stopping, so inference about the role 
of any particular brain region is limited. PUT, putamen; ctx, cortex. 
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In 2006, Aron et al reported such a study (Aron and Poldrack, 2006). They used an auditory 
stop-signal that activated a wide cortical and subcortical network (see Figure 6). Cortical 
areas activated included bilateral auditory cortex, pre-SMA, anterior cingulate, parietal 
cortex, and bilateral orbital/insular cortex extending into the right inferior frontal gyrus. 
Subcortical structures included the thalamus, putamen, pallidum and STN - although it must 
be acknowledged that the resolution of fMRI is too poor to definitively demonstrate activity in 
the STN, and such activity may be related to a nearby structure such as the red nucleus or 
substantia nigra.  The critical contrast of interest here is between successful and failed stop 
trials – the neural correlate of stopping. However this contrast is difficult because of two 
reasons. Firstly because failed trials are thought to have slower motor preparation than 
successful ones (reaction time confound) and because failed trials contain a motor response 
(movement confound). After accounting for these confounds the authors found no significant 
areas modulating successful and unsuccessful trials. As a secondary measure, the authors 
proceeded to compare successful stopping with go trials (to discount the effects of motor 
preparation). They found that activity in the right IFG, pre-SMA, GP and STN distinguished 
between these two conditions. In addition, activity of STN correlated only with the rIFG only, 
and rIFG activity negatively correlated with SSRT (Aron and Poldrack, 2006).  Activity in the 
right IFG and pre-SMA also was consistently activated during the inhibition of nonsense 
words, single letters and right-handed key presses (Xue et al., 2008) although this study 
similarly suffered from confounds relating to reaction time and movement.  Separate studies 
have supported the notion that the right (rather than left) IFG modulates stopping behaviour 
regardless of the hand that was used (Konishi et al., 1999).  
Further fMRI studies have used the change task with high and low error rate conditions and 
found evidence of error monitoring in the anterior cingulate, pre-SMA , right dorso-lateral 
prefrontal cortex, parietal lobule and cerebellum, however it is unclear if the authors 
appropriately corrected for reaction time (Brown and Braver, 2005).  
Studies with scalp EEG have consistently shown that stop signals are associated with a 
negative positive (N2P3) potential roughly 200ms – 300ms after the stop signal (Kok et al., 
2004; Schmajuk et al., 2006; Dimoska and Johnstone, 2008). The positive component is 
delayed in unsuccessful trials and starts around ~250 ms after the stop-signal, just around 
the time of the stop stimulus – so it is unclear if this causally contributes to successful 
stopping, or is the consequence of it (Kok et al., 2004). On the other hand, Schmajuk et al 
found a larger right frontal N2 component in successful, as compared to unsuccessful, trials 
at around 200ms (Schmajuk et al., 2006). However, scalp EEG has relatively little localising 
power at the sensor-level. Swann et al looked at a unique cohort of 4 subjects with epilepsy 
who also had subdural electrocorticograph electrodes in place for the investigation of 
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seizures (Swann et al., 2009). Such electrodes provide high spatial and temporal fidelity of 
signals, although they are also not immune to the effects of volume conduction etc.  They 
used a conditional stop-signal, where the subject ignores the stop-signal in a proportion of 
trials to improve the control condition of their recordings. They found an increase of beta 
activity in successful trials in electrodes over the right IFG around 100 – 250ms after the stop 
signal. A follow-up study in a subject with both right IFG and pre-SMA electrodes revealed 
that the pre-SMA was active at a higher frequency and (in the gamma region), and earlier in 
the task prior to stopping than the right IFG (Swann et al., 2012). Although interesting both 
studies suffer from a number of confounds. Firstly, both studies are on a small cohort of 
epilepsy subjects in whom brain activity may not represent that of healthy controls and also 
the authors used standard electrophysiological techniques which are incapable of handing 
the reaction time and movement confounds highlighted earlier. 
 
1.5.4 Pathophysiology in Parkinson’s Disease 
Although the neural mechanisms underlying response inhibition are still unclear, converging 
evidence suggests that cortico-basal ganglia interactions play a key role. In particular 
connections between the pre-SMA and the STN or the right-IFG and STN may be 
particularly important. Parkinson’s Disease offers a human model where the effects of a 
dopaminergic lesion on these cortico-basal ganglia interactions can be studied. 
Patients with Parkinson’s Disease have longer reaction times on simple and more complex 
tasks (Cooper et al., 1994).The SSRT is reported to be longer in treated PD than 
orthopaedic controls, even if the slowing of the primary task reaction time is taken into 
account (Gauggel et al., 2004).  Obeso et al used a conditional stop-signal task, where some 
stop-signals are ignored (but still interfere with the primary task), as well as standard bedside 
frontal executive tests in order to study behaviour in PD (Obeso et al., 2011a).  PD patients 
had a longer SSRT, compared to age-matched controls, even after controlling for 
depression, primary task reaction time and global cognitive impairment. In addition PD 
subjects found it more difficult to ignore stop-signals if instructed – suggested to be a defect 
of conflict resolution in the PD group.  Surprisingly, there were no effects of dopamine on 
SSRT measurement (Obeso et al., 2011b).  However, all studies of the stop-signal task use 
standard methodology to determine the SSRT. This may not be appropriate in Parkinson’s 
patients because of the relatively high lapse rate and guessing rate of this cohort.  For 
example, lapses in concentration, where the subject does not make a response, would be 
categorised as successfully inhibited trials unless due care is taken with the analysis.  
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Patients with PD undergoing DBS also offer an opportunity to study the role of the STN in 
stopping. Van den Wildenberg et al established that STN-DBS improved both primary task 
reaction time and SSRT in patients with PD, although both effects were independent of each 
other (Van den Wildenberg et al., 2006). The relationship between dopamine and STN 
stimulation is less clear. Treated PD patients undergoing unilateral STN-DBS with ‘normal’ 
initial SSRTs found that their SSRTs increased with stimulation – but only if the left STN was 
stimulated (Ray et al., 2009).  However, another study in OFF patients found no side-
specificity – only if both STN-DBS electrodes were stimulated, was there a reduction in 
SSRT. They additionally found no difference between dorsal and ventral stimulation and no 
change to primary task reaction times with stimulation. Finally PD patients OFF medications 
did not tend to wait and showed less post-stop reaction time slowing (Mirabella et al., 2011).  
In addition, STN-DBS shows inconsistent effects across other measures of inhibition. STN 
stimulation improved random number generation, but caused more errors in a Stroop task. 
No change was detected with dual-task performance (Witt et al., 2004). Using a go-no-go 
task, Hershey et al reported more errors with ventral rather than dorsal stimulation of the 
STN (Hershey et al., 2010). This suggests that response inhibition in different tasks may not 
be mediated by the same neural structures, and that STN-stimulation may have different 
effects on these structures. 
So what is the STN doing in the stop-signal task? Ray et al studied PD performing the stop-
signal task in patients ON meds whilst recording STN activity from intracranial electrodes. 
They found that variability in primary task reaction time corresponded to variability of beta 
ERD onset and timing of the gamma peak. They also found a post stop-signal increase in 
beta, the onset of which correlated with SSRT between subjects (Ray et al., 2011). This is 
consistent with a similar increase in STN beta activity found after no-go trials in a go-no-go 
task (Kuhn et al., 2004). 
Attempts to assess functional connectivity of cortical structures with the STN during the stop-
signal paradigm are sparse.  Swann et al stimulated bilateral STN whilst recording EEG (ON 
meds) whilst doing stop-signal task. They found that stimulation shortened SSRT without 
significantly affecting primary task reaction time. Stimulation also increased right frontal theta 
around the time of the stop-signal and started to increase right/midline frontal and parietal 
beta at 200ms after the stop-signal task (Swann et al., 2012). 
  
73 
 
1.6 Summary and thesis objectives 
Parkinson’s Disease is a common neurodegenerative condition characterised by basal 
ganglia dysfunction due to progressive dopamine depletion (Lees et al., 2009). Although 
typically presenting with movement impairment, more recent attention has also focused on 
the non-motor symptoms of PD (Evans and Lees, 2004; Chaudhuri et al., 2006). Treatment 
strategies include dopamine replacement therapy, and more recently deep brain stimulation.  
There is considerable variation in symptoms and treatment response between PD patients 
and treatment side-effects can be dramatic and difficult to predict (Evans and Lees, 2004; 
Voon et al., 2008). Individualising treatment in such a patient group requires a better 
understanding of the pathophysiology of basal ganglia circuits and an ability to characterise 
these circuits in humans. Recent anatomical and functional studies have suggested that 
distinct, spatially segregated, basal ganglia circuits have distinct functions (Alexander et al., 
1986; Haber, 2003; Postuma and Dagher, 2006). An intuitive extension of this hypothesis is 
that distinct symptoms in PD may be due to dysfunction of distinct basal-ganglia circuits 
(Alexander et al., 1986; Haber, 2003; Redgrave et al., 2010). Such circuit activity has proven 
difficult to characterise in humans and so far studies have had to rely on indirect measures 
of neuronal activity, such as blood oxygenation, or have been limited by poor spatial 
resolution. This thesis aims to take advantage of recent research about the frequency-
specific nature of abnormal neuronal activity in PD (Brown, 2007), and recent 
methodological advances (Litvak et al., 2010) to characterise the function and dysfunction of 
cortico-basal ganglia circuits in humans with PD. We will focus on PD patients who are 
undergoing DBS as they often have the greatest need for individualised treatment, and also 
because they offer the opportunity to record neuronal activity directly from targets within the 
basal ganglia such as the subthalamic nucleus (STN). Cortical activity will be measured by 
simultaneous magnetoencephalography (MEG) allowing cortico-basal ganglia network 
activity to be characterised in terms of coherence - an electrophysiological measure of the 
correlation between two signals (Fries, 2005).  We will characterise these networks initially at 
rest to determine if they can be spectrally and spatially disambiguated. Then we will 
interrogate how activity in these networks relates to a cognitive process – response 
inhibition, abnormalities in which may contribute to cognitive symptoms in PD. 
The objectives of this thesis are:  
1) To develop a study model and methodology to measure cortico-basal ganglia 
connectivity, based on simultaneous magnetoencephalographic and basal - ganglia 
recordings in Parkinsonian patients. 
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2) To determine if the cortical and subcortical spatial distribution of cortical-basal ganglia 
connectivity is frequency and dopamine dependent at rest. 
3) To characterise the role and spectral signature of different cortical areas during the stop- 
signal task.  
4) To characterise how activity in cortico-basal ganglia circuits changes during the 
performance of the stop-signal paradigm, and how these changes relate to behaviour in PD 
patients.  
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2. Methods 
 
2.1 Subjects and Operative Procedure 
 
2.1.1 Subject baseline clinical and psychological data 
We studied healthy adults as well as patients with PD. The healthy control study was 
approved by the Imperial College Ethics committee, whilst all patient experiments were 
approved by the joint ethics committee of the National Hospital of Neurology and 
Neurosurgery and the University College London Institute of Neurology.  All subjects gave 
their written informed consent. In addition to experimental data, age, gender and 
handedness were also recorded for healthy control subjects. 
All patients studied were diagnosed with PD according the Queen Square Brain bank criteria 
(Gibb and Lees, 1988).  They had recently undergone surgical implantation of intracranial 
electrodes prior to DBS therapy for PD. After the initial implantation procedure, these 
patients have their electrodes externalised for a period of about a week, during which 
recordings can be made from the implanted DBS electrode.  We studied patients who had 
DBS targeted to either the STN or the PPNR. In both cases we studied subjects with 
unilateral and bilateral implants. We recorded the age, clinical symptoms, medications, 
handedness and length of disease of all patients.  
Prior to surgery, the motor impairments of all patients were evaluated using part III of the 
Unified Parkinson’s Disease Rating Scale (UPDRS) (Goetz et al., 2008) after omitting all 
dopaminergic medication overnight and then following administration of 200mg of levodopa. 
This motor score includes 14 items which assess axial function, gait, balance, rest tremor, 
bradykinesia, rigidity and postural tremor. The UPDRS scale is validated and correlates with 
disability (Goetz et al., 2008). Overnight omission of medication is regarded as a “practically 
defined OFF” state - although the prolonged half-life of some medications, especially 
dopaminergic agonists, means that a longer medication-free period would be required to 
provide a complete OFF.  However such periods of time are too uncomfortable for the 
majority of patients. 
Further clinical and psychological data were collected in various subsets of patients (see 
relevant chapters) and included the following.  
The Gait and Falls Questionnaire (GFQ, score/64) which assesses Parkinsonian gait 
disturbance including gait freezing, festination and falls. The Freezing of Gait Questionnaire 
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(FOGQ, score/24) and Falls Question (FallsQ, score/4) are components of GFQ (Giladi et 
al., 2000, 2009).  
Global cognitive and mental state were assessed at the bedside with the Addenbrookes 
Cognitive Examination-Revised (including mini-mental state examination, verbal and 
category fluency), Beck’s depression inventory (Beck et al., 1988) and forward and 
backward digit span. 
 
2.1.2 Surgical procedure 
The indications for STN surgery were PD with motor fluctuations and/or tremors that were 
inadequately controlled with medical therapies (see section 1.2.8 and also (Foltynie et al., 
2010)). The indications for PPNR surgery were PD with predominant levodopa-unresponsive 
gait impairment and/or falls due to either freezing or postural instability.  Gait freezing and 
postural instability are common features of PD, especially as the disease progresses (Giladi 
et al., 2001; Bloem et al., 2004). However, medication-resistant gait freezing may also be 
due to atypical pathologies (Factor, 2008; Jankovic, 2008). In the absence of a definitive test 
in life, we stress that the diagnosis of PD in the PPNR implanted cohort is presumptive.  
Subjects with STN and PPNR implants were studied in London and Oxford. The DBS 
electrode used was always model 3389 (Medtronic, Minneapolis, MN) with four platinum-
iridium cylindrical surfaces of diameter 1.27mm, length 1.5mm, and centre-to-centre 
separation 2mm. The contacts were numbered 0 (lowermost) to 3 (uppermost). In the STN 
the inferior contact would usually lie just below or in the inferior portion of the STN whilst the 
superior contact would lie usually in the superior portion or just above the STN in the zona 
incerta. Electrode locations in the PPNR were more variable (see section 4). 
Surgical targeting of the DBS electrode was based on preoperative stereotactic imaging 
(stereotactic proton density weighted magnetic resonance imaging (MRI) in London, and 
stereotactic computerised tomography (CT) fused with T2 weighted MRI in Oxford).  
The STN, especially its medial border was targeted by examining it on the axial image 
containing the largest diameter of the ipsilateral red nucleus (Hariz et al., 2003). The centre 
of the STN was identified in a plane zero to one millimetre behind the anterior border of the 
ipsilateral red nucleus (Bejjani et al., 2000). Calculations of Cartesian coordinates of the 
target point were performed on Framelink software (Medtronic, Minneapolis, MN).  A double 
oblique trajectory was planned on reconstructed three-dimensional images to avoid entry 
into sulci and ventricles (Zrinzo et al., 2009).  The PPNR was targeted medial to the 
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lemniscal system and lateral to the superior cerebellar peduncle and its decussation (Pereira 
et al., 2008; Zrinzo et al., 2008; Foltynie and Hariz, 2010).  
After implantation, electrodes were connected to an accessory kit, typically both connectors 
being tunnelled to the left temporoparietal area and externalised through the frontal region. 
No microelectrode recordings were made. The locations of the electrodes were confirmed 
with immediate post-operative stereotactic imaging. In London fast spin-echo T2 weighted 
2mm thick contiguous axial slices were acquired with the Leksell frame still in situ. One 
patient was unable to tolerate a post-operative MRI and underwent stereotactic CT scanning 
instead. In Oxford postoperative stereotactic CT was routinely used. 
 
2.2 Electrophysiological Data Acquisition 
 
2.2.1 Magnetoencephalography 
MEG aims to record the magnetic field generated by neuronal activity. In an MEG system, 
the subject’s head is placed inside a helmet-shaped dewar, in which a number of magnetic 
sensors, called superconducting quantum interference devices (SQUIDS) are set. MEG 
recordings were performed in London with the 275 channel CTF (VSM MedTech Ltd., 
Vancouver, Canada) or in Oxford with the 306 channel Neuromag (Elekta Neuromag Oy, 
Helsinki, Finland) systems. The London CTF system is shown in Figure 7. Magnetic activity 
recorded from the brain is orders of magnitude lower than background activity due to the 
Earth’s magnetic field, the movement of nearby metal objects (e.g. cars) and other forms of 
electrical activity (e.g. muscle activity and the heart beat). However, sources of noise are 
also much further away and therefore the differential between two neighbouring sensors 
provides a better estimate of brain activity: noise from far away sources will be the same on 
both channels and is therefore subtracted out, whereas for closer sources (including the 
brain), small differences in sensor position result in different estimates of brain activity by 
both sensors, and a larger differential signal. The two MEG systems differ in their 
arrangement of the squids. The CTF has axial gradiometers, where each SQUID is 
referenced to another directly above it. The Neuromag system has both unreferenced 
sensors (magnetometers) and SQUIDS arranged tangentially to the surface of the scalp – 
planar gradiometers. Therefore theoretically the same cortical source will have different 
predicted activity on the sensors of the two MEG systems: an important consideration during 
analyses combining data from both systems. However these differences can be addressed 
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by individualised head models (see source localisation) and with appropriate statistical 
modelling. 
 
Figure 7: The CTF MEG system in London. The subject sits in the chair and places their 
head inside the helmet-shaped dewar. 
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Unlike electroencephalography (EEG), the subject’s head is free to move a small amount 
with respect to the electrodes. Therefore the head location is tracked using three or four 
head coils, which are placed with reference to easily defined locations on the head, the 
fiducial markers. The fiducials are usually at the bridge of the nose (nasion) and 1cm anterior 
to the superior fold of the tragus of both ears (pre-auricular).   
 
2.2.2 Intracranial electrode recordings 
In PD patients, STN or PPNR electrode local field potentials (LFPs), both right and left first 
dorsal interosseus (FDI) electromyographic (EMG) signals and MEG data were acquired 
simultaneously. All non-MEG signals were referenced to the right or left mastoid and, due to 
safety and technical limitations, were acquired using different amplifiers. Over different 
experiments we used a Digitimer D360 amplifier (Digitimer Ltd, Hertfordshire, UK), a 
BrainAmp MR (Brain Products GmbH, Gilching, Germany), and the integrated EEG system 
available at both sites.   
 
2.3 Pre-processing 
The data were analysed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) and Fieldtrip 
(http://www.ru.nl/neuroimaging/fieldtrip/), (Litvak et al., 2011b; Oostenveld et al., 2011).  Raw 
data contains both signals of interest (i.e. neural signals) and signals in which we have no 
interest (e.g. muscle activity, head movement). Transformation of the raw data in order to 
emphasise data features of interest, and supress other features is known as pre-processing 
and is a crucial step before statistical analysis can be meaningfully performed. Different 
research questions require different pre-processing pipelines, however here we will review 
some of the basic elements, the order and specifics of which are detailed within the results 
chapters.  
 
2.3.1 Sampling rate 
Data were usually acquired at high sampling rates (600 – 2400Hz). Higher sampling rates 
allow examination of higher frequencies of neuronal activity, up to the nyquist limit (nyquist 
frequency limit = sampling rate / 2). However, they also increase data storage requirements 
and computation demands. The CTF MEG system we used automatically  filters the raw 
acquisition at the sampling rate/4. Because we were primarily interested in frequencies up to 
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100Hz, we later further downsampled the data to 300Hz, which is still well above the nyquist 
limit for that frequency of interest.  
 
2.3.1 Filtering 
The acquired data were hardware filtered during acquisition but also filtered during the pre-
processing pipeline. Filtering the data essentially removes frequency components that we 
are not interested in. During acquisition, high frequency components are removed from the 
data with a low-pass filter (cut off e.g. 600Hz). This is essential as signal activity above the 
nyquist limit can cause artefacts at lower frequencies, unless they are removed. At the same 
time, a high-pass filter (cut off e.g. 1Hz) removes low frequency fluctuations in the signal due 
to gradual build-up of electrical charge [Direct Current (DC) offset] which may saturate the 
recording equipment. During processing, filters are also used to remove unwanted noise 
from mains interference (notch-filters) and to pre-process data acquired with different 
acquisition parameters into a standard format.  For this step a Butterworth filter is often used, 
which is designed to give a maximally flat frequency profile of the retained frequencies.  
 
2.3.2 Artefact rejection 
The acquired raw LFP and MEG data are usually contaminated with artefacts. These include 
spikes (brief large magnitude deflections which revert to baseline), jumps (brief large 
magnitude deflections which do not revert to baseline), interference from ferromagnetic 
components, and muscle activity artefact.  Different pre-processing techniques have been 
used to remove different types of artefact – for example beamformers were used to remove 
ferromagnetic artefact. However, simple techniques such as thresholding can remove 
important artefacts. Here the time domain data are visualised and data larger than a certain 
value are marked as bad. After marking, depending on the type of subsequent analysis to be 
performed, either just the bad segment can be removed from the data, the whole trial 
containing the bad segment, or even a whole channel if it contains many bad segments.  A 
crucial step is determining the threshold at which to reject bad trials. Although this is usually 
done visually, this process can also be partially automated by standardising the signal 
(subtracting the mean of the signal and dividing by the standard deviation), and setting the 
threshold as a number of standard deviations – for example eight standard deviations. 
Artefacts can also be handled at a group level by using robust averaging. Robust averaging 
is a special case of the robust general linear model (Holland and Welsch, 1977; Wager et al., 
2005; Litvak et al., 2012a) . In this framework, outliers are down-weighted when computing 
81 
 
the average, making it possible to suppress artefacts restricted to narrow time and frequency 
ranges without rejecting whole trials. 
 
2.3.3 Frequency transformation 
Interesting data patterns can be recognised by simply examining variation of the magnetic 
field with respect to time. When such analysis is locked to an event (such as a visual 
stimulus) and averaged over a number of trials, the resulting waveform is referred to as an 
evoked response or event-related field (ERF).  An alternative method of analysis can be 
performed in the frequency- (rather than time-) domain and is termed an induced response. 
The latter is sensitive to variations in underlying neuronal oscillations that are not phase-
locked to the stimulus. In order to perform such analysis, the data must first be transformed 
into the frequency-domain. This is done by the Fourier Transformation (FT), which results in 
a complex number representing the phase and amplitude of the oscillatory component of the 
signal at each given frequency. 
 
 ( )   ∫  ( )           
 
  
 
Equation 2: Continuous Fourier Transform. The signal over time, s(t), is transformed into 
a complex number representation of its frequency component S(f) at a certain frequency f. In 
signal processing the discrete version of this transform is used.  
 
The FT can be evaluated over multiple frequencies, and each resulting complex output 
squared (i.e. the complex conjugate calculated) to result in a single value per frequency. 
This value, termed power essentially discards the phase information of the initial signal. The 
distribution of power over different frequencies is a standard way to visualise the spectral 
properties of a signal and is termed the autospectrum, or simply the power spectrum. 
However, the FT assumes that the signal is stationary. In practice, neural signals are rarely 
stationary over periods of more than a few seconds, and therefore the FT is usually done on 
short segments of data. The advantage here is that phase and amplitude estimates can be 
calculated as a function of time – so called time-frequency analysis. FT over shorter 
segments provides a greater sensitivity to variations in neuronal responses, but at the cost of 
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a more noisy estimation of the Fourier coefficients and a loss of frequency resolution.  
Multiple techniques have been developed to provide optimal time and frequency resolution, 
including the use of overlapping temporal windows and convolutions of the time-domain 
signal with canonical shapes (e.g. Hanning windows, wavelets, multitapers). We have 
tended to use multitapers, which allow for greater flexibility in terms of frequency and time 
resolution (Thomson, 1982).  
 
2.4 Connectivity Metrics 
In addition to studying the activity of a single brain region, we can also examine how distant 
brain regions are coupled together. Indeed some behaviours may be better modelled as an 
emergent property of the functional relations between brain regions, rather than by the 
specialised activity in one region (Friston, 2002). There are many techniques available that 
quantify the connectivity between two regions, but it is customary to divide them into three 
groups: anatomical connectivity, based on retrograde tracing studies in animals or diffusion 
tractography in humans, aims to understand the static synaptic organisation of brain circuits; 
functional connectivity, based on human EEG/MEG or fMRI measurements, aims to 
determine how similar two brain regions are in terms of their activity over time – the 
statistical dependence of two signals; and finally effective connectivity aims to determine the 
influence of one brain region over another over time (Friston et al., 2012). In this thesis we 
are concerned with the various forms of functional connectivity.  
 
2.4.1 Coherence 
Coupling between different regions is probably both a linear and nonlinear process, and 
many different measures of functional connectivity have been put forward – each focusing 
on particular similarities between different signals. However as a first step, we focus on a 
linear measure of coupling called coherence (Thatcher et al., 1986; Rappelsberger and 
Petsche, 1988; Shen et al., 1999; Buzsaki and Draguhn, 2004; Magill et al., 2006a). 
 
     
|   |
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Equation 3: Coherence. At a given frequency, the coherence, Cxy, between two signals x 
and y is calculated by dividing the square of the modulus of the cross spectrum of the two 
signals, Gxy, by the product of the autospectra of each signal (Gxx and Gyy).  
 
Coherence is a value bounded between 0 and 1 and quantifies any linear relationship 
between two time-invariant signals at a specific frequency.  It is the frequency-domain 
counterpart of a cross-correlation and statistically similar to a correlation coefficient.  The 
coherence value can also be thought of as the fraction of one signal that contributes to the 
other (although it does not suggest causation). As such it is theoretically normalised to 
isolated variations of power. This metric also forms the basis for the communication-through-
coherence (CTC) hypothesis (Fries, 2005). In this hypothesis, coherent oscillations play a 
role in communication between different brain regions and neurons can be differentially 
sensitive to inputs arriving at different phases of the local oscillation. 
 
2.4.2 Granger causality  
After establishing that two signals are linearly coupled, i.e. are coherent, the question then 
arises as to which signal temporally precedes the other– the so called directed functional 
connectivity (Friston et al., 2012). Again, different techniques have been proposed to assess 
directed functional connectivity between different brain regions. In this thesis, we focus on 
Granger based techniques. Granger causality determines whether activity in signal A is a 
better predictor for later activity in signal B, than just signal B itself - i.e. how much the 
information in one signal temporally precedes another (Granger, 1969).  Originally 
developed for relationships in the time domain, this technique has been extended to the 
frequency domain (Geweke, 1982) and also the time and frequency domains (Geweke, 
1984; Chen, 2006). The most parsimonious explanation for such a relationship between two 
coherent population activities is that the temporally leading population drives the lagging 
population. However, this may not be the only explanation. Driving may be direct or indirect, 
via one or more unrecorded structures, or activity in both recorded structures may be driven 
by a third unrecorded structure (Sharott et al., 2005a). Given this, we use the term ‘effective 
direction of coupling’ to describe a pattern of temporal relationships rather than a measure of 
direct coupling. Crucially this is distinct from effective connectivity, which relies on generative 
neuronal models and differential equations (Friston et al., 2012). Different mathematical 
formulations of Granger causality exist, including the Directed Transfer Function (Kaminski 
and Blinowska, 1991; Korzeniewska et al., 2003) and the Partial Directed Coherence 
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(Baccala and Sameshima, 2001), which are designed to account for activity from multiple 
recorded sources, and which have differential sensitivity to pre-processing manipulations 
such as filtering (Florin et al., 2010). 
 
2.5 Source localisation 
Traditionally EEG and MEG data are analysed with regard to the distribution of the recording 
sensors at the scalp. This ‘sensor-space’ analysis, however has limited localising power, and 
at best, can be used to say something like ‘electrodes placed over the temporal lobe show 
an evoked response at 150ms’. As a result, EEG analysis has traditionally focused on 
temporal differences of evoked responses, or magnitude differences at particular sensors. 
However, more recent computational algorithms have been developed to use all the channel 
data simultaneously, to localise the origin of the source. To understand the principles behind 
such approaches, it is useful to review the basis of the electromagnetic signal generated by 
the brain. 
 
2.5.1 The basis of the electromagnetic signal recorded by EEG and MEG 
Similar to direct recording of local field potentials (LFPs), MEG and EEG activity represents 
the summed activity of dendritic potentials. Considering a typical cortical pyramidal cell as an 
example, cells are aligned such that their dendrites extend radially outward. Thousands of 
other neurons synapse onto each pyramidal cell’s dendritic tree and the resulting excitatory 
and inhibitory post-synaptic potentials (EPSPs and IPSPs) cause a gradient and therefore 
flow of current along the dendrites towards the cell body. This flow of current inside the cell 
(primary current) causes compensatory currents to flow in the opposite direction outside the 
cell (secondary currents). The activity of a single cell is too small to be detected by distant 
MEG/EEG sensors, but if many cells and dendrites are aligned, in the way that cortical 
pyramidal cells are, these currents can summate over space and time to be detectable by 
sensors that do not have the spatial resolution to pick up cellular processes. Such summed 
activity is called a local field potential, or, on a still larger scale the EEG, and can be 
modelled as an equivalent current dipole (ECD) - a single point source with a location, an 
orientation (which probably corresponds to the predominant direction of the dendrites), and a 
magnitude.  
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2.5.2 The inverse problem and its solutions 
Understanding the pattern of activity one would expect to detect on the EEG/ MEG sensors, 
given a particular ECD, is called the forward problem. This can be relatively easily predicted 
using Maxwell’s equations. The accuracy of this process is less for EEG, because the 
pattern of electrical activity is determined to a large extent by the not precisely known 
conductivity profiles of  neuronal tissue, bone, CSF and skin, whereas this is not the case for 
MEG. In spite of this, given a realistic head model, with different tissue compartments 
modelled accurately, an adequate forward model can be generated for both EEG and MEG. 
However, the reverse is more difficult. Predicting the source, given the data at the MEG or 
EEG sensors, is called the inverse problem and is ill-posed, because it does not have a 
unique solution (i.e. multiple source combinations can result in a similar pattern of activity at 
the EEG/MEG sensors).  
Different methods have been developed to address this, each relying on different 
assumptions about the nature of the data. The simplest of these, called a ‘dipole fit’ simply 
minimises the difference between the predicted and observed sensor data by optimising the 
dipole parameters: location and orientation. However, it assumes that the number of sources 
is known a priori and that there are only a few sources in total. An alternative to this are 
distributed solutions (e.g. ‘minimum norm’) – here, a cortical mantle of sources and 
orientations are pre-specified, leaving only the activity (energy) at each source to be fit to the 
data. Since the number of cortical sources exceeds by far the number of sensors, additional 
constraints are necessary to determine the most plausible solution. Different constraints 
result in different method variants.  Distributed solutions require a high signal-to-noise ratio 
(e.g. an evoked response), otherwise can lead to broad activation patterns and can be very 
sensitive to artefacts. Given our dataset has high noise levels, due to ferromagnetic artefact 
from DBS leads, and an unknown number of sources, we used another technique – 
beamforming (Litvak et al., 2010). 
 
2.5.3 Beamformers 
Unlike dipole fitting and minimum norm methods, beamforming does not set out to explain all 
the data at all the sensors. Rather it aims to find the combination of sensors that best explain 
activity from a given source location and orientation, whilst suppressing interference from 
other sources in the data. Crucially, other sources are separated out, based on the fact that 
they have a differential variance over time. Hence beamformers assume that activity at 
different sources is not highly correlated. Mathematically, the beamforming method is based 
on a linear projection of sensor data using a spatial filter computed from the lead field of the 
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source of interest and either the data covariance (time domain) ) (Van Veen et al., 1997) or 
cross-spectral density matrix (frequency domain) (Gross et al., 2001). The beamformer 
equation is below. 
 
 
 ( )     ( )     ( ) ( )     ( )     ( ) 
Equation 4: The beamforming spatial filter. The beamformer weights [w] for a given brain 
location [r], are a function of the lead field of that location [H(r)] and the covariance matrix of 
[Cov] the sensor activity [x]. In addition, two constraints ensure that the activity on the source 
of interest is amplified with a gain of 1 [w(r)H(r) =1], and that other sources are blocked – i.e. 
we minimise the variance of the filter output (min[var(s)]). S=activity at region r estimated 
with beamforming.  
 
2.6 Statistical analysis 
 
2.6.1 General Linear Model as applied to images 
Statistical analysis was performed by using a general linear model (GLM) approach with 
Statistical Parametric Mapping (SPM) software (Litvak et al., 2011b).  SPM is a specialised 
Matlab toolbox that was originally designed to make inferences about regionally specific 
effects in the brain. However, the underlying principles can also be extended to make 
inferences about regionally specific effects in any 2 or 3 dimensional space, for example 
time-frequency images (Kilner and Friston, 2010).  
SPM employs a mass univariate approach to the statistical analysis of images: statistical 
questions are posed in terms of differences between sets of images (for example images 
from group A are different to those from group B) and then each voxel undergoes a separate 
standard statistical test (such as a t- or F- test) using the relevant voxel values from all 
images (Friston et al., 1994). The resulting image is a statistical parametric map – an image 
of values distributed under the t- or F distributions. These values are thresholded to provide 
appropriate false positive rates (usually p=0.05). Those voxels lying above the threshold can 
be inferred to lie in regions showing a significant effect.  Depending on the question of 
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interest, different design variants such as ANOVAs, regression analysis and t-tests may be 
specified, but all designs are simply instances of the GLM outlined below. 
        
Equation 5: The General Linear Model. See text for discussion. 
 
The data [Y], are modelled by predictor variables X. The predictor variables are optimally fit 
to the data by choosing scaling variables [ ] that minimise in a least squares fashion, the 
error [e]. Alternatively,    estimates can also be obtained from more a robust maximum 
likelihood estimating algorithm. The predictor variables can be used to code factors (i.e. 
grouping variables) or continuous regressors (parametric modulators) or both. The key 
assumption is that the error term [e] is identically and independently distributed. However, 
this latter assumption is usually untrue in repeated measures designs, or if the data are 
temporally correlated.  Therefore, methods to handle this non-sphericity of error have been 
established and include using a whitening matrix, to account for such correlations in the 
model (Worsley and Friston, 1995).  
 
The simplicity of this approach and much of its appeal lies in the fact that it is based on 
standard well-understood univariate tests. If a statistical test is performed at every voxel, 
then a large multiple comparisons problem ensues. Given that the activity at individual 
voxels is correlated, the voxels more closely resemble a continuous random field of values, 
rather than truly independent measurements. This spatial correlation can be measured by 
the smoothness of the data, and given a specified smoothness, the number of expected 
topological features such as peaks and clusters can be estimated using the Euler 
characteristic (Worsley and Evans, 1992).  Hence if the expected or ‘null’ distribution of 
peaks is known, then this can be used to threshold the statistical parametric map.  
 
2.6.2 Event-related convolution analysis 
In chapters 5 and 6 we develop and use a convolution model for analysing event-related 
MEG data. We explain the approach fully in the methods sections of those chapters as the 
motivation is intrinsically linked to the aims of the data analysis. Briefly, MEG data are 
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presented as a continuous vector (Y) over time. Individual experimental events are modelled 
as a brief (about 2s) window of activity triggered to their time of onset (X) and regressed 
against the data. In chapters 5 and 6, this approach is used in the frequency domain and the 
output provides an estimation of the induced response to each experimental event. 
 
2.7 Summary of Limitations 
In this section, we will briefly recapitulate the major methodological obstacles, which we will 
attempt to overcome in the following experimental chapters.  
 
2.7.1 Phenotypic variation and lesion effects 
Although in some senses PD is well-characterised neurodegenerative disorder, there 
remains considerable variation in the clinical presentation of PD. Some subjects have 
predominant tremor, some have predominant gait difficulty, and some rapidly progress to 
dementia. In addition, treatment response is variable to both medical therapies as well as 
DBS. Finally, for a brief period after the DBS operation, peri-electrode oedema causes a 
temporary pathological lesion of the target nucleus, which clinically improves the patient’s 
Parkinsonian symptoms. This so called ‘stun effect’ is variable (Lalo et al., 2008).  
In summary, many factors conspire to introduce additional functional variation in our 
subjects. Therefore when performing functional imaging analyses, as we do, we must take 
care to ensure that our inferences reflect the symptoms and treatment responses of the 
cohort of subjects that we have studied. Indeed, it may be optimal to explicitly model some of 
this clinical symptomatic variation in our imaging analyses. 
 
2.7.2 Variation in surgical practice and MEG systems 
We have recorded data from subjects in both London and Oxford.  In some situations, we 
have included data from both centres in the same analysis. When doing so it will be 
important to account for different subject selection, surgical targeting techniques, and MEG 
systems. The later may especially result in artefactual differences between subjects and 
must be carefully evaluated, ideally by comparing data from different centres to ensure 
consistency. 
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2.7.3 Artefacts in the MEG signal 
Performing MEG of subjects with intracranial ferromagnetic extension wires results in 
prominent electrode artefact at the sensor level. This artefact is worsened by involuntary 
movements such as the tremor and dyskinesias associated with PD. Together, these 
artefacts are extremely challenging to overcome, and may lead to greatly reduced sensitivity 
in our analysis, unless handled appropriately. However, as we demonstrate, the analyses 
can be adequately performed in the presence of artefacts. 
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3: Resting cortico-subthalamic nucleus connectivity in 
Parkinson’s Disease 
 
3.1 Introduction 
In this chapter, we sought to investigate the functional connections underlying cortico-
subthalamic circuits in terms of the degree of electrophysiological synchronisation between 
spatially distributed neuronal populations. This chapter has been adapted from a published 
article (Litvak, Jha et al., 2011a) with permission from Oxford University Press. 
Recordings from PD patients undergoing surgery for DBS demonstrate prominent oscillatory 
synchronisation between different levels of basal ganglia-cortical loops (Brown et al., 2001; 
Marsden et al., 2001; Williams et al., 2002; Fogelson et al., 2006; Kuhn et al., 2006b; Lalo et 
al., 2008) and suggest that the preferred frequencies of such activity may vary between 
different loops (Fogelson et al., 2006). This synchronisation, or coherence, between levels 
appears to be exaggerated in PD (Sharott et al., 2005b; Mallet et al., 2008) and may have 
significance for our understanding of brain function. Moreover, the different resonance 
characteristics of distinct loops might be useful in characterising these circuits (Eusebio et 
al., 2009), and may ultimately prove useful in predicting the clinical response to particular 
DBS parameters.  
However, a clear relationship between the spectral range and cortical distribution of basal 
ganglia-cortical connections has proven difficult to establish in the electroencephalographic 
(EEG) studies made to date.  This is because scalp recording sites are necessarily very 
limited in peri-operative patients and the scalp topography of the EEG is deranged by the 
presence of burr-holes (Benar and Gotman, 2002; Oostenveld and Oostendorp, 2002). On 
the other hand, analysing simultaneously recorded magnetoencephalographic (MEG) signals 
and intracranial local field potentials (LFPs) in patients following DBS surgery is hampered 
by the presence of high-amplitude artefacts in the MEG due to the presence of percutaneous 
extension wires made of stainless steel close to the MEG sensors. Previously, Litvak et al 
described these artefacts and showed that despite their presence, topographical mapping of 
coherence between bipolar LFP channels and the MEG sensors can disclose physiological 
patterns (Litvak et al., 2010). Furthermore, they demonstrated that beamforming effectively 
suppresses artefacts and thereby enables both localization of cortical sources coherent with 
the STN and the extraction of artefact-free virtual electrode data from these sources.  Here, 
by building on these methodological advances, we establish the detailed cortical topography 
of subthalamic-cortical loops in PD patients at rest, characterised by different frequencies of 
91 
 
oscillatory coupling and different effects of dopaminergic medication. The results support the 
notion of spatio-temporal segregation in these circuits. 
 
3.2 Methods 
 
3.2.1 Participants and surgery 
We studied 13 patients who had undergone STN DBS electrode implantation prior to DBS 
therapy for PD. All but one patient were implanted bilaterally. Four additional patients were 
entered into the study but were unable to complete the experimental protocol of paired on 
and off-drug recordings and were excluded from analysis. Clinical details are given in table 
1. All patients were diagnosed with PD according the Queen Square Brain bank criteria 
(Gibb and Lees, 1988). The indications, operative procedure, targeting and beneficial clinical 
effects of STN stimulation have been described previously [see chapters 1.2.8, 2.1.2 and 
(Foltynie et al., 2010)]. Prior to surgery the motor impairments of all patients were evaluated 
using part III of the Unified Parkinson’s Disease Rating Scale (UPDRS) after omitting all 
dopaminergic medication overnight, and following administration of 200mg of levodopa.  
Although electrodes were considered to lie within or abutting STN, we cannot assume that 
all contacts on each electrode shared this localisation; indeed, this would seem highly 
unlikely given the size and orientation of the nucleus in relation to electrode trajectory. Given 
this, and to avoid any selection bias, we analysed the coherence between cortex and all 
three bipolar electrode pairs, and considered these to lie in the STN region.  
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Case Age 
(years)/ 
Sex 
Disease 
duration 
(years) 
Predominant 
symptoms (in 
addition to 
akinesia)  
UPDRS 
ON/OFF 
medication 
Pre-operative medication 
(total daily dose) 
1 40/M 10 Gait impairment, 
tremor 
9/30 Stalevo 600mg  
Co-careldopa 687.5mg 
Pramipexole 5mg 
 
2 55/M 15 Tremor, gait 
freezing 
5/19 Co-beneldopa 1000mg  
Ropinirole16mg 
Selegiline10mg 
Amantadine100mg 
 
3 
 
45/F 8 Tremor 50/50 Ropinirole 27mg 
4 58/F 14 Gait freezing, 
pain, dyskinesias 
18/71 Pramipexole 4mg 
Stalevo 250mg 
 
5 51/M 9 Gait impairment, 
tremor 
21/49 Co-beneldopa modified 
release 375mg 
Co-beneldopa 562.5mg 
Rasagiline 1mg 
6 60/M 15 Dyskinesias, gait 
freezing 
10/56 Co-careldopa 1125mg 
Co-beneldopa 250mg 
Ropinirole 18mg 
Selegiline 10mg 
Amantadine 200mg 
7 54/M 8 Gait impairment, 
dyskinesias 
9/38 Cabergoline 4mg 
Entacapone 800mg 
Co-careldopa 1200mg 
Amantadine 300mg 
8 48/M 11 Gait freezing, 
tremor 
16/72 Rasagiline 1mg 
Co-careldopa 1250mg 
Entacapone 500mg 
9 61/M 9 Gait freezing, 
tremor 
5/28 Co-careldopa 1875mg 
Pramipexole 
500micrograms 
 
10 58/F 10 Dystonia, 16/55 Pramipexole 3mg 
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dyskinesias Stalevo 400mg 
Rasagiline 2mg 
Co-beneldopa 62.5mg as 
required 
11 52/M 12 Dystonia 10/35 Rotigotine 4mg  
Stalevo 950mg 
Rasagiline 1mg 
 
12 58/M 13 Gait freezing 25/43 Co-careldopa 1000mg 
Co-careldopa modified 
release 125mg 
Amantadine 400mg 
Co-beneldopa 125mg 
Entacapone 600mg 
Rasagiline 1mg 
 
13 57/M 17 Gait impairment, 
pain, dyskinesias 
14/54 Co-careldopa 1125mg 
Co-careldopa modified 
release 250mg 
Co-beneldopa 200mg 
Entacapone 1600mg 
Selegiline 10mg 
Amantadine 200mg 
Table 3: Clinical features of patient cohort. All patients received bilateral STN DBS 
electrodes except for case 3. Stalevo is a proprietary combination of levodopa, carbidopa 
and entacapone for which the dose of levodopa is given. The dose of pramipexole is given 
as a salt.  
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3.2.2 Simultaneous STN-LFP and MEG recordings 
Patients underwent simultaneous STN electrode LFP and 275 channel MEG (CTF/VSM 
MedTech, Vancouver, Canada) recording between 2-6 days post-operatively. The data were 
sampled at 2400 Hz and stored to disk. For subsequent off-line analysis the data were low-
pass filtered at 100 Hz and down-sampled to 300 Hz. Simultaneous to the MEG signal, the 
LFP, electro-oculographic (EOG) and electromyographic (EMG) signals were recorded using 
the integrated EEG system and high-pass filtered in hardware above 1 Hz to avoid 
saturation of the amplifiers due to DC offsets. Four intracranial LFP channels were recorded 
on each side, referenced to a cephalic reference (forehead for the first two patients, right 
mastoid for the rest). LFP recordings were converted off-line to a bipolar montage between 
adjacent contacts (3 bipolar channels per side) to limit the effects of volume conduction from 
distant sources. EMG was recorded from right and left first dorsal interosseous (FDI) 
muscles with a reference at the muscle tendon. 
Recordings were done twice. Once after omitting all dopaminergic medication overnight and 
once during the patient's usual medication regime, in an order counterbalanced across 
patients. Each recording involved rest blocks and task blocks in a randomised order. In this 
chapter, we will focus on data collected during the resting blocks which lasted 3 minutes 
each and were cued visually using Matlab (The Mathworks, Inc, Natick, MA) and a custom 
script based on the Cogent toolbox (http://www.vislab.ucl.ac.uk/cogent.php). During the rest 
block, the patient was asked to keep still, relax with their eyes open and focus on a fixation 
point. A neurologist was present in the magnetically shielded room during the experiment to 
monitor the patient’s well-being and performance of the task. 
 
3.2.3 Data pre-processing and beamformer approach to localisation of 
coherent sources 
The data were analysed using custom Matlab scripts based on SPM8 
(http://www.fil.ion.ucl.ac.uk/spm/) and Fieldtrip (http://www.ru.nl/neuroimaging/fieldtrip/) 
toolboxes.  The continuous resting recording was divided into arbitrary epochs with duration 
of 3.41 sec (1024 samples). In all but the first subject head position was recorded 
continuously during the rest recording. After the data were epoched, trials with greater than 
1cm head displacement (compared to the mean) were rejected.  All subjects had at least 
48/52 acceptable trials apart from one (31/52 trials).  In the first subject, trial-rejection based 
on head location was omitted but this subject was relatively young and was able to keep 
quite still. The data were high-pass filtered above 1 Hz and the line noise artefacts at 50 Hz 
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and 100 Hz were removed using notch filters (5th order zero-phase Butterworth filters). 
Trials with artefacts in the LFP recording were rejected by thresholding the peak-to-peak 
LFP amplitude at 100 µV.  
Coherence was the principal measure of functional connectivity used in this study. It 
provides a frequency-domain measure of the linear phase and amplitude relationships 
between signals (Thatcher et al., 1986; Rappelsberger and Petsche, 1988; Shen et al., 
1999; Buzsaki and Draguhn, 2004; Magill et al., 2006a). Cortical sources coherent with STN-
LFP activity were located using the Dynamic Imaging of Coherent Sources (DICS) 
beamforming method (Gross et al., 2001). To begin with, all MEG and bipolar STN-LFP 
channel trial data were converted to the frequency domain (range 5 to 45 Hz with frequency 
resolution of 2.5 Hz) using the multitaper method (Thomson, 1982). Coherence can then be 
calculated at the sensor level between each STN-LFP channel and each MEG channel or, 
using beamforming, coherence can be calculated between each STN-LFP channel and a 3 
dimensional grid of points representing potential sources within the brain (Gross et al., 
2001).  We used the former approach to define frequency bands of significant coherence 
within each patient (see below) and the latter to locate coherent cortical sources spatially.   
The beamforming method is based on the linear projection of sensor data using a spatial 
filter computed from the lead field of the source of interest and either the data covariance 
(time domain) (Van Veen et al., 1997) or cross-spectral density matrix (frequency domain) 
(Gross et al., 2001). Lead fields were computed using a single-shell head model (Nolte et al., 
2004) based on an inner skull mesh derived by inverse-normalizing a canonical mesh to the 
subject's individual pre-operative MRI  image (Mattout et al., 2007). Co-registration between 
the MRI and MEG coordinate systems used 3 fiducial points: nasion, left and right pre-
auricular. The coherence values were computed on a 3 dimensional grid in MNI space with 
spacing of 5 mm bounded by the inner skull surface.  Values at the grid points were then 
linearly interpolated to produce volumetric images with 2 mm resolution. These images were 
further smoothed with an 8 mm isotropic Gaussian kernel. 
 
3.2.4 Characterisation of coherent sources within a single patient 
Single-subject analyses were designed to ensure that cortical–STN coherence was 
spectrally and spatially restricted within each patient, before group analysis.  Coherence was 
computed at the sensor level between each bipolar STN-LFP and all MEG channels 
between 5-45 Hz (low frequency) with 2.5 Hz resolution and between 60-90 Hz (high 
frequency) with 7.5 Hz resolution. Scalp maps of coherence for each frequency bin were 
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linearly interpolated to produce a 2D image (64 x 64 pixels). The resulting images were 
stacked to produce a 3D image with two spatial and one frequency dimension (Kilner & 
Friston 2010). This resulted in separate images for high and low frequency. To determine 
significant regions within this image it was compared with null (surrogate) data in which any 
coherence was destroyed. Ten surrogate coherence images were generated from the same 
MEG data but with the order of STN-LFP trials shuffled. The original and surrogate images 
were smoothed with a Gaussian kernel (a 10 mm x 10mm x 2.5 Hz for the lower frequencies, 
10 mm x 10mm x 7.5 Hz for the higher frequencies to ensure conformance to the 
assumptions of Random Field Theory) and subjected to a two-sample t-test, using standard 
Statistical Parametric Mapping (SPM) procedures. The SPMs were thresholded at p<0.01 
(family-wise error corrected) to identify significant regions in sensor space and frequency. 
For each STN-LFP, this provided frequency ranges where there was significant sensor level 
coherence over channels. These frequency ranges were entered into a DICS beamformer 
and the global maximum of the resulting DICS image was defined as the location of the 
cortical source coherent with the STN. Crucially, the significance of this source is established 
by the SPM analysis. This is because the significant (frequency-specific) coherence, seen in 
the sensors, has to be caused by sources. The orientation of the cortical source was defined 
as the normalized imaginary part of the cross-spectral density vector between STN-LFP and 
the three orientations of MEG source, located at the grid point closest to the optimal location. 
Typically orientation is defined by the direction of maximum power (Gross et al., 2001).  We 
chose the imaginary part (i.e. non-zero lag) to specifically focus on physiological signals 
transmitted with delay between the STN and the cortex (Nolte et al., 2004) assuring 
additional immunity from the artefact.  
 
A DICS beamformer image always has a global maximum even in cases of meaningless or 
erroneous localization. Therefore, we performed supplementary analyses to verify the 
internal consistency of the implicit source localisation. The idea was to generate a simulated 
coherence pattern that would be expected from the localized source and compare it with the 
original coherence pattern. The observed coherence pattern is determined by the location 
and orientation of the generating source as well as by the signal-to-noise ratios at different 
MEG channels or, in other words, by other cortical sources and artefacts. In our case, large 
metal artefacts might distort the observed coherence patterns, relative to what would be 
expected on the basis of source lead field alone. We therefore combined the simulated data 
with the original data to make the simulation as realistic as possible. STN-LFP data and the 
corresponding extracted source data were shifted by one trial with respect to the original 
data. The source data were then projected through the source lead field and added to the 
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original (non-shifted data) to create simulated MEG data. We then computed the coherence 
between the shifted STN-LFP and the simulated MEG. Shifting eliminated the coherence 
between STN-LFP and the original MEG. Thus the coherence between shifted STN-LFP and 
simulated MEG was solely due to the simulated component of the MEG. However, the 
artefacts and non-coherent brain sources were the same as in the original data. The 
simulated and original coherence topographies for all sources were inspected.  In the case 
of any discrepancy (on visual inspection), sources were excluded from further analysis. 
 
3.2.5 Characterisation of effect of dopaminergic medication and 
frequency on coherence topography across patients 
The aim of this analysis was to determine if the topography of cortico-subthalamic coherence 
was frequency and medication dependent. To allow group comparison of data, DICS images 
were generated at fixed frequency bands in the alpha (7-13 Hz) and beta (15-35 Hz) ranges 
in all patients using each of the bipolar STN-LFP channels as a reference. Unthresholded 
Individual images were normalised by dividing the coherence value at each beamformer grid 
point by the mean value of that image. This potentially removes confounds related to 
nuisance variations in signal-to-noise ratio such as variable head distance from MEG coils. 
However, it also constrains the analysis to distinguish changes in topography (not absolute 
values). Images were smoothed as described previously. To account for the predominantly 
asymmetric nature of the disease and to increase our sample size, each STN was treated as 
a separate subject. Half of the resulting images (all left STN) were reflected across the 
median sagittal plane to allow comparison of ipsilateral and contralateral sources to the STN 
regardless of original STN side. These images were then subjected to a fixed-effect 2x2 
factorial ANOVA, with frequency and medication as factors in SPM. The main effects of 
frequency and medication were estimated with an F-contrast whilst post-hoc one-tailed t-
contrasts were used to determine the direction of significant effects and to generate 
frequency-specific search volumes, within which to search for a simple main effect of 
medication at a particular frequency. All analyses were corrected for multiple comparisons 
within the search volume (using random field theory) and thresholded at p<0.01. 
Peak voxels resulting from group-level SPMs underwent further exploratory analysis for 
directionality, local power and correlation with clinical features. First, we performed 
extraction of the time-series (virtual electrode) data using a linearly constrained minimum 
variance (LCMV) beamformer (Van Veen et al., 1997) and 0.01% regularization. The 
covariance matrices for beamforming were computed based on the epoched data and the 
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position and orientation of the source was as defined above.  Source and STN-LFP power 
estimates are presented as the mean across all STN bipolar contacts and patients. 
Directionality: Coherence per se gives no information about the direction of coupling 
between synchronized populations of neurons, i.e. which population activity leads in time. 
The most parsimonious explanation for such a relationship between two coherent population 
activities is that the leading population drives the lagging population. However, this may not 
be the only explanation for such a relationship, and driving may be direct or indirect, via one 
or more unrecorded structures, or activity in both recorded structures may be driven by a 
third unrecorded structure (Sharott et al., 2005a). Finally, most connections in the brain are 
bidirectional (reciprocal), which means the concept of a driving population is a category 
error. Given this, we use the term ‘effective direction of coupling’ (distinct from effective 
connectivity (Friston et al., 2012)) to describe a pattern of temporal relationships rather than 
a measure of coupling. We characterised this using partial directed coherence or PDC 
(Baccala and Sameshima, 2001). Previous studies (Cassidy et al., 2002; Sharott et al., 
2005b; Lalo et al., 2008) have used directed transfer function or DTF (Kaminski and 
Blinowska, 1991) which is another measure based (as with PDC) on the notion of Granger 
causality (Granger, 1969). Granger-based estimates have the advantage that, unlike phase 
estimates, there is no ambiguity in systems with bidirectional coupling, such as basal 
ganglia-cortical loops (Cassidy and Brown, 2003). We used PDC in the present study as this 
measure has been recently shown to be more robust to distortions resulting from filtering 
and downsampling of the data (Florin et al., 2010).  Where the PDC of coherent activity at 
two sites is asymmetrical, the ‘effective direction of coupling’ is said to predominate in one 
direction and coherent activity or activities in one population of neurons tend to lead in time 
(Sharott et al., 2005a).  Within each hemisphere and frequency band, we considered the 
STN-LFP with the largest coherence to give the best estimate of source activity and used 
this contact to calculate the PDC. We computed the PDC with the multivariate 
autoregressive modelling toolbox in SPM8. This relies on a Bayesian estimation algorithm 
described by Penny and Roberts (Penny and Roberts, 2002). PDC was computed for each 
trial in the original data and in surrogate data generated by shifting the STN-LFP by one trial 
with respect to the virtual electrode data above. Two-sample t-tests were then performed 
between the original and surrogate PDC estimates averaged over the frequency range of 
interest for each direction. If both t-tests were significant (p<0.05) the connection was 
categorised as, “bidirectional”. Chi-squared tests were used to determine significant variation 
in the proportional distribution of directionality estimates in different frequency bands and 
medication states. 
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Correlation with clinical features: To explore whether motor function correlated with activity in 
any of the circuits identified, we correlated three pre-operatively determined clinical scores 
with cortico-subthalamic coherence and log cortical power. The clinical scores were the total 
Unified Parkinson’s Disease Rating Score (UPDRS) part III score, a hemi-body akinesia and 
rigidity (Hammond et al., 2007) score (sum of items 22-26 of the UPDRS part III) and a 
hemi-body tremor score (sum of items 20-21 of the UPDRS part III).  Correlations with 
symptom severity were assessed with data collected when patients were withdrawn from 
their medication overnight. The motor UPRDS was tested in this practically defined off state 
(so that patients had their last antiparkinsonian medication 9 -12 hours prior to testing).  The 
effect of dopamine was assessed by correlating the change in clinical variables after 
dopamine with the change in electrophysiological variables. Spearman’s rho was used for all 
correlations and correction for multiple comparisons was performed by a Bonferroni 
correction, set to an alpha of 0.05. It should be noted that patients studied post-operatively 
often have a temporary amelioration of their Parkinsonism due to a ‘stun’ or ‘microlesional 
effect. This was not quantified in the present study. 
To ensure that significant medication effects on coherence were not merely due to 
confounding local changes in cortical power we also correlated change in cortico-
subthalamic coherence after dopaminergic medication with change in local cortical power, 
for each source. 
 
3.3 Results 
 
3.3.1 Clinical features 
Clinical details are presented in Table 3. The mean age of this cohort was 53.6yrs, with a 
male: female sex ratio of 3.3:1. All patients responded to levodopa (mean UPDRS score off 
medication = 46, on medication = 16), except case 3 who was unable to tolerate the 
medication.  Although no subjects had active psychiatric symptoms during the time of the 
operation, patients 7 and 11 had previously reported symptoms of medication-induced 
hypersexuality and patient 5 had previously developed dopamine dysregulation syndrome.  
 
3.3.2 Contact location 
Out of 25 STNs, the most superior contact was located rostral to the STN in 6 hemispheres, 
rostral but near the superior border of the STN in 4 hemispheres, rostral and touching the 
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superior border of the STN in 6 hemispheres, medial to the superior STN in 7 hemispheres 
(five touching), touching the medial aspect of the middle anteromedial region in one 
hemisphere and inside the superior region in one hemisphere.  
The most inferior contact was usually located inside (8 hemispheres) or outside, but near (10 
hemispheres), the inferior STN. Two cases were medial and touching and one case lateral 
and touching the inferior STN. Two cases were touching the medial aspect of the middle 
posterolateral region and one case was inside this region. The final case was outside but 
medial to the centre of the STN. No contact was lateral to the STN. 
 
3.3.3 Individual patients display spectrally and spatially restricted 
sensor-level patterns of cortico-subthalamic coherence  
Sensor level coherence analysis identified significant areas of cortico-subthalamic 
coherence over neighbouring channels and frequency bins.  An example of coherence in the 
beta frequency range is given in Figure 8.  The frequency band over which coherence was 
significant was used to create a DICS image. The global maximum of the DICS image was 
registered onto the patient’s pre-operative MRI. Figure 8 demonstrates that in this individual, 
an ipsilateral cortical source was coherent with the left STN in the beta frequency range.  
Further analysis of this source with an LCMV beamformer identified the frequency at which 
there was maximal coherence and confirmed that maximal coherence was within the 
significant frequency range identified by the sensor-level SPM analysis.  
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Figure 8: Example analysis representing beta frequency coherence referenced to a 
bipolar left STN DBSE channel in one patient.  Scalp maps of coherence at each 
frequency bin were interpolated to a 2D grid (64x64 points) and stacked to produce an 
image with two spatial and one frequency dimension (top left images). Frequency bands with 
significant coherence were identified by shuffling STN-LFP data and performing t-tests with 
SPM (top right image). The significant frequency range (in this case 20.5-27.5 Hz) was used 
to create a DICS image, and the global maximum was plotted on the patient’s MRI (bottom 
left image, yellow circle is DICS maximum, and line represents orientation). An LCMV 
beamformer was used to extract the source activity at this location and the coherence 
between this and the STN bipolar channels was calculated across the entire frequency 
range (bottom right image: the significant range is represented by a solid blue line (other 
frequencies by a semi-transparent blue line). Anterior (A), posterior (P), left (L), right (R),  
frequency (F). Warmer colours correspond to increased cortico-subthalamic coherence.   
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3.3.4 Spatial location of cortical sources coherent with STN is consistent 
across patients  
In total, cortico-subthalamic coherence was estimated for 25 subthalamic nuclei from 13 
patients (one with a unilateral electrode). Each of the three STN bipolar channels (apart from 
one STN where only one bipolar channel was available due to an artefact in the other 
channels) was used as a reference to calculate the location and frequency range over which 
significant cortical coherence existed.  Although the frequency ranges spanned 5 – 90 Hz, 
none of the sources above 45 Hz had a scalp pattern typical of a focal cortical source. These 
high-frequency sources were therefore excluded from further analysis (see section 3.2 and 
Figure 9). It was also apparent that two DICS images from separate bipolar contacts within 
one STN could generate two spatially and spectrally similar cortical sources which were in 
fact slightly different estimations of the same cortical source. To counter this redundancy, we 
only included the maximally coherent source from each STN, if sources were within 15 mm 
and 3 Hz of each other. This resulted in a total of 68 cortically coherent sources in the alpha 
and beta ranges whilst patients were off their medication, and 67 sources whilst patients 
were on their medication (mean of 5.2 cortical sources per STN in each medication 
condition). In the off medication condition, nine patients had at least one alpha source, and 
11 patients had at least one beta source. In the on medication condition, 10 patients had 
alpha sources and 12 patients had beta sources. The peak frequency and spatial location of 
coherent cortico-subthalamic sources are displayed in Figure 10 and Figure 11. In the 
frequency range below 45 Hz, sources fell into two broad bands, which we will term the 
alpha band at 7-13 Hz and the beta band at 15-35 Hz. These ranges formed the basis of the 
fixed frequency bands used for group analysis.  Sources in the beta range clustered around 
medial motor/premotor areas ipsilateral to the STN, whilst alpha range sources clustered in 
bilateral temporoparietal regions, but with ipsilateral predominance. The peak coherences in 
the two bands were not (inversely) correlated within hemispheres (Figure 12), so that it is 
unlikely that the different spectral activities were mutually exclusive. 
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Figure 9: Topographical maps of coherence. Maps from a significant beta source (top 
row, A) and a significant gamma source (bottom row, B). The first image in each row is the 
original coherence scalp map (the black dots correspond to channel location), the second is 
the map of absolute values of the putative source lead field and the third is the simulated 
coherence plot (after adding in noise). The beta source shows a convincing relationship 
between the images whereas the gamma source shows no such characteristic pattern, and 
has a much smaller maximum coherence. 
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Figure 10: Frequency distribution of potential cortical sources. Thirteen patients (25 
STNs) recorded twice in PD patients with (ON) and without (OFF) dopaminergic medication 
(n=135).  We searched for coherent sources between 5-45 Hz and 60-90 Hz, although after 
subsequent visual lead field inspection we excluded sources above 45 Hz (see methods). 
Note that notch filters were used to remove line noise at 50 and 100 Hz. 
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Figure 11: The variation in location and peak frequency of significant cortical sources 
coherent in the 5-45 Hz frequency range. Results from 25 STNs. The images are ‘glass 
brains’ (inner boundary of skull marked with grey mesh) viewed from the above, right and 
front. All left STN sources are reflected across the middle sagittal plane to allow comparison 
of ipsilateral (right) and contralateral (left) sources.  Results are separately displayed for the 
ON (bottom row) and OFF (top row) medication conditions. The peak frequency of the 
coherence is represented by a colour scale where warmer colours reflect higher frequencies. 
Black squares have been used to represent the middle of the motor cortex (most posterior, 
lateral), supplementary motor area (SMA, medial), and pre-SMA (most anterior, medial). The 
distribution of sources remained remarkably similar in both drug conditions, in spite of the 
fact that these recordings were acquired on different days and undoubtedly with different 
confounding parameters (e.g. distance of head from the MEG sensors).   
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Figure 12: Independence of peak alpha and beta coherence within individual 
hemispheres. To ensure that the group analysis did not mask an individual tendency to 
have either ipsilateral alpha or ipsilateral beta coherence, but not both, we compared the 
peak beta coherence (premotor location) with peak alpha coherence (superior temporal 
gyrus, STG, location) within hemispheres. There was no significant correlation in either the 
OFF medication condition (Pearson’s r=0.09, p=0.66, see graph), or the ON medication 
condition (Pearson’s r= -0.08, p=0.70, not shown). 
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3.3.5 Topography of cortical activity coherent with STN activity is 
frequency dependent across patients 
We tested for the effect of frequency and dopaminergic medication on coherence by 
performing a group analysis. We computed DICS images with the standardised frequency 
bands (alpha 7-13 Hz and beta 15-35 Hz). All three bipolar images per STN were entered 
into a fixed-effect ANOVA with frequency and medication as factors. To address 
confounding issues, and allow a meaningful comparison between different frequencies (see 
methods) DICS images were normalised by dividing by the mean value over voxels. 
Consequently, we were comparing differences in the topography of cortico-subthalamic 
coherence. The mean of all the normalised DICS images revealed a temporoparietal and 
brainstem preponderance for alpha coherence and a supplementary motor area 
(SMA)/premotor preponderance for beta coherence (Figure 13). The main effect of 
frequency was highly significant across multiple brain regions (Figure 14). Regional 
coherence was greater in the beta band than the alpha band in a predominantly ipsilateral 
fronto-medial distribution. Conversely, regional coherence was greater in the alpha band in 
bilateral temporoparietal regions, with an ipsilateral predominance, and in the brainstem 
(SPM thresholded at t(1,264)=5.45, p=0.01 for display purposes). In addition, the mean 
absolute (non-normalised) coherence spectra were computed for virtual electrode data 
extracted for the peak voxel within each cluster using an LCMV beamformer. These 
coherence spectra (Figure 14, right) confirmed the group (normalised) analysis findings that 
beta coherence was higher in the premotor and prefrontal regions and alpha coherence 
higher in the temporoparietal regions and brainstem. 
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Figure 13: Mean of the normalised DICS images. Unthresholded alpha (blue) and beta 
(yellow) coherence superimposed is onto a T1 weighted canonical MRI. Coronal, sagittal 
and axial sections through the image are displayed, oriented to the image local maxima in 
the temporoparietal region (A, alpha, centred at global alpha peak) and the premotor/SMA 
region (B, beta, centred at global beta peak). The colour scale is coherence normalised to 
individual image global values (arbitrary units). A value greater than 1 unit means that the 
activity in that voxel is consistently greater than the mean across the image. 
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Figure 14: SPMs showing differences in the relative topography of alpha and beta 
band coherence between cortex and subthalamic region. [Top Row] Voxels where beta 
is significantly greater than alpha coherence normalised with respect to image mean. A local 
maxima was identified in the supplementary motor/premotor area (18 -6 58, F(1,264) = 192, 
p<0.001, red arrowhead). The mean absolute coherence spectrum for this voxel (labelled 
Beta Premotor) is shown on the right. [Bottom row]  Voxels where alpha was significantly 
greater than beta coherence normalised with respect to image mean. Local maxima were 
identified in the ipsilateral superior temporal gyrus (STG, 46 -30 -2, F(1,264)=119, p<0.001, 
red arrowhead), and brainstem (20 8 -44, F(1,264)=29, p=0.001) and also in the 
contralateral medial temporal gyrus (CMTG, -44 -54 4, F(1,264)=32, p<0.001) and inferior 
parietal lobule (CIPL, -54 -34 40, F(1,264)=25, p=0.004). The mean absolute coherence 
spectrum for these voxels is shown on the right. Colour bar indicates t statistic. 
  
110 
 
3.3.6 Dopaminergic medication has an effect on topography of cortico-
subthalamic coherence in the beta frequency band  
There was no significant main effect of dopaminergic medication. However, there was a 
significant simple main effect of dopaminergic medication on coherence in the beta 
frequency band in two ipsilateral prefrontal regions (SPM thresholded at t(1,264)=4.10, 
p=0.01, small volume corrected for a search volume specified by the main effect of beta 
frequency; Figure 15). This was not due to confounding local changes in power (Figure 16). 
There were no medication effects detected in the alpha band. 
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Figure 15: SPMs testing for the effect of dopaminergic medication on coherence. Beta 
coherence relative to image mean, increased with dopaminergic medication in two prefrontal 
clusters medially (PFCM, 6 30 36, t(1,264)=4.52, p=0.002, red arrowhead) and laterally 
(PFCL, 34 28 54, t(1,264)=4.42,p=0.003, small volume corrected). Colour bar indicates t-
statistic.  
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Figure 16: Simple effect of dopaminergic medication on beta frequency coherence 
was not due to local changes in cortical power. To determine this we performed a 
Pearson’s correlation between log source peak beta frequency power and beta frequency 
coherence across STNs. There was no significant relationship in either the medial (PFCM, 
r=-0.19, p=0.37) or lateral (PFCL, r=-0.15, p=0.47) prefrontal sources. 
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3.3.7 Relationship between cortical activity, STN activity and coherence 
For each STN, cortical source activity (non-normalised) was extracted at each of the (seven) 
peak voxels from the group SPMs above.  The mean cortical source activity in each 
medication condition is shown in Figure 17 together with mean STN-LFP power (across all 
three bipolar contacts) and mean coherence.  Dopamine subtly increased beta coherence in 
the PFC regions, but the relatively small effect suggests the group effect of dopamine on 
these regions could also have been partially explained by a reduction in mean beta 
coherence across other brain regions with medication; so that beta coherence became more 
focal with dopamine. Beta activity in the STN was divided into a lower frequency component 
(15-20 Hz), which was more prominent in the OFF condition and highly responsive to 
dopamine, and a higher frequency component (25-35 Hz), which was most evident in the ON 
condition; although also suppressed by treatment, and was at the same frequency as 
cortico-subthalamic beta coherence. Cortical activity was concentrated below 15 Hz in all 
sources, even in those displaying maximal coherence at higher beta frequencies.   
 
3.3.8 Effective direction of cortico-subthalamic connectivity 
Extracted, non-normalised, cortical source and STN activity (see above) was also used to 
investigate functional connectivity. The partial directed coherence was used to ascribe an 
effective direction of connectivity between each cortically coherent source and each STN 
bipolar contact. The connectivity was categorised as STN leading, cortex leading or 
bidirectional. Connectivity was predominantly cortex leading (chi-squared (d.f. =2) =239, 
p<0.001;Figure 18) and was not affected by dopaminergic medication (Pearson chi-squared 
(d.f. =2) =2.0, p=0.32).  However, cortical source location (Figure 19; Pearson chi-squared 
(d.f. =12) = 37, p<0.001) and frequency of coherence (Figure 18; Pearson chi-squared (d.f. 
=2) = 54, p<0.001) with the STN did modify the effective direction of connectivity.  
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Figure 17: Relationship between cortical activity and cortico-subthalamic coherence. 
The cortical power spectrum and cortico-subthalamic coherence spectrum is shown for the 
seven peak voxels (panels A-G) derived from the group comparison. Each graph displays 
the mean non-normalised activity ON (red line) and OFF medication. Panel H shows the 
mean STN activity for comparison. Note that alpha sources (panels A,B,E,F) show larger 
alpha coherence, whilst beta sources (panels C,D,G) show larger beta coherence. Most 
cortical power is below 15Hz. Note also that peak beta power in the STN region is at a much 
lower frequency than peak beta coherence for the beta sources. Panels are labelled A, alpha 
superior temporal gyrus (STG); B, alpha contralateral medial temporal gyrus (CMTG); C, 
beta premotor; D, beta medial prefrontal cortex (PFCM); E, alpha brainstem; F alpha 
contralateral inferior parietal lobule (CIPL); G beta prefrontal cortex (PFCL); H subthalamic 
nucleus (STN) region. 
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Figure 18: Effective direction of coupling between cortex and subthalamic region. 
Frequency does, but dopaminergic state does not, have an effect on the effective direction of 
cortico-subthalamic connectivity. Cortical sources led in both medication conditions. 
 
 
Figure 19: Variation in the effective direction of coupling between cortex and 
subthalamic region according to cortical location. Sources are in the premotor 
area/SMA (Beta Premotor), superior temporal gyrus (Alpha STG), contralateral medial 
temporal gyrus (Alpha CMTG), the brainstem (Alpha Brainstem), the contralateral inferior 
116 
 
parietal lobule (Alpha CIPL), the medial prefrontal cortex (PFCM) and the lateral prefrontal 
cortex (PFCL).  
 
3.3.9 Correlation between effect of dopaminergic medication on source 
activity and clinical variables 
We investigated whether clinical symptom severity (as assessed by the total UPDRS score, 
hemi-body tremor score and hemi-body akinesia-rigidity score recorded preoperatively OFF 
dopaminergic medication) correlated with cortical coherence or log cortical power at each of 
the source locations from the group analysis. To investigate the effect of dopaminergic 
medication on these correlations, we also compared change in these clinical scores with 
dopamine (ON – OFF medication) with change in the same electrophysiological parameters.   
No comparisons survived the Bonferroni correction for 84 multiple comparisons (equivalent 
to uncorrected p < 0.0006).   
 
3.4 Discussion 
We have demonstrated two major spatio-temporally organised and stereotyped patterns of 
coupling between the cerebral cortex and STN region in patients with PD. The first was 
manifest in the alpha frequency band and involved coherence between the subthalamic area 
and bilateral temporoparietal cortex and the brainstem. It was distinct from the previously 
described alpha network coherent with Parkinsonian rest tremor (Timmermann et al., 2003; 
Pollok et al., 2009). Changes in alpha activity in the subthalamic region have also been 
reported in response to emotional stimuli (Brucke et al., 2007). However, the areas of 
cortical involvement and the fact that subjects were at rest, suggest that the network 
involving the subthalamic area, bilateral temporo-parietal cortices and the brainstem might 
influence attentional levels, particularly as the processes controlling the latter often involve 
oscillations at about 10 Hz (Palva and Palva, 2007). Similarly, alpha band oscillations with a 
putative role in attention have been recorded in the brainstem pedunculopontine region, 
which is directly connected with the STN (Androulidakis et al., 2007). The ability of MEG to 
pick up signals from the brainstem is not well-established in the literature. However, 
Parkkonen et al reported recording of brainstem early auditory evoked responses with 
MEG(Parkkonen et al., 2009) and Schnitzler et al showed, using DICS beamformer, that the 
brainstem is involved in the network associated with essential tremor (Schnitzler et al., 
2009). Therefore, our finding of brainstem involvement in the alpha network is not 
implausible. Additionally we should note that the spatial resolution of beamforming is poor in 
117 
 
this area (due to the correlation between lead fields) and therefore we have been 
conservative in our interpretation of statistically significant activity near the brainstem (e.g. in 
the cerebellum). Further studies are needed to identify whether this activity truly represents 
other sources separate from the brainstem. 
 
The second pattern of coupling was evident in the beta frequency band and predominantly 
involved coherence between the subthalamic area and the ipsilateral anterior parietal and 
frontal cortices. The areas of cortical involvement suggest that this network, recorded at rest, 
might be engaged in setting the level of preparedness for executive functions. This would be 
compatible with the emerging view that beta activity may promote the status quo at the 
expense of action (Hammond et al., 2007; Engel and Fries, 2010).  Overall, there were clear 
topographical differences between the activities in the alpha and beta frequency bands, 
despite normalisation to the mean power in each band. The results support the general 
hypothesis described by Fogelson et al. (Fogelson et al., 2006) that “frequency of 
synchronisation may be exploited as a means of marking and segregating processing in the 
different functional subloops, over and above any anatomical segregation of processing 
streams.”  
 
Importantly our findings are broadly consistent with a parallel study performed in a similar 
group of subjects with non-ferromagnetic wires (Hirschmann et al., 2011). The use of such 
wires, reduces sensor-level ferromagnetic artefact – a major challenge for MEG recordings. 
Hirschmann et al used similar beamforming techniques to localise beta cortico-subthalamic 
coherence in motor areas and alpha coherence in temporal areas supporting our findings of 
two separate networks at rest. 
 
3.4.1 Supremacy of the cortical drive to the STN area 
One marked finding was the predominance of the PDC from cortex to the STN region. 
Similar apparent driving of LFP activity in the STN  region in the beta band by cortex in PD 
patients has been noted using linear regression of phase (Brown et al., 2001; Williams et al., 
2002; Fogelson et al., 2006) and the DTF (Lalo et al., 2008). This has been further replicated 
in animal models of PD (Sharott et al., 2005a; Lalo et al., 2008; Mallet et al., 2008). These 
observations are compatible with the recent demonstration in a rodent model of PD that it is 
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sufficient to stimulate the afferents to the subthalamic nucleus at high frequency, rather than 
the local neurons themselves, to overcome Parkinsonism (Gradinaru et al., 2009). 
 
The asymmetry of the PDC is also important in suggesting that coherence represented 
physiological coupling with delays, rather than volume conduction. Volume conduction 
between high amplitude cortical sources and low amplitude subthalamic LFPs is a real 
concern given the similarity between subcortical and cortical activities and their coupling. 
Many arguments have been put forward to refute an influence of volume conduction under 
these circumstances (reviewed in (Brown and Williams, 2005)), but the most convincing is 
the demonstration that the discharge of neurons in the STN tends to be locked to the beta 
activity in the LFP (Levy et al., 2002; Kuhn et al., 2005). In the current study, we limited the 
effects of volume conduction by estimating coherence between cortex and the subthalamic 
region using only bipolar derivations of DBS electrode contacts.  
 
3.4.2 Frequency of subthalamo-cortical coherence 
Another interesting feature of the subthalamo-cortical coherence is that it was focussed in 
the upper beta frequency band. LFP power in the STN region, on the other hand, was 
greater in the lower beta frequency range, in patients withdrawn from medication. The 
implications are twofold. First, the difference in frequencies between peak subthalamic 
power and peak subthalamo-cortical coherence reinforces the notion that subcortico-cortical 
coherence is not a simple passive phenomenon, but that its pattern is dictated by the 
transfer characteristics of the pathways involved. Second, the difference in frequencies adds 
weight to the argument that subthalamic activities in the lower and upper ranges of the beta 
frequency band may have somewhat different functional significance (Williams et al., 2002; 
Priori et al., 2004; Fogelson et al., 2006). Activity in the upper beta band seems to be more 
strongly coupled with cortical activity, and relatively less modulated by dopaminergic 
therapy. 
 
3.4.3 Is subthalamo-cortical coherence at rest due to default brain 
networks? 
Why should there be such a spatio-temporally organised and stereotyped pattern of coupling 
between the cerebral cortex and STN region at rest? Current thinking is that when one is 
awake and at rest, brain activity, as reflected in blood oxygenation-level-dependent and 
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electroencephalographic signals, switches to default processes (Laufs et al., 2003). The 
present findings could be interpreted as extending this notion of default networks to include 
basal ganglia-cortical coupling. The characterisation of these networks as default, as 
opposed to resting, would also seem preferable, as it allows for ongoing postural activity, 
rigidity and rest tremor in our patients. However, it should be acknowledged that we have not 
directly shown that these basal ganglia-cortical networks are suppressed when subjects are 
engaged with novel stimuli or new tasks. On the other hand, previous studies have 
demonstrated that beta band coupling between cerebral cortex and the STN region drops 
before and during movement (Cassidy et al., 2002; Lalo et al., 2008), during imagination of 
movement (Kuhn et al., 2006a) and during action observation (Alegre et al., 2010).  The 
functional networks described here are also entirely consistent with anatomical evidence 
from humans and non-human primates, which have shown that the basal ganglia project to 
the frontal and prefrontal cortex (Alexander et al., 1986; Middleton and Strick, 2002; Lehéricy 
et al., 2004; Akkal et al., 2007; Draganski et al., 2008), temporoparietal regions (Alexander 
et al., 1986; Middleton and Strick, 1996; Lehéricy et al., 2004) and the brainstem (Lehéricy et 
al., 2004; McHaffie et al., 2005).  
So are the two networks primarily pathological or physiological, given that they were 
recorded in patients with PD? Without the opportunity to record from the subthalamic area in 
healthy subjects, or at least non-Parkinsonian patients, we cannot answer this question 
directly. A common approach under these circumstances is to determine whether 
dopaminergic therapy alters the pattern of activity noted in the untreated state. The approach 
is based on the premise that the core deficit in PD is partially reversed by exogenous 
dopaminergic input, although the homology between brain states in treated PD and the 
healthy subject is only likely to be approximate at best. Surprisingly, then, treatment with 
levodopa made relatively little difference to the default functional connectivity between STN 
and cortex, other than to increase coupling in the beta band in the region of the prefrontal 
cortex. Similarly, Lalo et al. (2008) found little effect of medication with levodopa on the STN-
cortex DTF below 35 Hz, although there was an increase in the gamma band. Williams et al. 
(2002) did find a suppression of beta band STN-cortex coherence at rest following 
medication, but this was in a much smaller sample of patients.  It may be that some of the 
negative findings relate to stun effects in the immediate post-operative period (Lalo et al., 
2008).  However, the limited changes in the networks following dopaminergic therapy might 
also suggest that they may be at least partly physiological phenomena in patients.  Further 
support for this is provided by recent studies of cortico – basal ganglia functional connectivity 
based on functional magnetic resonance imaging and positron emission tomography. Both 
healthy subjects (Postuma and Dagher, 2006) and PD patients (Helmich et al., 2010; 
120 
 
Hirschmann et al., 2011) show resting connectivity between the basal ganglia and the 
supplementary motor area, the temporoparietal area and parts of the prefrontal cortex.  
Additionally, one study found connectivity between the brainstem and putamen in some 
healthy subjects (Kelly et al., 2009).  
 
The limited changes following dopaminergic therapy are themselves surprising, given that 
such therapy leads to a marked improvement in motor behaviour. However, other studies 
comparing PD patients with controls (Helmich et al., 2010) and healthy subjects before and 
after receiving levodopa (Kelly et al., 2009) have also been unable to detect a change in 
motor or premotor cortex connectivity with the basal ganglia. This raises the possibility that 
the major effect of dopaminergic medication on coherence is not to modify the nature of 
basal ganglia-cortical connectivity at rest, but to increase its reactivity to stimuli and task 
demands. Indeed recent studies have found a link between movement-related cortico-
subthalamic gamma coherence and effect of levodopa on bradykinesia (Litvak et al., 2012a). 
Furthermore, reduction in rigidity associated with stimulation of the STN correlates with low 
alpha (6-10Hz) and low beta (12-20Hz) frequency activity over central motor 
regions(Airaksinen et al., 2012). Therefore although we have identified two resting networks 
at alpha and beta frequencies, different frequencies and/or a multivariate frequency 
spectrum may correspond better with behaviour during task performance.   
 
In summary, the findings support the general hypothesis that basal ganglia-cortical loops are 
characterised by both their topography and also by the pass band of their activities. More 
specifically, the results suggest the existence of two networks involving the subthalamic area 
and particular cortical regions synchronised at different frequencies. It remains to be seen 
whether these networks identified at rest are functionally involved in disengaging attention 
and action.  
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4: Resting cortico-pedunculopontine nucleus region 
connectivity in Parkinson’s Disease  
 
4.1  Introduction 
The pedunculopontine nucleus (PPN), located at the junction between the midbrain and 
pons, is comprised of cholinergic, glutamatergic and GABAergic cells (Wang and Morales, 
2009) and has been implicated in locomotion (Garcia-Rill et al., 1987; Skinner et al., 1990), 
sleep (Boeve et al., 2007; Lim et al., 2007, 2009; Arnulf et al., 2010), reward (Chen et al., 
2006b; Norton et al., 2011), and arousal (Moruzzi and Magoun, 1949; Garcia-Rill and 
Garciarill, 1991). Recently, its role as part of the functionally defined mesencephalic 
locomotor region (an area that generates walking behaviour when stimulated in decerebrate 
animals) has become paramount because of its emergence as a stimulation target in 
patients with Parkinson’s Disease (PD) and gait problems (Pahapill, 2000; Mazzone et al., 
2005; Plaha and Gill, 2005; Stefani et al., 2007b; Ferraye et al., 2010; Moro et al., 2010; 
Alam et al., 2011). However, the efficacy of PPN deep brain stimulation (DBS) is variable 
(Stefani et al., 2007a; Ferraye et al., 2010), and the optimal target location is unclear.  One 
possibility underlying variability in outcome is that different areas in the PPN region (PPNR) 
are functionally coupled with and modulate different brain circuits, only some of which are 
dysfunctional in gait disorders. Indeed whether the PPN itself or a neighbouring region is 
empirically the optimal surgical target region remains unclear. The importance of functional 
specialization in this region, particularly along the long axis of the PPN, is becoming 
increasingly apparent in animal studies (Martinez-Gonzalez et al., 2011). 
In humans, functional magnetic resonance imaging (fMRI) and positron emission 
tomography (PET) have insufficient spatial resolution to reliably discern different areas of the 
PPNR (Ballanger et al., 2009; Snijders et al., 2011). However, direct recordings of local field 
potentials (LFPs) from intracranial electrodes afford excellent spatial and temporal 
resolution: we recently demonstrated that the nature of spontaneous oscillatory synchrony 
picked up in the LFP is topographically organized in the PPNR (Thevathasan et al., 2011, 
2012).  In particular, we showed that local activity in the alpha frequency band is maximal in 
a region that lies 2 mm to 6 mm below the pontomesencephalic junction. This area may 
correspond to the caudal PPN, and specifically to the caudal ‘pars dissipata’ – a diffusely 
bordered region containing a greater number (but lower concentration) of cholinergic 
neurons than the central PPN ‘pars compacta’ (Manaye et al., 1999). Importantly, alpha 
activity in this area correlated with gait performance, and DBS improved gait more when 
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delivered to this area, as opposed to more rostral and caudal regions of the 
PPNR(Thevathasan et al., 2012). Studies that have recorded EEG simultaneously with 
PPNR LFP have been encouraging in so far as functional coupling can be demonstrated 
between the PPNR and cerebral cortex, but these studies could not associate this coupling 
with particular cortical regions, due to the necessarily limited scalp recording sites in peri-
operative patients and the presence of burr holes, which together preclude any spatial 
mapping (Gaynor et al., 2008; Classen and Schnitzler, 2010; Tsang et al., 2010; 
Thevathasan et al., 2012). Neither have these studies addressed the issue of how any 
coupling with cortical areas varies within the PPNR. 
Here, we characterise how different brain areas may be differentially coupled at rest within 
the PPNR, taking advantage of recent methodological developments to simultaneously 
record LFP data from intracranial electrodes and magnetoencephalography (MEG) in a 
cohort of five Parkinsonian patients undergoing surgery for PPN DBS. MEG allows dense 
sampling of cortical activity even in post-surgical patients and is resistant to distortion by 
skull defects, so that cortical localisation can be performed in spite of prominent artefact due 
to the ferromagnetic electrode extension wires (Litvak et al., 2010, 2011a). Accordingly, we 
test whether PPNR coupling with different distant brain areas is frequency specific, 
modulated by dopamine and depends upon the position of the electrode within the PPNR.  
The results are important in understanding the diverse nature of the distributed brain 
networks involving the PPNR and how these may be organized through spatio-temporal 
patterning in this region. 
 
4.2 Methods 
 
4.2.1 Participants and surgery 
We studied 5 (4 from Oxford, 1 from London) patients who had undergone PPN DBS 
electrode implantation prior to DBS therapy for PD.  Four subjects had bilateral implants; 
although we were not able to record from one electrode in a subject due to a damaged 
electrode extension wire.  One patient had a unilateral implant. These patients also took part 
in other experiments, some of which involved electrophysiological recordings and all of 
which have been reported elsewhere (Thevathasan et al., 2012). Clinical details (adapted 
from Thevathasan et al., 2012) are given in Table 4.  Note that EMG recordings performed 
at the time of MEG demonstrated tremor in subject 4, who was known to have tremor, and in 
123 
 
subject 2, who was not known to have clinically significant tremor. However, in both cases, 
tremor was detectable for less than approximately a third of the time. 
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1 55 14 35/24 7/6 55/38 22 4 1600 A,P 
2 55 25 33/22 6/5 36/15 15 3 300 D,A,P 
3 68 9 40/26 11/8 49/42 24 2 1650 A,P 
4 70 20 35/22 6/5 36/28 13 3 900 D,A,T,P 
5 71 20 37/19 10/5 na na 2 1450 D,A,T,P 
Table 4: Clinical details of the study participants (adapted from (Thevathasan et al., 
2012)). All patients were operated in Oxford except patient five (London). All patients were 
male. All subjects had bilateral PPNR implants except subject 5, who had a unilateral right 
PPNR implant. We were only able to record from the right PPNR in subject 1 due to a 
damaged electrode extension wire. Rostro-caudal stimulation location and clinical outcome 
data for all these subjects has been reported previously, with cases 1-5 corresponding to 
cases 1 and 3-6 in Thevathasan et al., (2011). Outcome was assessed by a drop in GFQ 
postoperatively. Outcome in patient 5 was assessed with UPDRS II items scoring freezing, 
falls and gait with the combined score being 5/16 preoperatively and 4/16 postoperatively 
(on medication).UPDRS III = part III (motor) of the Unified Parkinson’s disease rating scale 
(score/108). IT27-30 = items 27-30 UPDRS III assessing gait, posture and balance 
(score/16). GFQ = Gait and Falls Questionnaire (score/64). FOGQ = Freezing of Gait 
Questionnaire (score/24). Falls Q = Falls Questionnaire (score/4). NA = not assessed. For all 
motor scales, higher scores indicate worse function. Key to UK Brain bank criteria; 
D=dyskinesias, A = asymmetry persistent, T=tremor at rest, P=progressive disease course. 
*Additional to disease duration and levodopa response as documented elsewhere in the 
table.  
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The indications for surgery were PD with predominant levodopa-unresponsive gait 
impairment and/or falls due to either freezing or postural instability.  
Prior to surgery, the motor impairments of all patients were evaluated using part III of the 
Unified Parkinson’s Disease Rating Scale (UPDRS) after omitting all dopaminergic 
medication overnight and then following administration of 200mg of levodopa. Patients 
treated in Oxford also prospectively completed the Gait and Falls Questionnaire (GFQ, 
score/64) which assesses Parkinsonian gait disturbance including gait freezing, festination 
and falls. The Freezing of Gait Questionnaire (FOGQ, score/24) and Falls Question (FallsQ, 
score/4) are components of GFQ (Giladi et al., 2000, 2009). The London patient was 
assessed with UPDRS (part II) items assessing gait, freezing and falls (combined score/16). 
For all motor scales, higher scores indicate worse function. 
Techniques to target and implant DBS electrodes in the PPN have been described 
previously (Pereira et al., 2008; Zrinzo et al., 2008; Foltynie and Hariz, 2010). In this study, 
preoperative stereotactic imaging (stereotactic proton density weighted magnetic resonance 
imaging (MRI) in London, and stereotactic computerised tomography (CT) fused with T2 
weighted MRI in Oxford) were used to target the PPN medial to the lemniscal system and 
lateral to the superior cerebellar peduncle and its decussation. The DBS electrode used was 
model 3389 (Medtronic, Minneapolis, MN) with four platinum-iridium cylindrical contacts of 
diameter 1.27mm, length 1.5mm, and centre-to-centre separation 2mm. After implantation, 
electrodes were connected to an accessory kit, typically both connectors being tunnelled to 
the left temporoparietal area and externalised through the frontal region. No microelectrode 
recordings were made. To confirm correct placement, electrodes were visualised on 
immediate post-operative imaging with the surgical frame in situ (proton density weighted 
MRI in London and CT (1mm slice thickness) fused with pre-operative T2 weighted MRI in 
Oxford). To facilitate comparison across subjects, the postoperative images were linearly 
transformed into Montreal Neurological Institute (MNI) space using the fMRIB Software 
Library (Smith et al., 2004). The coordinates of each contact were determined (in 
millimetres) relative to the midline (X, laterality), ventrodorsal distance from floor of the fourth 
ventricle (d, anteroposterior location) and rostro-caudal distance from a pontomesencephalic 
(PM) line connecting the pontomesencephalic junction to the caudal end of the inferior 
colliculi (h, height), as described previously (Ferraye et al., 2010). Lead locations are 
summarised in Figure 20. 
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Figure 20: Localisation of contact locations within the brainstem, represented in 
Montreal Neurological Institute (MNI) space (sagittal view). PM = Pontomesencephalic 
line connecting the pontomesencephalic junction to the caudal end of the inferior colliculi. 
Electrodes from different subjects have different coloured tips. Not all contacts are within the 
PPN, affording us the opportunity to divide the sampled brainstem region according to height 
with respect to the PM line. Note that this Figure is adapted from (Thevathasan et al., 2012) 
to show only those five subjects that were recorded concurrently with MEG. We were unable 
to record from one of the 9 electrodes shown, because of a damaged electrode extension 
wire. Flair MRI of case 2 showing axial slices at different depths is illustrated in 
supplementary material to (Thevathasan et al., 2012). 
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4.2.2 Simultaneous PPNR-LFP and MEG recordings 
MEG recordings were performed in London with the 275 channel CTF (VSM MedTech Ltd., 
Vancouver, Canada) or in Oxford with the 306 channel Neuromag (Elekta Neuromag Oy, 
Helsinki, Finland) systems. Simultaneous to the MEG recording, both right and left first 
dorsal interosseus (FDI) electromyographic (EMG) signals, and four intracranial LFP 
channels were recorded per electrode.  All EMG recordings, and London LFP recordings, 
were referenced to the right mastoid and acquired using the integrated EEG system In 
Oxford, LFP signals in the PPNR were acquired in a bipolar configuration via a Digitimer 
D360 amplifier (Digitimer Ltd, Hertfordshire, UK), and high-pass filtered at 0.5 Hz. All data 
were sampled at 2400 Hz and stored to disk for subsequent off-line analysis. MEG, LFP and 
EMG data were hardware high-pass filtered at 0.03Hz (Oxford MEG and EMG) or 1Hz 
(London EMG and LFP; Oxford LFP only) and low-pass filtered at 600Hz (all signals). 
London LFP recordings were converted off-line to a bipolar montage between adjacent 
contacts (3 bipolar channels per side) to limit the effects of volume conduction from distant 
sources (Oxford LFP recordings were already recorded in this format).  
Recordings were performed between 2-6 days post-operatively, after omitting all 
dopaminergic medication overnight (OFF condition). The recording was then repeated 
approximately 30-60mins after administration of the patient’s usual dopaminergic medication 
dose (minimum given was 200mg levodopa, ON condition). One subject (from London) only 
completed the OFF recording. Each recording comprised rest blocks followed by task blocks. 
In this report, we focus only on the resting data, which was collected in two blocks lasting 3 
minutes each (except the subject from London who only completed one 3 minute block). 
During the rest block, the patients were asked to keep still, relax with their eyes open and 
focus on a fixation cross. A neurologist was present in the magnetically shielded room during 
the experiment to monitor the patient’s well-being. It is worth noting that due to the often frail 
nature of these patients, we performed only one recording session, and were therefore 
unable to counterbalance the ON and OFF conditions.  
 
4.2.3 Data pre-processing, artefact rejection, and head localisation 
The data were analysed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) and Fieldtrip 
(http://www.ru.nl/neuroimaging/fieldtrip/), (Litvak et al., 2011b; Oostenveld et al., 2011). The 
continuous resting recording was down-sampled to 300 Hz, high-pass filtered above 1 Hz 
and the line noise artefacts at 50 Hz and 100 Hz were removed using notch filters (5th order 
zero-phase Butterworth filters). It was then divided into arbitrary 1 second trials. EMG data 
were divided into arbitrary 1 second blocks, rectified and then converted to the frequency 
128 
 
domain (range 5 to 45 Hz with frequency resolution of 2.5 Hz, and 2.5Hz spectral smoothing) 
using the multitaper method (Thomson, 1982). The presence of resting tremor was 
determined visually. 
Head position was recorded continuously within the MEG, and in London was recomputed to 
correspond to the mean of the trials used for the analysis.  Similar head movement 
compensation could not be made for Oxford subjects as the proprietary software had 
difficulty extracting the head location signal in the presence of metallic artefact from DBS 
extension leads. We therefore used the starting head location in these cases. Unlike the 
CTF system, the Neuromag MEG system contains magnetometers (a type of sensor) which, 
due to their greater sensitivity to distant sources and environmental noise, are more 
contaminated by metal artefacts. We, therefore, only based our analysis on planar 
gradiometers similarly to Hirschmann et al. who also used the Neuromag 
system(Hirschmann et al., 2011). Oxford subjects had 360 trials (from 6 min of data), whilst 
the London subject had 180 trials (from 3 min of data) per condition. 
 
4.2.4 The beamformer approach to coherent source localisation 
Coherence was the principal measure of functional connectivity used in this study. It 
provides a frequency-domain measure of the linear phase and amplitude relationships 
between signals (Thatcher et al., 1986; Rappelsberger and Petsche, 1988; Shen et al., 
1999; Buzsaki and Draguhn, 2004; Magill et al., 2006b). Cortical sources coherent with 
PPNR-LFP activity were located using the Dynamic Imaging of Coherent Sources (DICS) 
beamforming method (Gross et al., 2001).  To begin with, all MEG and bipolar PPNR-LFP 
channel trial data were converted to the frequency domain (range 5 to 45 Hz with frequency 
resolution of 2.5 Hz, and 2.5Hz spectral smoothing) using the multitaper method (Thomson, 
1982). Using beamforming, coherence can be calculated between each PPNR-LFP channel 
and a 3 dimensional grid of points representing potential sources within the brain (Gross et 
al., 2001). The beamforming method is based on the linear projection of sensor data using a 
spatial filter computed from the lead field of the source of interest and either the data 
covariance (time domain) (Van Veen et al., 1997) or cross-spectral density matrix (frequency 
domain) (Gross et al., 2001). Lead fields were computed using a single-shell head model 
(Nolte et al., 2004) based on an inner skull mesh derived by inverse-normalizing a canonical 
mesh to the subject's individual pre-operative MRI  image (Mattout et al., 2007). Co-
registration between the MRI and MEG coordinate systems used 3 fiducial points: nasion, 
left and right pre-auricular; see (Litvak et al., 2010) for further details.  The coherence values 
were computed on a 3 dimensional grid in MNI space with spacing of 5 mm bounded by the 
129 
 
inner skull surface.  Values at the grid points were then linearly interpolated to produce 
volumetric images with 2 mm resolution. These images were further smoothed with an 8 mm 
isotropic Gaussian kernel.  Although we do not perform sensor-level analyses in this paper, 
we acknowledge that if sensor-level coherence data are severely affected, this may produce 
noisy source-level results. We, therefore, checked the plausibility of our source-level results 
by comparing the actual coherence topography with that expected from the sources we 
found with and without artefacts. The procedure for this comparison is described in detail in 
Litvak et al. (Litvak et al., 2010, 2011a). Briefly, virtual electrode data from the peak source 
coherent with PPNR-LFP were projected back to the sensors, via the source’s putative lead 
field and added to the original MEG data shifted by one trial. This shifting destroys the 
original coherence between PPNR-LFP and MEG so that the coherence pattern observed in 
the synthetic data can be used to disambiguate between true coherence and the effects of 
artefacts on coherence estimates.  We also compared the original and synthetic coherence 
patterns with the topographical map of absolute values of the lead field coefficients, which 
resembles the expected coherence pattern of a single focal source coherent with PPNR in 
the absence of artefacts and additional brain sources. 
 
4.2.5 Characterisation of effects of dopaminergic medication, frequency 
and electrode height on coherence topography across patients 
The aim of this analysis was to determine if the topography of cortico-pedunculopontine 
region coherence was frequency and medication dependent, and also if these effects 
depended on the position of the electrode along the rostro-caudal axis of the PPNR (termed 
‘height’ from now). To allow group comparison of data, DICS images were generated at fixed 
frequency bands in the alpha (7-13 Hz) and beta (15-35 Hz) ranges in all patients using each 
of the three bipolar PPNR-LFP channels as a reference. Unthresholded individual coherence 
images were normalised by dividing the coherence value at each beamformer grid point by 
the mean value of that image. This potentially removes confounds related to nuisance 
variations in signal-to-noise ratio such as variable head distance from MEG coils and the use 
of different MEG systems. However, it also constrains the analysis to distinguish changes in 
the relative topography of coherence, rather than absolute values. Images were smoothed 
as described above. Half of the resulting images (all left PPNR) were reflected across the 
median sagittal plane to allow comparison of ipsilateral and contralateral sources to the 
PPNR regardless of original PPNR side. These images were then analysed using standard 
procedures to produce statistical parametric maps (SPMs) testing for regionally specific 
effects of interest. 
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The coherence data at each voxel were subjected to a fixed-effects ANCOVA with frequency 
and dopamine as factors of interest, the interactions of those factors with electrode height 
position as covariates of interest, and subject and side as nuisance factors. In our cohort, the 
height of electrode placement (taken as the mean height of all 4 contacts per electrode), 
varied between PPNRs from  -9.4mm to +2.1mm relative to the PM line. Previous PPNR-
LFP recordings suggest that centrally placed contacts between -2mm and -6mm relative to 
the PM line exhibit greater local alpha power, and that activity in this region correlates with 
gait speed (Thevathasan et al., 2012). Given this variation, in addition to testing for effects 
on coherence with the PPNR as a whole, we also endeavoured to model differential effects 
across subregions of the PPNR. This was done by modelling the effect of electrode (taken 
as a mean of the height of all 4 contacts per electrode) as a quadratic function of electrode 
height. This allowed for a maximum effect between -2mm and -6mm, thereby mirroring the 
variation in local alpha power previously reported (Thevathasan et al., 2012). Modelling 
interactions between electrode height and other factors allowed us to test for differential 
effects of dopamine and frequency across subregions of the PPNR. All main effects, 
interactions and covariates were estimated with F contrasts; while post hoc one-tailed t 
contrasts were used to visualise the direction of significant effects. The form of significant 
covariate interactions was examined by plotting the predicted effect (based on the significant 
parameter estimates of our model) and residuals, adjusted for confounding factors. All 
analyses were corrected for multiple comparisons (using random field theory) and 
thresholded at p<0.05, with a minimum cluster volume of 5 voxels. The anatomical locations 
of the peak voxels showing significant effects were labelled using AAL software (Tzourio-
Mazoyer et al., 2002). 
 
4.2.6 Directionality 
A variant of Granger causality was used to explore the direction of coupling between 
synchronized populations of neurons, i.e. which population activity leads in time. The most 
parsimonious explanation for such a relationship between two coherent population activities 
is that the leading population drives the lagging population. However, this may not be the 
only explanation. Driving may be direct or indirect, via one or more unrecorded structures, or 
activity in both recorded structures may be driven by a third unrecorded structure (Sharott et 
al., 2005a). Given this, we use the term ‘effective direction of coupling’ to describe a pattern 
of temporal relationships rather than a measure of direct coupling. Finally, volume 
conduction artefact may manifest as ‘bidirectional’ coupling in such an analysis. However 
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this is unlikely in the current study because we use bipolar montages of the electrode 
recordings and orient the beamformer sources to the direction of maximal imaginary 
coherence with the PPNR (see below).  
Significant peak voxels resulting from the SPMs underwent further quantitative analysis of 
the effective direction of coupling and local power. First, we extracted time-series (virtual 
electrode) data at significant SPM maxima, using a linearly constrained minimum variance 
(LCMV) beamformer (Van Veen et al., 1997), 0.01% regularization and orientation in the 
direction of maximum imaginary coherence (Litvak et al. 2010). Coherence was then 
calculated between each peak voxel (‘the source’) and each PPNR-LFP contact in each 
subject. The effective direction of coupling was tested between each bipolar contact and the 
source using a non-parametric variant of Granger causality (Brovelli et al., 2004).  Both 
measures were computed based on multitaper spectral analysis with spectral resolution and 
smoothing of 2.5 Hz. The significance of Granger causality was tested by repeating the 
computation 100 times for data with the PPNR signal reshuffled across trials. The 
significance level used was p<0.01 (corrected), i.e. frequencies were declared significant 
where the spectra exceeded the 99th percentile (across all frequencies) of the Granger 
causality values computed from reshuffled data for the same pair of channels and direction. 
To be more conservative we also applied an extent threshold and excluded the cases when 
only a single frequency bin was significant and the adjacent ones were not. Subsequently 
the effective direction of coupling in each frequency bin was categorised as either ‘source-to-
PPNR’ , ‘PPNR-to-source’, ‘bidirectional’  or ‘none’ depending on whether it showed 
significant Granger causality for one of the directions, both or none, respectively. Note that 
effective directions were characterised separately for different conditions.  
 
4.3 Results 
 
4.3.1 Intracranial electrode recordings correspond to activity of the PPN 
and neighbouring regions.  
Electrode positions are summarised in Figure 20.The mean ± SD distance from the PM line 
was -3.9 ± 4.9 mm, the mean anteroposterior distance was 7.4 ± 1.8mm and the mean 
laterality was -6.7 ± 1.7mm on the left side and 9.0 ±  3.0mm on the right side. There 
greatest anatomical variation in contact location was therefore along the rostrocaudal axis.   
This variability along the rostrocaudal axis meant that many electrode contacts lay out with 
the assumed boundaries of the PPN, affording us the opportunity to examine the distribution 
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of subcortico-cortical coherence with respect to this broad PPN region (PPNR). We thus 
divided this region covered by electrode contacts into three subregions and considered the 
nature of subcortico-cortical coherence with respect to these. The three subregions were the 
(1) upper PPNR (e.g. structures near to and including the rostral PPN); (2) middle PPNR 
(e.g. structures near to and including the caudal PPN) and (3) lower PPNR (e.g. structures 
caudal to the PPN).    
Still the above detail would only be useful if LFPs were focal, allowing discrimination 
between subregions. Both alpha and beta band power were relatively focal. Alpha power 
dropped to 44.4 ± 7.2 (SEM) % from the contact with peak alpha power to the mean of the 
remaining contacts on each electrode. Beta power similarly dropped to 49.8 ± 7.2 %. The 
mean frequency of the maximum power in the alpha and beta bands was 8.3 ± 0.1 and 16.9 
± 0.3 Hz respectively.  
 
4.3.3 Networks involving the PPNR are frequency specific 
The mean images of alpha and beta coherence shown in Figure 21 highlight both a large 
central overlap region (including the brainstem, thalamus and anterior basal ganglia) and 
regions that show a differential effect of frequency.  Although the central activity may 
represent genuine coherence with the PPNR - across both alpha and beta frequency bands - 
we should note that beamformers also tend to project noise centrally. However, we can 
make less ambiguous inferences by comparing conditions in an ANCOVA framework. In 
accord with this, the main effect of frequency was significant in the ipsilateral cerebellum and 
a broad medial frontal region centred at the cingulate, but including the SMA and the 
premotor regions (Table 5, Figure 21 and Figure 22). Post hoc tests indicated that regional 
beta coherence was greater in the medial frontal areas, whilst alpha coherence was greater 
in the cerebellum. Note that although the main effect of frequency was detected at two 
cerebellar sources, to avoid bias from this region, only the most significant one was included 
in the subsequent LCMV and directionality analyses (i.e. Figure 25 and Figure 26). The 
mean frequency of the peak voxel coherence in the alpha and beta bands was 9.6 ± 0.1 and 
24.8 ± 0.7 Hz respectively. 
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Figure 21: Mean beamformer images of coherence with PPNR activity. Mean alpha 
(blue) and beta (green) range coherence images are shown thresholded to 2 standard 
deviations. Images are a series of axials separated by 15mm intervals along the z axis and 
overlayed onto corresponding sections through an averaged T1 weighted MRI in MNI space. 
Overlap regions are cyan and may represent either genuine coherence at both frequencies, 
or projected noise. Coherence is in arbitrary units. 
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Contrast Location Peak co-
ordinates 
Statistic p value 
Frequency Cingulate -2 -6 46 F(1,76)=40.73 <0.001 
Ipsilateral cerebellum 34 -52 -46 F(1,76)=24.71 0.010 
Ipsilateral cerebellum* 56 -74 -36 F(1,76)=20.34 0.043 
Dopamine x  
Frequency 
Ipsilateral inferior 
temporal 
58 -74 -6 F(1,76)=22.52 0.020 
Ipsilateral superior 
temporal 
66 -42 20 F(1,76)=20.39 0.042 
Depth x 
Frequency  
Contralateral orbitofrontal  -46 34 -10 F(1,76)=21.56 0.028 
Depth x 
Dopamine  
Contralateral precuneus -8 -52 56 F(1,76)=24.39 0.011 
Table 5: Brain regions where a significant condition effect or an interaction between 
condition effects was detected. The statistics shown correspond to the peak voxel in each 
cluster. *This cluster is slightly posterolateral to the other ipsilateral cerebellar cluster 
showing a main effect of frequency. 
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Figure 22: SPMs testing for the main effect of frequency on coherence with the 
pedunculopontine region. Images are overlayed onto corresponding orthogonal sections 
through an averaged T1 weighted MRI in MNI space. Top: Voxels where regional alpha is 
greater than beta coherence.  Bottom: Voxels where regional beta is greater than alpha 
coherence. The colour bar represents the post hoc t statistic (see Table 5 for F statistics). 
Images are thresholded to p<0.05 (corrected). 
4.3.4 Networks involving the PPNR are modulated by dopamine in a 
frequency-specific manner 
The main effect of dopamine was not significant. However, the interaction between 
dopamine and frequency was significant in the ipsilateral inferior and superior temporal lobe 
(Table 5 and Figure 23). Post hoc tests suggested that dopamine decreased regional alpha 
coherence, whilst increasing regional beta coherence at both locations. To confirm that the 
dopaminergic effects on coherence at these peak voxels were not due to spurious non-linear 
effects of power, we correlated the dopamine induced change in log source power with the 
dopamine induced change in source-PPNR coherence.  There were no significant 
correlations in the alpha (r=0.11, p=0.64) and beta (r=0.14, p=0.55) frequency bands in the 
inferior temporal lobe, and the alpha (r=0.03, p=0.88) and beta (r=0.03, p=0.9) bands in the 
superior temporal lobe. Therefore these effects cannot be accounted for by potentially 
confounding changes in local power. 
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Figure 23: SPMs testing for an interaction between the effects of dopamine and 
frequency on coherence with the pedunculopontine region. Images are overlayed onto 
corresponding orthogonal sections through an averaged T1 weighted MRI in MNI space. 
Both rows of images show voxels where dopaminergic medication reduces alpha coherence 
whilst increasing beta coherence. The colour bar represents the post hoc t statistic (see 
Table 5 for F statistics). Images are thresholded to p<0.05 (corrected). We note that some 
voxels in the top panel appear out with the standard averaged template MRI used for 
presentation and may therefore represent edge artefact. However, the underlying t image, 
when thresholded to p<0.001 uncorrected shows that this region is the outer tip of a larger 
intracranial activation, suggesting that it is not a mere extracranial artefact. 
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Figure 24: SPMs testing for an interaction between the effect of height (of electrode 
relative to PM line) and other effects of interest.  Images are overlayed onto 
corresponding orthogonal sections through an averaged T1 weighted MRI in MNI space.  
Top row: Voxels where frequency interacts with a quadratic function of height. Top right: The 
modelled effect of height (line), and the model plus residual error (crosses) are plotted 
separately for alpha (blue) and beta (red) coherence at the corresponding peak voxel. 
Relative to beta coherence, alpha coherence with the contralateral orbitofrontal cortex is 
increased centrally within the pedunculopontine region (which may correspond to the caudal 
PPN). Bottom row: Voxels where dopamine interacts with a quadratic function of height.  
Bottom right: The modelled effect of height (line), and the model plus residual error (crosses) 
is plotted separately for OFF (blue) and ON (red) medication conditions at the corresponding 
peak voxel. Coherence with the contralateral precuneus is greater OFF dopaminergic 
medication centrally within the pedunculopontine region (which may correspond to the 
caudal PPN). Effects are in arbitrary units and are adjusted for confounding factors. The 
colour bar represents the F-statistic. Images are thresholded to p<0.05 (corrected). 
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4.3.5 Coherence is topographically modulated within the PPNR in a 
frequency and dopamine dependent manner 
Alpha power in the PPNR LFP has been reported as maximal around 6 to 2 mm below the 
PM line which may correspond to the caudal PPN (Thevathasan et al., 2012); given that the 
present cases represent a subset of this earlier report, we evaluated the effect of electrode 
height on coherence by modelling it with a quadratic function (centred at -4mm with respect 
to the PM line, in the middle of the region of maximal alpha power noted by Thevathasan et 
al). Note that here the main effect of electrode height was not estimable, as all between-
PPNR variation was already modelled by nuisance regressors. The interaction between the 
effect of frequency and electrode height was significant in the contralateral inferior frontal 
area (Table 5 and Figure 24). Plots of the adjusted effects suggested that alpha coherence 
with the inferior frontal region was predominantly within the middle PPNR (defined here as -2 
to -6 mm with respect to the PM line). In addition, the interaction between the effects of 
dopamine and electrode height was significant in the precuneus (Table 5 and Figure 24). 
Plots of the adjusted effects suggested that dopamine decreased coherence with the 
precuneus mainly within the middle PPNR. There was no three-way interaction. To support 
our findings and their relationship to previous work (Thevathasan et al., 2012), we confirmed 
a similar distribution of alpha coherence within the PPNR, as that previously reported for 
power. Figure 25 illustrates the distribution of raw unnormalised coherence between all 
significant cortical sources and the PPNR at different distances from the PM line. Spatial 
resolution is effectively determined by the binning of electrode height relative to the PM line 
and is sparse. Nevertheless, alpha band coherence with distant sites tends to be maximal in 
the middle PPNR, which includes the caudal PPN. Coherence in the beta band was lower 
and more diffusely spread. To detect any differences between data collected from the two 
MEG systems, we also present the mean power spectra and coherence spectra at peak 
voxels from the SPM analysis in Figure 26.  Data from Oxford and London show broadly 
similar features in spite of different surgical targeting, MEG sensor types and LFP 
amplification.  However, not all effects highlighted by the SPM analysis are apparent in the 
raw coherence data averaged across subjects, presumably because they are masked by 
variation with depth or between subjects.  
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Figure 25: Mean unnormalised coherence between the PPNR and significant peak 
voxels from the SPM analysis, plotted as a function of electrode height (mm). Values 
are plotted separately for alpha (left) and beta (right) coherence. Means were calculated ON 
(red) and OFF (blue) dopaminergic medication. Error bars represent SEM.  
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Figure 26: Individual subject mean log source power (top row) and source-PPNR 
coherence (bottom row) data for the 4 Oxford subjects (red and blue lines) and the 
London subject (green lines). Each column represents spectra for one source from the 
SPM group analysis or the PPNR electrode. The alpha range (7-13Hz) is shown bounded by 
dashed lines and the beta range (15-35Hz) is shown bounded by dotted lines. Spectra are 
plotted separately for OFF medication (blue) and ON medication (red) conditions for the 
Oxford patients. Note the London subject was only recorded OFF medication. Although 
magnitude of source and PPNR LFP power are very different between the Oxford MEG 
system and the London MEG system, their general features and the source-PPNR 
coherence data are similar as expected. Both London and Oxford subjects show a 
predominance of alpha power in all cortical locations and the PPNR, and a predominance of 
alpha coherence between cortical sources and the PPNR. Beta power peaks can also be 
seen in some individual PPNRs and to a lesser degree in some cortical sources. Individual 
beta coherence peaks are visible, mainly in the cingulate, but also in other cortico-PPNR 
coherence spectra.  There is relatively greater ratio of beta, to alpha coherence in the 
cingulate when compared with the cerebellum in the Oxford subjects, but interestingly the 
opposite is seen in the London subject. Given the similar source and PPNR power spectra, 
this is unlikely due to a difference in recording equipment, but rather represents a biological 
difference possibly due to the relatively rostral location of the contacts in the London subject 
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(mean height +0.8mm) relative to the mean of the cohort (-3.9mm). The effect of dopamine 
on PPN coherence with the temporal lobe cannot be seen underlining the importance of 
modelling subject and depth effects to increase sensitivity in this small cohort of subjects. Inf 
(inferior), Sup (Superior), c (contralateral), i (ipsilateral), PPNR (pedunculopontine region). 
Note that a 50Hz notch filter has been applied to all power spectra. 
 
4.3.6 Variation in the effective direction of coupling with height of 
electrode 
We examined the effective direction of coupling at the peak voxels from the SPM analysis 
using a non-parametric Granger technique (Figure 27). This is presented as the fraction of 
electrodes (i.e. the number of electrode contacts per directional category divided by the total 
number of electrode contacts) showing significant directionality per frequency bin. Graphs 
are presented separately for dopaminergic state and bipolar contact height (categorized into 
3 bins). Inspection of these distributions suggests that coupling is maximal below -2mm, and 
especially in the middle PPNR (which includes the caudal PPN), between -2mm and -6mm 
relative to the PM line, and that, at least in the alpha band such coupling is mainly 
bidirectional. There is a tendency for treatment with levodopa to increase PPNR-to-source 
coupling particularly in the beta band and in the middle PPNR, where bidirectional coupling 
is reduced to almost undetectable levels after levodopa.  
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Figure 27: The effective direction of coupling. A: Coupling OFF and ON dopaminergic 
medication (top and bottom respectively) grouped for electrodes at different heights within 
the PPNR (left, above -2mm termed the upper PPNR (including the rostral PPN); middle, -2 
to -6mm termed the middle PPNR (including the caudal PPN); and right, below -6mm termed 
the lower PPNR (including the region below the caudal PPN).  Each chart shows the fraction 
of PPNRs in different directionality categories stacked on top of each other (sum is always 
1). B: Pie chart showing coupling in the -2mm to -6mm region only, averaging across alpha 
(left) and beta (right) frequency ranges in the OFF (top) and ON (bottom) dopamine 
conditions. Blue represents ‘source-to-PPNR’, green ‘bidirectional’ and red ‘PPNR-to-source’ 
directionality. Clear space means that there was no definite effective direction. 
  
143 
 
4.3.7 Assessment of the impact of ferromagnetic electrode artefact and 
the use of different MEG systems on sensor and source level coherence. 
Beamforming has previously been shown to extract source-level coherence from MEG 
recordings contaminated by DBS electrode metal artefact (Litvak et al., 2010, 2011a), and 
reassuringly these results are similar to data acquired using non-ferromagnetic wires 
(Hirschmann et al., 2011).  However, to confirm the validity of sensor-level coherence 
estimates in this cohort, we considered the effect of simulated noise on the sensor-level 
coherence patterns of peak beamformer sources in different conditions, subjects and MEG 
systems (Figure 28).  By comparing original coherence patterns (a combination of genuine 
source-PPNR coherence possibly from multiple sources, and contributions of artefacts from 
ferromagnetic electrodes and non-coherent brain activity), with absolute values of the source 
lead field (representing only genuine source-PPNR coherence) and simulated coherence (a 
combination of genuine single source-PPNR and artefacts), we were able to determine the 
effect of the artefact on sensor-level coherence.  We present four cases that all show 
distinguishable sensor-level coherence patterns but that also contain variable amounts of 
noise.  In some cases, artefactual effects on coherence dominate at the sensor-level. To 
determine whether the beamformer was able to suppress artefactual noise adequately, and 
to compare recordings from different MEG systems we present individual subject coherence 
and power spectra in Figure 26.  These figures show a large variation in power between the 
different MEG and intracranial electrode amplification systems used in London and Oxford.  
However, in spite of this, the profile of power spectra in both groups was similar and crucially 
coherence estimates were relatively comparable between MEG systems, even before 
normalisation.  Individual alpha and beta coherence peaks can be seen in a range of 
sources and subjects.  
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Figure 28: Sensor level analysis. Coherence patterns (top row), absolute values of lead 
fields (middle row) and simulated coherence (bottom row) for four MEG-PPNR electrode 
pairings. Absolute values of lead fields have been differentially multiplied by 1x1012 
(columns B and D), 2x1012 (column C) and 4x1012 (column A) for visualisation purposes. 
Column A is an example of alpha coherence, off medications in the London subject and 
column B is beta coherence in the same subject. Column C represents beta coherence on 
medication, and column D represents alpha coherence on medication, in two separate 
Oxford subjects. In cases B and D, there is a clear consistency between the original 
coherence pattern, the lead field and simulated coherence at the same location with 
simulated noise. In cases A and C, although features resembling the lead field can be 
identified to a varying degree in the original and simulated coherence patterns, both sensor-
level maps are contaminated with noise either from other brain sources or from 
ferromagnetic DBS electrode artefact. 
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4.4 Discussion 
We have shown that the PPNR in patients with PD is functionally coupled with diverse brain 
regions in two frequency bands at rest. Although possibly partially overlapping in a central 
area that includes the brainstem, thalamus and anterior basal ganglia, each resting state 
network (RSN) can be shown to dominate in different regions. The alpha band RSN 
dominates in the cerebellar cortex, whereas the beta band RSN dominates in frontal motor 
cortical areas. This broad distinction into two networks, reinforced by the selective effects of 
treatment with levodopa, highlights the functional position of the PPNR at the junction 
between motor cortical planning areas and the cerebellum. The extent of functional coupling 
with the PPNR was remarkable, given the evidence of partial loss of cholinergic neurons in 
the PPN pars compacta, in PD (Jellinger, 1999; Manaye et al., 1999).   
 
Before discussing the implications of these findings, we should outline some of the important 
limitations of this study.  Firstly, we studied a relatively small number of subjects. However, 
given the scarcity of human PPNR functional connectivity data, we believe these results are 
still valuable. Secondly, these data are susceptible to confounds related to the use of 
different MEG systems and to ferromagnetic artefact from DBS electrodes. However, by 
using techniques such as spatial filtering (beamforming) and spatial normalisation, we were 
able to obtain comparable coherence estimates between subjects and conditions – although 
this constrains the analysis to distinguish changes in the relative topography of coherence, 
rather than absolute values. Finally, some of the intracranial electrodes lie outside the 
presumed PPN, therefore we primarily report connectivity with the PPNR as a whole. 
However, as we had both electrode contacts within and outside of the PPN we were able to 
contrast activities across this area and define effects of dopamine and frequency that were 
highly specific to a central subregion within the PPNR, corresponding to the caudal PPN. 
Overall, we acknowledge that our analysis may have reduced sensitivity, and what we 
present is a conservative, but specific account of PPNR functional connectivity.     
 
The extensive patterns of cortical coupling with the PPNR are in keeping with this region’s 
rich direct and indirect, polysynaptic connectivity in humans and other animals (Sesack et 
al., 1989; Hazrati and Parent, 1992; Pahapill, 2000; Mena-Segovia et al., 2004; 
Aravamuthan et al., 2008; Schofield and Motts, 2009; Alam et al., 2011; Martinez-Gonzalez 
et al., 2011). More specifically, the cortical and subcortical topographies of the two RSNs 
characterised by activities in the alpha and beta bands share some similarity with those with 
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similar spectral organization demonstrated to be coupled with the subthalamic nucleus 
(STN) in PD patients (Hirschmann et al., 2011; Litvak et al., 2011a), underscoring the 
functional interdependency of the PPNR and STN. However, it is important to acknowledge 
that although the pattern of distributed connectivity may be broadly similar between these 
two subcortical hubs (although the STN was not coherent with the cerebellum), the 
directionality of effective coupling was rather different. Coupling from source to STN 
dominates (Litvak et al., 2011a), but this was certainly not the case for coupling from source 
to PPNR. This tendency to more bidirectional and efferent (PPNR-to-source) coupling, 
particularly in the treated Parkinsonian state, is in line with the PPNR’s position closer to the 
outflow of the basal ganglia to the brainstem and thalamus.  
 
Many of the areas of the brain coupled with the PPNR at rest have been shown to be 
modulated by gait or differ in activity between PD patients with and without FOG -the major 
symptom in our cohort (reviewed in (Bartels and Leenders, 2008)).  For example, PD 
patients show altered gait-related perfusion in the precuneus (reviewed in (Nutt et al., 2011)) 
and temporal cortex (Hanakawa et al., 1999) compared to controls, while gait reduces 
dopamine transporter (DAT) availability in the orbitofrontal cortex of patients with PD but not 
in control subjects (Ouchi et al., 2001). The suggestion in these previous studies has been 
that these distinct areas are enlisted in an attempt to compensate for gait impairment. It is 
interesting to note that we have identified a corresponding set of functional connections 
between all these areas and a key locomotor region, the PPNR, suggesting that the PPNR 
may act as a hub through which these cortical effects are co-ordinated. Indeed, low 
frequency stimulation of the PPNR alters resting cortical glucose metabolism and cerebral 
blood flow in a large network of areas that include the orbitofrontal cortex, cingulate, 
prefrontal areas, temporal lobe, thalamus and cerebellum (Ballanger et al., 2009; Ceravolo 
et al., 2011). 
 
What specialised functions might the two RSNs mediate? The alpha frequency band has 
often been associated with attention and the allocation of processing resources (Palva and 
Palva, 2007), and we have previously suggested that the somewhat similar alpha band RSN 
with the STN may subserve attentional functions in patients with Parkinson’s Disease (Litvak 
et al., 2011a).  The latter may be particularly critical in the present patient group which was 
preselected for the prominence of gait difficulties, particularly freezing. A relationship 
between attentional control and gait performance is increasingly recognised (Yarnall et al., 
2011). Gait speed reduces in healthy subjects, elderly fallers and in Parkinson’s disease 
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during the performance of a second, unrelated task (‘dual tasking’) (Hausdorff et al., 2003; 
Springer et al., 2006; Lamoth et al., 2011). Dual tasking and other processes that divert 
attention away from walking can all also precipitate gait freezing (Springer et al., 2006). In 
PD, attentional deficits are increased in patients that fall (Allcock et al., 2009) and freeze 
during gait (Amboni et al., 2008; Yogev-Seligmann et al., 2008).   
 
The PPN is considered a component of the ‘reticular activating system’ and may modulate 
states of arousal and attention (Winn, 2006). In line with such a role, PPN stimulation in 
patients with Parkinson's disease (PD) may increase rapid eye movement sleep (Romigi et 
al., 2008; Lim et al., 2009) and diurnal vigilance (Ferraye et al., 2010), and there is PPNR-
cortical coherence in the alpha band during wakefulness (Androulidakis et al., 2008). We 
suggest that the PPNR may be another subcortical relay in attentional networks 
characterised by oscillatory activity in the alpha frequency band (Litvak et al., 2011a; 
Thevathasan et al., 2012). That said, the precise homology between the alpha band RSNs 
coherent with the STN and PPNR can only be determined in the future through simultaneous 
recordings of MEG and subthalamic and PPNR LFPs in the same subjects. Given the 
functional and anatomical heterogeneity of the PPNR, and the spread of electrodes within it, 
one may have expected a large variation in coupling due to electrode position within the 
PPNR.  Indeed single-subject raw coherence data do suggest considerable variation 
between subjects exists (Figure 26) presumably partially due to differences in electrode 
position. The middle PPNR (including the caudal PPN), between 2 to 6mm below the PM 
line, may be particularly important in supporting a possible role in gait control through 
attentional modulation. Local oscillatory synchrony in the alpha band was maximal here and 
has been shown to correlate with gait performance (Thevathasan et al., 2012). Consistent 
with the special importance of this middle section of the PPNR, this region showed the 
greatest average raw coherence with different cortical locations (Figure 25). It was 
preferentially coherent with the inferior frontal region in the alpha band and was coupled to 
the precuneus in a dopamine sensitive manner.  We have previously argued that this middle 
section of the PPNR includes the caudal part of the ‘pars dissipata’ of the PPN (Thevathasan 
et al., 2012). The pars dissipata of the PPN, as defined by immunohistochemical labelling of 
choline-acetyltransferase in humans, extends both rostrally and caudally from the central 
pars compacta, (Mesulam et al., 1989; Manaye et al., 1999), and has been implicated in gait 
and its dysfunction (Karachi et al., 2010). It should, however, be acknowledged that the pars 
dissipata of the PPN has indistinct boundaries, and of note, just medial to its caudal 
boundary is the laterodorsal tegmental nucleus which is also rich in cholinergic neurons 
(Manaye et al., 1999). 
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Still, it must be stressed that the association of the PPNR alpha band RSN with attentional 
function remains speculative. Nor does it discount the possibility that the beta band RSN 
may also play a role in attention, possibly through its functional connectivity with the medial 
prefrontal cortex, including the cingulate. Thus it has been suggested that the medial 
prefrontal cortex is involved in compensation for low-arousal states where attention is still 
necessary, such as in monotonous vigilance tasks like walking (Portas et al., 1998; Coull et 
al., 2004; Gilbert et al., 2006; Fischer et al., 2008). This compensation has been linked to 
enhanced frontal power in the beta frequency band (Fischer et al., 2008) - precisely the 
frequency of dominant connectivity between midline frontal regions and the PPNR. Of 
course task-related modulation of activity in the beta RSN, with its extensive connectivity to 
motor areas, may also contribute to more explicitly motor aspects of gait. Consistent with 
this, both beta band LFP power in the PPNR, and beta coherence between the medial 
frontal cortex and the PPNR are reactive to movement in patients with PD (Tsang et al., 
2010).  
 
Our results may also afford insight into dysfunction in the PPNR and its functional 
connectivity in the Parkinsonian state. Basal ganglia pathophysiology in PD is classically 
modelled as a relative overactivity of the polysynaptic indirect pathway. This potentially 
upregulates two sets of competing inputs to the downstream PPN:  inhibitory GABAergic 
influences from the GPi and SNr and excitatory glutamatergic influences from the STN. 
Although still debated, several lines of evidence suggest that the inhibitory inputs dominate, 
resulting in an overall pathological inhibition of the PPN in PD (but on the other hand, see 
(Teo et al., 1997, 1998)). Hence acetylcholine synthesis is suppressed in the PPN in the 
Parkinsonian state (Gomez-Gallego et al., 2007). Reducing PPN activity, as occurs with 
destructive lesions, leads to a Parkinsonian-like state (Aziz et al., 1998), and there is a 
relationship between the loss of cholinergic neurones in the PPN pars compacta and the 
severity of Parkinson's disease (Zweig et al., 1989). Furthermore, akinesia in MPTP treated 
monkeys may be reversed by the microinjection of the GABA antagonist, bicuculline, into the 
PPN (Nandi et al., 2002). Our directionality data were broadly in keeping with an 
exaggerated inhibition of the PPN in untreated PD, in so far as the dopamine prodrug 
levodopa released outflow from the PPNR, most clearly in the beta frequency band. This 
was evident as a shift in favour of effective coupling directed from PPNR, particularly the 
middle PPNR, to distal sources at the expense of source-PPNR and bidirectional coupling. 
Furthermore, the emphasis on a change in directionality in the beta band supports and 
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extends the hypothesis that dopamine-induced beta activity in the PPNR is ‘prokinetic’ in 
contrast to the posited ‘antikinetic’ nature of beta activity in the basal ganglia in PD (Classen 
and Schnitzler, 2010; Tsang et al., 2010).  
 
Although we cannot discriminate the specific effect of dopamine on the coupling from 
pallidum to PPNR, our methodology does help define effects on the coupling between the 
cerebral cortex and PPNR. Treatment with levodopa led to a retuning of coherence between 
the PPNR and temporal cortex in favour of activities in the beta band, at the expense of 
those in the alpha band. In addition, dopamine reduced coherence in the alpha and beta 
band between the precuneus and middle PPNR (which includes the caudal PPN).  
 
Our results support the notion of two principal RSNs involving the PPNR, which may be 
distinguished in terms of their spectral tuning and their wider connectivity. This represents an 
initial step in determining the different functional associations of these circuits which, 
although characterised here at rest, may still be important during gait. In particular, the 
results lead us to posit a contrasting beta-tuned predominantly motor planning RSN and 
alpha-tuned predominantly attentional RSN, and encourage future explorations of how these 
networks are modulated during walking or imagined gait. Eventually, it may be possible to 
differentially modulate these systems through stimulation, by harnessing their different 
resonance properties and any fine scale differences in their organisation within the PPNR.  
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5. Functional roles of the pre-SMA and right IFG during 
stopping in healthy controls 
 
5.1 Introduction 
So far we have demonstrated how the spatial and spectral properties of cortico- subthalamic 
and cortico-pedunculopontine connectivity can be used to distinguish different cortico- basal 
ganglia networks.  But do these networks subserve different functions? As we have 
reviewed, the particular spatial and spectral properties of each of the resting networks can 
suggest that the basal ganglia are involved in motor, cognitive and attentional processes, but 
this has to be experimentally confirmed using dynamic tasks. In this chapter, we first pilot 
novel experimental and analytical methods to examine dynamic task-related electromagnetic 
activity in healthy controls. In doing so, we disambiguate the specialised function of two key 
cortical areas involved in the act of stopping.  Directly following on from this work, we apply 
the same analysis procedure to understand the cortico- basal ganglia dynamics responsible 
for stopping in PD in the next chapter.   
Stopping may imply an absence of movement, but it does not imply the absence of action. 
This is because an action is defined not only by the mechanics of its execution but also by 
the conditions that attend it.  Indeed the importance of stopping usually lies in the context – 
stopping may be particularly important if one hears a car horn whilst walking across a road – 
rather than the execution itself. Therefore the neural correlate of stopping must invoke brain 
regions which are sensitive to the context, in addition to those responsible for executing the 
stop.  
Stopping has been experimentally studied using the stop-signal paradigm (Logan and 
Cowan, 1984). Here, the subject is asked to press a left or right button in response to a 
directional go cue – the primary task. In a minority of trials, a second visual cue (the stop-
signal) is presented quickly after the first, instructing the subject to inhibit the planned 
response. The efficiency of stopping can be estimated by varying the time in which the 
subject has to stop (the delay between the primary task and stop cues – termed the stimulus 
onset asynchrony (SOA)), and relating this to the success rate of stopping.  This 
relationship, known as the inhibition function, has a midpoint that represents the average 
time taken to stop – the stop-signal reaction time (SSRT) (Logan and Cowan, 1984; Hanes 
and Carpenter, 1999; Band et al., 2003; Congdon et al., 2012). 
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Using this paradigm, two candidate regions have been identified as pre-eminent within the 
cortical network associated with stopping: the pre-supplementary motor area (pre-SMA) 
(Isoda and Hikosaka, 2007; Nachev et al., 2007) and the right inferior frontal gyrus (IFG) 
(Aron et al., 2003; Aron and Poldrack, 2006).  Although lesions in both regions reduce 
stopping efficiency (Aron et al., 2003; Nachev et al., 2007), their individual roles remain 
controversial. Nachev et al. reviewed different experimental paradigms implicating the pre-
SMA and hypothesised that activity in this region corresponded to the contextual complexity 
of a task:  tasks which are more contextually complex, having a greater number of contextual 
factors (Nachev et al., 2008).  In contrast, converging evidence directly relates right IFG 
function to the efficiency of stopping (i.e. its execution) regardless of the experimental 
context (Aron et al., 2003, 2007a; Aron and Poldrack, 2006; Xue et al., 2008). However, the 
role of these two regions has yet to be disambiguated, partly due to the inherent 
methodological limitations when associating human behaviour with neuronal activity. 
Functional magnetic resonance imaging (fMRI) studies routinely use a convolution model in 
order to disambiguate the haemodynamic responses associated with different events during 
the stop-signal task. However most fMRI studies have not found convincing differences 
between successful and unsuccessful stopping (Aron and Poldrack, 2006; Aron et al., 
2007b), and it can be difficult to meaningfully relate behaviour occurring over hundreds of 
milliseconds to a dispersed haemodynamic response occurring a few seconds later. 
Electroencephalographic studies generally afford greater temporal information (Kok et al., 
2004; Schmajuk et al., 2006), but at the cost of spatial precision.  Recent studies, though, 
have measured electrophysiological activity more focally in rarer patient populations with 
intracranial (Ray et al., 2011) or subdural electrodes (Swann et al., 2009, 2012) and have 
suggested that during the stop-signal task, early gamma frequency activity in the pre-SMA 
and later beta frequency activity in the right IFG and subthalamic nucleus may be important 
in stopping.  However, unlike routine fMRI analysis, conventional electrophysiological 
averaging techniques cannot disambiguate the induced responses to closely temporally 
related events such as the go signal, stop-signal and the button press during the stop-signal 
paradigm.  This is critical because if the neuronal responses to individual events cannot be 
disambiguated, successful-stop and failed-stop trials cannot be compared meaningfully 
without the confounding presence of a movement during failed-stop trials only.  
In this study we overcame previous methodological limitations by applying a novel 
convolution model for electrophysiological analysis (Litvak et al., 2012b) to simultaneously 
acquire high temporal and spatial resolution magnetoencephalography (MEG) data. We 
hypothesised that the pre-SMA is preferentially sensitive to the context of stopping, whilst 
the right IFG is preferentially involved in the efficiency of its execution. 
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5.2 Methods 
 
5.2.1 Subjects and paradigm 
Nine healthy right-handed subjects were studied (mean age 31 years (range 21 – 38yrs); 5 
females). To dissociate the effects of contextual complexity, we used four variants of the 
stop-signal paradigm that all had the same requirement for inhibition – the inhibition of the 
primary task – but with additional modulators of the contextual parameters of the action (see 
Figure 29). We modulated the contextual parameters in two ways. Firstly, we manipulated 
the complexity of the required response by using both the stop-signal task and the change-
of-plan task. In the latter, visual cues remain the same as in the stop-signal paradigm, but 
the subject is required to inhibit the primary task and also press the opposite button in 
response to the stop-signal, - now called a change-signal in this context (Logan and Burkell, 
1986; Brown and Braver, 2005; Nachev et al., 2007).   However, a direct comparison of stop-
signal and change-of-plan tasks would not only represent increased contextual complexity 
but would also be confounded by increased conflict between the tasks (Botvinick, 2007). 
Therefore, secondly, we manipulated the stop/change instruction, using either a vertical bar 
or a directional arrow always opposite to the primary task arrow. The interaction between 
both manipulations isolates the effect of conditional complexity, where more complex actions 
are conditional on a greater number of contextual factors (Nachev et al., 2007). An arrow is a 
contextually simpler change cue, because it explicitly specifies the direction of change 
whereas the direction of change to a vertical bar is additionally dependent on a second 
contextual parameter – the direction of the primary go cue. The reverse is true for stopping 
only. Now, a vertical bar stop cue always means stop. However, in the arrow condition, 
because the both the primary task cue and stop cue are directional arrows, the stop arrow 
only means stop if it is following another arrow i.e. it is dependent on an additional contextual 
cue. This reversal of effects isolates contextual complexity whilst removing idiosyncratic cue 
or response related confounds.  
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Figure 29: Paradigm details. We used four variants of the stop-signal paradigm arranged 
within a 2x2 factorial design. Each trial consisted of a left- or right- pointing go arrow 
instructing the subject to press the corresponding button quickly (go trials, e.g. trial n in 
figure). In 50% of trials, after a variable delay (the SOA), a further visual stimulus was 
presented. Depending on the variant of the paradigm (a single variant was used per task 
block) the subject was asked to either inhibit the planned response (stop response context) 
or to inhibit the planned response and additionally press the opposite button (change 
response context), in response the second visual stimulus. In addition to response context, 
we manipulated the stop/change stimulus context by using either a vertical bar or a 
directional arrow (always opposite to the primary task arrow) as the instruction to change or 
stop. The interaction between both manipulations isolates the effect of contextual complexity 
A successful change in response to a vertical bar is conditional on the direction of the 
primary go cue (complex context), whereas the direction is explicitly specified if the change 
stimulus is an arrow (simple context). The reverse is true for stopping – stopping to a vertical 
bar requires no additional information as a bar always means stop (simple context), but one 
usually presses a button in response to an arrow, and only stops to an arrow in the context 
of an immediately preceding arrow (i.e. it is dependent on a second piece of information - 
complex context). The SOA was dynamically altered between trials to strive for a 50% 
correct response rate. RT is the trial reaction time. 
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Each task block contained only one paradigm variant, and the order of task blocks was 
balanced across subjects. During each paradigm, the subject was presented with a fixation 
cross (lasting 1.3 – 1.5s, the duration was drawn from a uniform distribution) which, after a 
200 ms pause with a blank screen, was followed by a green left- or right- pointing arrow (the 
primary task stimulus, or ‘go signal’). The subject was asked to make a button-press with the 
thumb of the corresponding hand as quickly as possible. In a randomly selected 50% of 
trials, a further red visual signal was presented at a variable latency (called the stimulus 
onset asynchrony, SOA) after the primary task stimulus. In response to this second signal, 
the subject was asked to either inhibit the button press (stop-signal task) or change to 
pressing the opposite button (change-of-plan task) depending on the task variant. We used 
two different symbols as the stop/change cue in each task: a directional arrow (<) or a 
vertical bar (|).  The SOA was dynamically altered on a trial-by-trial basis according to a 
staircase – a correctly switched/stopped response resulted in the SOA increasing by 50ms 
(making the task more difficult) whereas after a failure to change/stop, the SOA reduced by 
50ms (allowing more time to stop/change the response, making the task easier) (Levitt, 
1971). This staircase tracking procedure aims to fix the probability of successfully 
stopping/changing at ~0.5 so that successful-stop/change and failed-stop/change conditions 
were equally sampled. The SOA was randomly drawn from 2 independent staircases, so that 
both the presence and timing of the stop/change-signal remained difficult for the subject to 
predict.   
 
5.2.2 Behavioural analysis 
The aims of the behavioural analysis were threefold: to determine whether experimental 
modulations were evident in behaviour; to identify and exclude experimental runs where 
behaviour was anomalous; and to provide behavioural summary measures which could be 
used as predictor variables in the electrophysiological analysis.  Stimuli and response 
timings were recorded and analysed offline using custom Matlab scripts, the Psignifit toolbox 
(Fründ, I, Haenel, NV, Wichmann, 2011) and SPSS software version 20.   
Three key trial-types were considered: go only trials (where the stop/change-signal is not 
presented), successful-stop/change trials (where the stop/change signal is presented and 
subject successfully changes or stops) and failed-stop/change trials (where the stop/change 
signal is presented, but the subject fails to inhibit or change the response). Other trials, such 
as non-change signal trials where the left button was pressed in response to the right arrow 
were considered unclassified errors and discarded.  
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1 
3 155 10 145 0.49 0.31 0.64 0.59 0.94 0.50 0.45 161 
4 154 14 140 0.48 0.34 0.54 0.48 0.84 0.35 0.30 217 
3 
1 155 8 147 0.50 0.49 0.43 0.39 
 
0.25 0.20 189 
2 153 10 143 0.50 0.42 0.44 0.42 
 
0.30 0.25 154 
3 156 12 144 0.51 0.47 0.41 0.38 0.52 0.25 0.15 215 
4 155 20 135 0.50 0.45 0.37 0.34 0.43 0.20 0.15 189 
4 
1 155 8 147 0.50 0.35 0.71 0.66 
 
0.55 0.45 212 
2 122 8 114 0.48 0.29 0.73 0.70 
 
0.58 0.50 165 
3 155 14 141 0.49 0.33 0.71 0.60 1.01 0.48 0.45 212 
4 155 12 143 0.47 0.33 0.63 0.54 0.94 0.47 0.40 179 
5 
1 153 4 149 0.49 0.33 0.57 0.54 
 
0.42 0.40 101 
2 155 4 151 0.50 0.20 0.72 0.71 
 
0.60 0.55 55 
3 155 12 143 0.49 0.35 0.78 0.68 1.09 0.60 0.50 228 
4 155 36 119 0.48 0.27 0.63 0.50 0.79 0.40 0.35 139 
6 
1 154 6 148 0.51 0.40 0.53 0.48 
 
0.35 0.30 208 
2 151 4 147 0.48 0.39 0.65 0.61 
 
0.50 0.45 204 
3 151 18 133 0.50 0.23 0.86 0.71 1.10 0.70 0.60 134 
4 155 12 143 0.52 0.37 0.76 0.69 0.95 0.60 0.50 200 
7 
1 156 10 146 0.49 0.42 0.54 0.48 
 
0.40 0.35 189 
2 154 6 148 0.49 0.40 0.50 0.47 
 
0.35 0.30 149 
3 155 16 139 0.49 0.43 0.55 0.50 0.72 0.35 0.30 208 
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4 155 14 141 0.50 0.44 0.61 0.56 0.85 0.45 0.40 185 
8 
1 155 7 148 0.48 0.42 0.43 0.42 
 
0.25 0.25 169 
2 155 8 147 0.50 0.38 0.54 0.50 
 
0.30 0.30 240 
3 154 31 123 0.48 0.24 0.74 0.56 0.86 0.50 0.45 96 
4 156 38 118 0.48 0.24 0.58 0.48 0.75 0.32 0.33 110 
9 
1 154 10 144 0.48 0.44 0.57 0.53 
 
0.30 0.25 302 
2 154 8 146 0.50 0.36 0.56 0.47 
 
0.35 0.30 172 
3 154 25 129 0.50 0.35 0.60 0.52 0.67 0.35 0.30 201 
4 156 37 119 0.49 0.34 0.53 0.51 0.61 0.35 0.30 161 
M 
 
153 12 141 0.49 0.39 0.57 0.52 0.80 0.39 0.34 194 
Table 6: Trial numbers and reaction time data for each subject and condition. Note 
data from subject two, and conditions 1 and 2 from subject one were discarded due to 
drowsiness and a software error, respectively. Otherwise each subject performed four 
variants of the task defined by the stop/change stimuli (| or >) and the response required 
(stop or change). The conditions were: (1) stop |, (2) stop <, (3) change |, (4) change <. The 
total of presented trials per condition is shown with the number of classified trials taken onto 
further analysis. Unclassified trials include the first 5 trials of every condition and trials where 
the subject lapsed or made unclassified errors (e.g. pressed two buttons). The change 
fraction is the fraction of change trials/ total trials. The fail fraction is the fraction of 
unsuccessful trials/all change trials.  The median reaction times of go only trials (Go RT), 
failed stop/change trials (Fail RT) and successful stop/change trials (Succ RT) are 
presented. Successful stop trials do not have a reaction time. Median SOA for failed and 
successful stop/change trials is presented. The stop-signal reaction time (SSRT) estimate 
(as the threshold of the psychometric function) is also given for each condition. Some 
subjects and conditions were rejected from further analysis due to low fail fractions 
(highlighted by red fail fractions) and poorly fitting psychometric functions (highlighted by red 
SSRTs). The mean (M) of the data, after having removed these trials, is given in the bottom 
row.  
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We performed two analyses to check that the subject had engaged in the task appropriately. 
Firstly, we looked at basic reaction time measures: we calculated the median reaction times 
for each trial type in each condition, the median SOA in each condition and the proportion of 
unsuccessful stop/change trials (error fraction) per condition. One subject was excluded at 
this stage because of reported drowsiness during the experiment and reaction times greater 
than 1s (data not presented), and two conditions were discarded for another subject due to a 
software error. Trial numbers and these behavioural summary measures are presented per 
subject in Table 6.   
Secondly, we modelled the inhibition function of each data run whilst trying to protect against 
non-stationarities in the data (e.g. reaction time drift) and behavioural confounds (guessing 
and lapses in concentration). The inhibition function models the proportion of correct 
responses, i.e. successful stops or changes, as a function of the SOA and is linear around 
central SOAs. To allow comparison between conditions with different primary reaction times 
it is often normalised - for example by subtracting the SOA from the median primary task 
reaction time (Logan and Cowan, 1984; Band et al., 2003).  We began by visually inspecting 
reaction time trends and the SOA staircases to ensure that the both SOA staircases 
converged (see %% for an example).  Whist performing the task, subjects tended to 
progressively delay responses to the primary task – to wait for the stop/change signal, 
presumably to increase their success-rate. However, this creates a non-stationary primary 
task reaction time which violates the underlying assumptions of the horse-race model. To 
adjust for this we fitted cubic splines to the SOA and the go only reaction time data. This 
provides a predicted go reaction time for stop/change trials – an estimate of how the subject 
would have responded on stop/change trials if they had been go only trials, based on the 
reaction times of neighbouring trials (Nachev P, unpublished, 
http://ukpmc.ac.uk/theses/ETH/445162).  On stop/change trials we subtracted the SOA from 
the predicted go spline to estimate the decision time per trial - the post-stop/change signal 
latency required to make a correct or incorrect decision on that trial, correcting for reaction 
time drift in the data. The ratio of successful:total stop/change trials was calculated as a 
function of decision time in 100ms bins. We fitted an inhibition function to this data using a 
Bayesian Markov Chain Monte Carlo (MCMC) procedure, which is superior to other methods 
such as bootstrapping (Kuss et al., 2005; Fründ, I, Haenel, NV, Wichmann, 2011). The 
psychometric function fitted was a sigmoid defined by four parameters (with standard prior 
distributions): the upper limit of the function or ‘lapse rate’ (prior: gamma(2,400)), the 50% 
point of the function or ‘threshold’ (prior: beta(1.5,10)), the ‘slope’ at 50% of the function 
(prior: beta(1.5,10)), and the lower limit or ‘guess rate’ (prior: gamma(2,400)). Calculating the 
Bayesian posterior for such a model is analytically intractable, but it can be approximated by 
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the MCMC procedure, which generates many samples of the posterior according to a 
particular algorithm (Kuss et al., 2005). We generated 4000 samples, discarding the first 
2000 samples, to estimate an approximation to the posterior of the inhibition function. In this 
scenario the threshold of the function, i.e. the decision time which reflects mid-point of the 
inhibition function, is equivalent to the SSRT of that subject during that condition. We 
assessed the goodness-of-fit of the model by calculating the deviance, which is a 
generalisation of the sum-of-squares metric that applies to binomial data (Fründ, I, Haenel, 
NV, Wichmann, 2011). 
To look for behavioural evidence of complexity, median reaction time estimates were 
subjected to a mixed hierarchical model in SPSS with response (stop or change), cue type (| 
or >) and previous trial (previous successful stop/change, previous failed stop/change, 
previous go only trial) as fixed factors and subject as a random factor. SSRT and the slope 
of the inhibition function were subjected to similar models, omitting the previous trial factor. 
We confirmed that post-stop signal changes apparent when examining median reaction 
times were not merely due to different amounts of drift, by limiting the analysis to only post 
stop/change-signal trials and calculating a corrected post-stop signal reaction time (current 
trial go only reaction time - previous go only trial reaction time). To increase trial numbers, 
we included trials where a go only trial was preceded by several stop/change trials, as long 
as the outcome for all stop/change trials was the same (similarly to (Bissett and Logan, 
2011)). The median of these corrected reaction times per condition were also subjected to a 
mixed hierarchical general linear model with stop/change stimulus (< or |), response (stop or 
change) and previous trial history (previous successful stop/change trial, previous 
unsuccessful stop/change trial) as fixed-factors and subject as a random factor.  
 
5.2.3 Magnetoencephalographic data acquisition and pre-processing 
MEG data were acquired at 600Hz with a 275 channel CTF system.  The data were stored 
and analysed off line using SPM8 (Litvak et al., 2011b) and Fieldtrip (Oostenveld et al., 
2011) toolboxes. They were down-sampled to 300Hz, high-pass filtered above 0.1 Hz, and 
the line noise artefacts at 50 Hz and 100 Hz were removed using notch filters (5th order 
zero-phase Butterworth filters).  We then extracted time-series data from cortical regions of 
interest using a linearly constrained minimum variance beamformer (LCMV) beamformer 
(Van Veen et al., 1997). Although we were primarily interested in the right IFG and pre-SMA, 
we also looked at other cortical regions implicated within the stopping network, to support 
the regional specificity of the effects of interest (Aron et al., 2007a). The MNI co-ordinates 
(x,y,z) of locations of interest were taken from the literature and included the pre-SMA 
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(2,30,48 taken from (Nachev et al., 2007)), the right and left IFG (±42,26,14 from (Aron et al., 
2007a)), the SMA (-2,-10,59 adapted from (Mayka et al., 2006)) and both the primary motor 
cortices (±37,-25,62 adapted (Mayka et al., 2006)).  Locations obtained from  Mayka et al. 
were converted from Talaraich to MNI space using a transform devised by Mathew Brett 
(http://imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach). The beamforming method 
involves linearly projecting the MEG sensor data using a spatial filter computed from the lead 
field of the source of interest and the data covariance (Van Veen et al., 1997). The spatial 
filter is designed to extract activity from the region of interest, whilst suppressing activity from 
other sources. Lead fields were computed using a single-shell head model (Nolte et al., 
2004) based on an inner skull mesh derived from a canonical T1 MRI.  We specified 0.01% 
regularization and defined the orientation of each source to be in the direction of maximum 
power. In order to determine if we had sufficient signal separation for the different sources of 
interest, we correlated the beamformer filter coefficients between each source of interest and 
all the other sources (Barnes et al., 2004).  
Time-series data were then standardised by subtracting the mean and dividing by the 
standard deviation. To make standardization robust to possible artefacts, medians of the raw 
and squared signals were computed for non-overlapping 10 s segments and averaged 
yielding first and second moment estimates.  Time-frequency representation of the data was 
generated using multitaper spectral analysis (Thomson, 1982). We computed continuous 
power over the whole data run in time windows of 0.4s shifted in steps of 0.05s over a 
frequency range of 2.5 to 90 Hz in steps of 2.5 Hz. The frequency resolution was set to the 
inverse of the time window (2.5 Hz) for up to 25 Hz, then 0.1 times the frequency for 25 to 50 
Hz and then to a constant 5 Hz.  Because power is a non-linear measure, the square root of 
power (i.e. root mean square (RMS) amplitude) was taken forward to the following linear 
convolution model. 
MEG data were analysed hierarchically: summary measures of induced responses were 
obtained with a first-level convolution model, then transformed into time-frequency images 
and finally subjected to a standard general linear model at the second level. 
 
5.2.4 The convolution model for magnetoencephalographic data 
To characterise and disambiguate induced responses to the events of interest, regressors 
were generated for each event-type, and assembled as predictors of continuous amplitude in 
a general linear model (GLM) at each frequency. Each event was modelled as a delta 
function (a spike) and then convolved with a set of Fourier basis functions spanning -0.5 to 
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+1.5s relative to each event (the peri-stimulus time-window).  GLM coefficients were 
estimated using ordinary least squares. The induced response for a particular event-type 
and frequency can be reconstructed by multiplying the basis functions with the parameter 
estimates corresponding to the event-type and frequency in question (Litvak et al., 2012b). 
When this is repeated for all frequencies – and the same event-type – the ensuing response 
functions of peri-stimulus time constitute a time-frequency image of the amplitude per event-
type. In the simplest case, with non-overlapping events, this would be equivalent to 
averaging time-frequency images centred on an event of interest. However, our data 
contains multiple temporally overlapping responses. Therefore the convolution model was 
superior to event-locked routine averaging. This is because, at each frequency, multiple-
event types are modelled in the same GLM, and therefore the variance that each regressor 
(corresponding to an event-type) explains is independent of every other regressor. As a 
result, closely overlapping responses can be disambiguated if they do not always occur 
together. For example, the induced response to a failed stop-signal can be disambiguated 
from the associated button press, allowing for a direct comparison of successful and failed 
stop-signal induced responses, having accounted for the confounding button press. 
Individual regressors were specified for the fixation cross, the primary task stimulus 
(separately for left and right arrows), and button press responses (separately for left and 
right responses) and the stop/change signal (separately for successful and failed change 
conditions). Separate models were used to estimate induced responses during different 
stop-signal task variants. The data and the design were filtered below 0.25 Hz.  
   
Previous studies have shown that post stop-signal trials are longer than other trials 
(Verbruggen and Logan, 2009a; Bissett and Logan, 2011) and that the medial frontal cortex 
is sensitive to reaction time changes (Grinband et al., 2011; Yeung et al., 2011). Increasingly 
conditionally complex tasks increase reaction time, therefore we sought to model the neural 
responses associated with contextual complexity, having taken into account any changes in 
reaction time not due to contextual complexity. In order to do this, we included trial reaction 
time in our model by using the predicted go spline as a parametric modulator of the go signal 
event. After modelling the mean go event, and variation due to go-reaction time drift, we then 
estimated induced responses separately for all combinations of the current trial (left or right 
cue) and previous trial-type (go only trial, successful stop/change trial, failed stop/change 
trial). The resulting induced responses across different go events are independent of 
reaction time drift (e.g. due to attentional lapses, or strategic changes), independent of 
reaction time changes due to previous trial-type, and balanced across different conditions 
with potentially different percentage of stop/change errors. In addition, stop/change 
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successes have longer reaction times than stop-change failures. We modelled this variation 
by using the stationary measure of decision time (primary task go only reaction time – SOA 
spline) as a parametric modulator of the stop/change signal. Use of the spline, rather than 
actual reaction times allows estimates of decision time where no reaction time is available 
(e.g. successful stopping). 
 
5.2.5 Analysis of time-frequency images 
After eliminating reaction-time confounds, we generated time-frequency images for each 
event-type and entered these into within-subject ANOVAs for each cortical source. We 
studied responses to two event-types statistically: the stop/change signal - with success 
(successful or failed), stop/change stimulus (< or |) and response (stop or change) as 
factors, and the go signal – with the current trial (left or right cue) and previous trial-type (go 
only trial, successful stop/change trial, failed stop/change trial) as factors. Two tailed t-tests 
were performed for each main effect and interaction and were thresholded at p=0.05 FWE, 
taking non-sphericity of error into account using standard procedures (Litvak et al., 2011b).    
 
5.3 Results 
5.3.1 Subject task performance 
Nine subjects performed all four conditions of the task in an order counterbalanced across 
subjects. One subject was drowsy during the experiment, with resulting primary task reaction 
times greater than 1s and was excluded from further analysis. A software error made data 
from two conditions from subject one uninterpretable, and so data from these experiments 
were discarded. Trial numbers and behavioural estimates from the remaining subjects and 
conditions are shown in Table 6. The lowest number of trials per condition was 118. 
To determine whether subjects performed the tasks appropriately, we examined the 
following data features: SOA staircase convergence; the number of unsuccessful 
stop/change trials as a fraction of the total number of stop/change trials (fail fraction); and 
the fit of the psychometric inhibition function, based on the deviance estimated from the 
Bayesian MCMC procedure. An example of this process can be seen in Figure 30, and the 
psychometric fits for all the subjects and conditions can be seen in Figure 31. 
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Figure 30: Behavioural data examples. The top image shows the timing of various trial 
events during 150 sequential trials in one subject during a stop-signal task. Green circles 
represent the reaction time during go only trials. A green spline has been fitted through these 
trials to highlight reaction time drift. Half of the trials had a stop signal, after a delay (SOA) 
represented by a red circle. Again a spline has been fitted to the SOA to visualise drift. Note 
how the two SOA staircases converge during the first few trials. Finally blue circles represent 
reaction times during stop-fail trials. Although there is some drift to both go reaction time and 
SOA, the resulting stop/change decision time (Go only spline – SOA spline) is stationary. 
The first 5 trials of every block (shown here) have been excluded from behavioural and 
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electrophysiological analysis, as the stop/change decision time is poorly estimated here. The 
plots beneath show the inhibition functions for the same dataset (left) and a separate run 
(right). The plot on the left shows the proportion of successful responses to the stop-signal 
as a function of predicted RT (the Go RT spline) – SOA. The data are represented by blue 
circles, with larger trials numbers resulting in larger circles. The fitted psychometric function 
is also displayed by a blue line, with 20 alternative samples from the distribution of the 
function presented in light blue. The 50% threshold of the function, equivalent to the SSRT, 
is highlighted with a red circle. The deviance (Dev) of the model represents the goodness-of-
fit to the data. The condition on the left shows a good fit (Dev=2.4), whereas the condition on 
the right shows a poor fit (Dev=28.7) – the latter was rejected from further analysis.
164 
 
Figure 31: Inhibition functions for each subject and condition. Each plot shows the proportion of correct stops or changes as a 
function of the SOA, normalised by subtracting the predicted go reaction time. The trial data is binned in 100ms bins and plotted as blue 
circles – a larger circle corresponding to more trials. The Bayesian MCMC fit is plotted in darker blue, and 20 samples from the posterior 
are plotted in lighter blue in order to aid visualisation of the posterior distribution. The threshold (equivalent to the SSRT) is highlighted by 
a red circle. The deviance (Dev) of the data is also shown - three data runs with deviance greater than 8 were excluded and are 
highlighted by a red cross. A p value, reflecting the Bayesian probability of the fit being part of the initial data distribution is also 
presented, but this value was redundant in calculations and not used further. 
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Both SOA staircases converged in all conditions of all subjects. The fail fraction varied from 
0.2 to 0.49. Although lower than other studies, the higher fraction of stop/change trials in this 
study affords a greater stop/change signal expectancy and therefore a higher stop/change 
success rate. However, very low error fractions may be indicative of waiting, where a subject 
delays the primary task reaction time as a strategy to increase success rate on stop/change 
trials. The resultant non-stationarity in the primary task reaction time can compromise the 
SSRT estimate. Visual inspection of the inhibition functions revealed that the majority of 
subjects performed as expected resulting in a sigmoidal psychometric function. However, 
some runs displayed poor data fit (high deviance), suggesting that during some conditions 
the subjects were not adhering to the task rules appropriately (e.g. by waiting, or guessing). 
In order to balance removal of outliers whilst conserving as much data as possible, we 
removed data runs with either an arbitrary error fraction less than 0.28 or a deviance greater 
than 8. Two data runs had both a high deviance and error rate, one run had only a high 
deviance and 3 further runs had only low error rates – therefore a total of 6 out of 30 runs 
were excluded from further analysis.  
 
5.3.2 Primary task reaction time depends on task complexity and the 
previous trial 
We examined primary task reaction times in order to confirm that modulations of conditional 
complexity were evident in behaviour as increased primary task reaction time. We 
additionally modelled the effects of previous trial type on current trial type (Bissett and 
Logan, 2011), to ensure that complexity was behaviourally evident, even after the effects of 
previous trial type had been accounted for.  
 
In order to obtain a stable reaction time estimate for this analysis, we discarded the first and 
last 15 trials of each data run. With the remainder, we calculated the median reaction time of 
go only trials, and subjected it to a mixed hierarchical general linear model with stop-change 
stimulus (< or |), response (stop or change) and previous trial history (previous go only trial, 
previous successful stop/change trial, previous unsuccessful stop/change trial) as fixed-
factors and subject as a random factor. A full factorial model was specified. Here, because 
the conditional complexity of the stop/change cue is reversed for stop versus change trials, 
the effect of complexity is seen as an interaction between the stop/change cue and 
response. The main effect of previous trial (F(2,52.81)=12.50, p<0.001) and the interaction 
between stop/change stimuli and response (F(2,53.44)=4.27, p=0.044) were significant, 
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whereas the interaction between response and previous trial (F(2,52.81)=3.01, p=0.058) 
almost reached significance (Figure 32). All other effects were not significant. These results 
confirm that primary task reaction time increases with task complexity, and that this cannot 
be explained by differences in accrual of post-stop signal changes. In addition, although all 
post stop/change trials appear to be slower than post go only trials, the plots suggest that go 
only reaction time may be relatively longer after stop-fail and change-success trials (although 
the equivalent statistical test, the interaction between response and previous trial, was just 
non-significant). However, post stop-signal reaction times calculated in this manner are 
confounded if reaction time drift is different in different conditions (Bissett and Logan, 2011). 
In order to address this we re-analysed only post stop/change go only trial reaction times. 
We subtracted the previous go only trial reaction time from the current go only trial reaction 
time to eliminate the effects of drift in the data. To increase trial numbers, we included trials 
where a go only trial was preceded by several stop/change trials, as long as the outcome for 
all stop/change trials was the same (similarly to (Bissett and Logan, 2011)). The median of 
these adjusted reaction times per condition were subjected to a mixed hierarchical general 
linear model with stop/change stimulus (< or |), response (stop or change) and previous trial 
history (previous successful stop/change trial, previous unsuccessful stop/change trial) as 
fixed-factors and subject as a random factor. A full factorial model was specified. The 
interaction between response and previous trial was now significant (F(1,34.97)=17.10, 
p<0.001) - all other effects were not significant (Figure 33). Therefore there is a genuine 
dissociation between greater post-stop slowing after a stop-fail trial but greater post-change 
slowing after a change-success trial, and this is not due to go reaction time drift. 
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Figure 32: GO reaction time and trial history. Go only reaction time is shown grouped 
according to previous trial type, response type (stop or change) and the stop/change signal 
stimuli (| or >). The median primary task reaction times for go only trials are shown as a 
function of the stop-signal task variant and previous trial. See text for discussion. Error bars 
represent ± standard error. 
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Figure 33: Post stop/change trial go only reaction times adjusted for the 
previous go only reaction time. Times therefore represent the adjustment to go 
reaction time made after a stop/change signal as a function of previous trial history and 
response. See text for discussion. Error bars represent ± standard error. 
 
5.3.3 Complexity affects the slope of the inhibition function but not the 
stop-signal reaction time  
We looked for evidence for the effect of complexity on a measure of stopping efficiency, the 
SSRT, expecting to find that experimental modulations of conditional complexity do not 
affect stopping efficiency – consistent with the view that all stop-signal task variants require 
the same inhibition process. The SSRT was subjected to a mixed hierarchical general linear 
model with stop-change stimulus (< or |) and response (stop or change) as fixed-factors and 
subject as a random factor.  Again the effect of complexity is the interaction between 
response and stimuli. The effect of signal (F(1,20)=3.01, p=0.098), response (F(1,20)<0.01, 
p=0.985) and their interaction (F(1,20)=0.32, p=0.578) were not significant. The slope 
parameter of the inhibition function was subjected to a similar analysis. The effect of 
response (F(1,18.02)=0.693, p=0.416) and signal (F(1,15.761)=0.01), p=0.91) on the slope 
were not significant, but there was a significant interaction between the two 
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(F(1,15.76)=10.28, p=0.006). Therefore complexity does affect the slope of the inhibition 
function. Although this suggests that contextual complexity affects the relationship between 
successful stopping and the time given to stop, it is difficult to be certain about the 
mechanism underlying this process. This is in part due to the fact that contextually complex 
tasks also have greater primary task reaction times which may confound estimates of 
inhibition function slope. At most we can say that complexity non-specifically affects 
sensitivity of the inhibition function to the SOA. 
 
 
Figure 34: Effects of stimuli type (< or |) and response (stop or change) on the slope 
of the inhibition function. There is a significant effect of complexity (interaction between 
signal and response). Error bars represent standard error. 
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5.3.4 Beamforming adequately separates cortical sources involved in the 
stop/change process 
Source activity was extracted from six a priori cortical locations: the pre-SMA, the SMA, and 
the left and right primary motor cortex and inferior frontal gyri. To determine whether data 
from these sources were adequately separated we correlated the beamformer filters 
(weights applied to the sensor data) of each source with all other sources per data run. 
These coefficients (Pearson’s r2) were then averaged across conditions and subjects. The 
maximal mean correlation was low at 0.05 (between the SMA and the pre-SMA, see Figure 
35) confirming that cortical sources were adequately separated (i.e. on average only 5% of 
the variance shared between these two sources can be attributed to non-physiological 
factors). To illustrate these correlations, we correlated the source filter at the locations of 
interest with the filter of every other voxel in the image and then averaged these images over 
runs and subjects. This image shows the spatial specificity of the beamformer in terms of the 
region of interest from which our source data come from (see Figure 35).  
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Figure 35: Regions of interest. A: Beamformer filters for each location of interest were 
correlated with filters for the rest of the brain. These correlation images were averaged 
across subjects and then thresholded at r2=0.2. Each resulting image represents a maximal 
region of interest. Locations are the left (red) and right (yellow) inferior frontal gyrus, the pre-
SMA (blue), the SMA (purple), and the left (green) and right (cyan) primary motor cortices. 
The colour scale represents r2. B: Individual correlations of filters between point source 
locations are presented. Values represent r2. Locations are left (M1l) and right (M1r) primary 
motor cortex, SMA, pre-SMA, right (rIFG) and left (lIFG) inferior frontal gyri.  
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5.3.5 The convolution model extracts time-frequency data typical of 
basic responses 
We used a novel convolution model to address reaction time confounds between contrasts 
of interest. Although we were primarily interested in cortical activity during the 
stopping/changing processes, given the novelty of our methods, we present the induced 
responses to the primary task go stimulus and the button press to demonstrate that they are 
similar to induced responses reported from standard analyses elsewhere (see Figure 36). 
 
5.3.6 Stop/change signals are associated with a rapid, global theta/alpha 
synchonisation  
Because all stop-signal task variants have the same requirement for stopping, we predicted 
that cortical areas involved in stopping would be similarly activated by the stop/change signal 
in all tasks. Stop/change induced responses were estimated by the convolution model and 
converted to time-frequency images in peri-stimulus time (from 0.5s before to 1.5s after the 
stop/change stimulus). We subjected these time-frequency images to a within-subject 
ANOVA with success (successful or failed), stop/change stimulus (< or |) and response (stop 
or change) as factors in a full factorial design. Two-tailed tests of main effects and 
interactions were thresholded at p=0.05 FWE. The results of significant tests are shown in 
Figure 37 and Figure 38. The mean overall response to a stop/change signal is a global 
theta/alpha RMS amplitude increase that was significant in all areas except primary motor 
cortex. This activity peaks between 200 and 250ms post stop/change signal, and has an 
onset just before stop/change-fail trials terminate and a peak just before go only trials 
terminate, confirming that it is in a temporal window consistent with the neural correlate of 
the stop/change signal. Similar to the SSRT, task stimuli, response requirements and 
conditional complexity do not significantly affect the theta/alpha component of the induced 
response.  
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Figure 36: Estimated event-related activity from the convolution models of cortical 
activity. Each image is the induced response to the go signal (top row, go event is at 
time=0), and to the button press (bottom row, button press is time=0) at different cortical 
locations.  Locations are left (M1l) and right (M1r) primary motor cortex, SMA, pre-SMA, right 
(rIFG) and left (lIFG) inferior frontal gyri. Note that the button press causes a global induced 
response involving all areas tested. The colour scale represents the RMS amplitude in 
arbitrary units. 
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Figure 37: Time-frequency SPMs triggered to the stop/change signal. Each subimage 
displays RMS amplitude changes associated with the stop/change signal as a function of 
frequency (y axis, Hz) and peri-stimulus time (x-axis, seconds, the stop change event occurs 
at t=0). Each row contains information from separate cortical areas. Images are in pairs: the 
colour image is the contrast image, whilst the greyscale image is a mask identifying 
significant increases (white) and decreases (black) in RMS amplitude triggered to the 
stop/change signal. The first column displays the mean induced response to the stop change 
signal across all conditions (labelled ‘mean all’), with the associated statistical maps on the 
right. The third column displays the difference image between successful and unsuccessful 
stop/change trials (labelled ‘succ – unsucc’) and the associated statistical maps on the right. 
Two major frequency patterns are visible (black arrows): a global theta increase around the 
time of stop/change signal presentation, and a later beta increase in successful stop/change 
conditions restricted to more frontal regions. The colour scale represents the RMS amplitude 
in arbitrary units. 
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The data suggest that a global theta/alpha response time-locked to the stop/change signal 
may be causal to inhibiting an action (Figure 38). If this is correct then theta/alpha activity 
should be more efficient during stop/change-fail trials which occur close to the stop-change 
signal, as opposed to trials which occur longer after the stop/change signal.  We therefore 
divided subjects and conditions into those that had a shorter than average and those that 
had longer than average fail decision times (fail decision time = median fail trial RT – median 
SOA). We calculated the peak rate of rise of the theta/alpha activity in a -0.2 s to 0.5s 
window relative to the stop/change signal, in the right and left IFG and the pre-SMA and 
entered this into a mixed hierarchical linear model with source location (left IFG, right IFG 
and pre-SMA), and average fail decision time (long or short) as fixed factors and subject as 
a random factor (Figure 39). Short decision times had a greater rate of theta/alpha rise than 
long decision times (mean short=0.032, mean long=0.022, F(1,44.71)=8.70, p=0.005), and 
there was a significant source x decision time interaction (F(2,62.10)=4.027, p=0.023). Post 
hoc t-tests showed that the right IFG was affected by fail decision time (t(1,16.03)=2.98, 
p=0.009), but not the left IFG (t(1,18.95)=-0.43, p=0.67), or the pre-SMA  (t(1,22.95)=-0.98, 
p=0.34). These results suggest that although the theta/alpha induced response is global, the 
right IFG is coupled most closely with the efficiency of the actual stopping process. 
  
5.3.7 Stop signals are followed by changes in beta activity in frontal 
structures 
The contrast between successful and unsuccessful stop/change trials reveals increased beta 
band activity in the successful condition in the pre-SMA, right and left IFG, regardless of trial 
complexity (see Figure 37 and Figure 38). However, the interaction between success and 
response was also significant at the same time-frequency region (Figure 40). Inspection of 
the underlying beta amplitude dynamics in different conditions suggests that in the left IFG, 
right IFG and pre-SMA, stop-success is associated with a post-signal increase in beta, whilst 
stop-fail is associated with a post-signal decrease in beta amplitude. Switching does not 
have a significant effect on beta amplitude.   
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Figure 38: Timing of significant theta/alpha and beta RMS amplitude changes induced 
by the stop/change event. The theta/alpha RMS amplitude (2-12 Hz, left) and beta RMS 
amplitude (15-25 Hz, right) changes (y axis) are plotted over time (x axis). Raw RMS 
amplitude estimates (from the convolution model) have been averaged over subjects and 
conditions and are represented as a mean (dark lines) and standard error (shaded area).  
Different rows display activity from different cortical sources during successful (red) and 
unsuccessful (blue) change trials. Behavioural data have been overlaid onto these plots: the 
median timings of the button press in stop/change-fail (blue) and change-success (red) trials 
of each subject are plotted as circles (calculated as the difference between the SOA and the 
reaction time of each condition). The overall median timing of button presses is presented for 
stop/change-fail trials (a solid black line), and change-success trials (dashed black line). The 
median predicted Go only reaction time during stop/change trials (derived from the Go only 
reaction time spline) is presented as a gray line, whilst the actual cumulative Go only 
reaction time distribution (after the mean SOA has been subtracted) is plotted as a green 
line with a separate y axis (right). In order for an oscillatory change to be potentially causal to 
switching/stopping, it must occur or have a substantial portion between 0s and the predicted 
go reaction time. This criteria is fulfilled by theta/alpha changes whereas beta changes 
predominantly occur after this behavioural marker. Units are arbitrary units of RMS 
amplitude. 
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Figure 39: Peak rate of theta/alpha rise in different cortical locations. The peak rate of 
rise of the theta/alpha response is steeper for efficient (short stop/change-fail RT- SOA) as 
compared to less efficient stopping/changing (short stop/change-fail RT- SOA) in the right 
IFG only. Peak rate of theta/alpha is presented as arbitrary units of RMS power per second. 
 
178 
 
 
Figure 40: Time-frequency SPMs (A) and beta RMS amplitude plots (B) showing the 
interaction between the success and response in the pre-SMA and the right IFG. 
Figure conventions and behavioural markers are the same as for Figure 37 and Figure 38. 
A significant beta power decrease can be seen in both areas following the stop/change 
event. RMS amplitude in pre-SMA over time is shown separately for stop (top plot) and 
change (bottom plot) conditions and for successful (red) and unsuccessful (blue) trials, to 
highlight the success x response interaction, in panel B.  Beta activity rises after successful 
stopping, drops after unsuccessful stopping (black arrows), but does not change during 
switch trials. Activity in the right IFG (not shown) shows a similar pattern. Units are arbitrary 
units of RMS amplitude. 
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5.3.8 Task complexity modulates go signal related activity.  
To look for the electrophysiological correlate of the effect of trial history and complexity on go 
reaction times, we modelled the effect of the stop/change stimulus (< or |), response (stop or 
change) and previous trial history (previous go only trial, previous successful stop/change 
trial, previous unsuccessful stop/change trial) on the induced response to the go signal 
event. Crucially, we excluded drifts in reaction time (modelled by the go only reaction time 
spline) by modelling it as a confounding covariate in the convolution model.  Two-tailed tests 
of the main effects and interactions were thresholded at p=0.05 FWE. The results of 
significant contrasts are shown in Figure 41. There was a significant effect of trial complexity 
(the interaction between stop/change stimuli and response) on the gamma induced response 
in the pre-SMA before the average onset of the stop/change signal. There were no effects of 
trial history on the go induced response. 
 
Figure 41: Time-frequency SPMs and RMS amplitude plots showing the effect of 
complexity on the induced response to the Go signal in the pre-SMA. Panel A displays 
the effect of complexity on the mean induced response to the Go signal (see Figure 34) as a 
function of frequency (y axis, Hz) and peri-stimulus time (x-axis, seconds, the go signal 
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occurs at t=0). The neighbouring greyscale image is a mask identifying significant increases 
(white) and decreases (black) in RMS amplitude triggered to the go signal. The colour scale 
represents the RMS amplitude in arbitrary units. Panel B presents the significant effects as 
gamma amplitude changes over time in the pre-SMA. Behavioural markers showing timing 
of the median SOA (dashed black line) and the median button press to go only trials (solid 
black line) have been overlaid onto the plot. Increased complexity (and increased go only 
reaction time) is associated with increased gamma activity in the pre-SMA.  
 
5.4 Discussion: 
In this study, we set out to dissociate the function of the pre-SMA and the right IFG whilst 
stopping a prepared movement. To this end, we designed four variants of the stop-signal 
paradigm that allowed us to modulate the context of the task, whilst keeping the inhibited 
response the same. We found that neural activity underlying stopping was dissociated 
spatially, temporally and spectrally into two components: the conditional complexity of the 
task was modulated most by an early persistent gamma response in the pre-SMA, whilst the 
efficiency of stopping was closely related to the post stop/change-signal theta/alpha induced 
response in the right IFG. We additionally found post-stop signal changes in beta activity in 
the left and right IFG and pre-SMA. 
 
5.4.1 Pre-SMA gamma and modulation of context 
We modulated the contextual complexity of stopping in two ways: firstly by changing the 
response required from a stop to a change (which includes stopping the primary task) and 
secondly by changing the stop/change instruction cue from a vertical bar to a directional 
arrow. Crucially, the complexity of the context effect is reversed for stopping versus 
changing: a vertical bar results in a more complex change, but a simpler stop. Therefore the 
interaction between response required and stop/change cue isolates the effect of conditional 
complexity whilst controlling for idiosyncratic confounds related to the stop/change cue and 
the type of response required, including possible increased conflict in the change task. 
Behavioural measures were in keeping with this because more contextually complex tasks 
had significantly longer reaction times (i.e. a significant response x signal interaction). This 
effect was true of reaction times even after taking into account, post stop/change-signal 
effects on reaction time, suggesting that the effect of complexity is a set effect that applies to 
all trial types. Complexity also interacted with the inhibition process in a non-specific way – 
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as shown by modulation of the inhibition function slope – without the altering the mean 
marker of stopping efficiency – the SSRT.   
 
The neural correlate of contextual complexity was identified as an early and persistent 
gamma response found in the pre-SMA. This feature is particularly interesting as gamma 
responses generally represent local cortical processing (e.g. (Swettenham et al., 2009)) 
rather than network processing, and early gamma activity in the pre-SMA has been seen in a 
conditional variant of the stop-signal task in a single subject with subdural electrodes over 
the medial frontal wall (Swann et al., 2012). However, previous studies have conflicted as to 
whether neuronal firing in the pre-SMA differentiates successful and unsuccessful 
stop/change trials early enough to be potentially causal (Isoda and Hikosaka, 2007; Scangos 
and Stuphorn, 2010). Our findings are separate from this debate: we found contextual 
modulation of pre-SMA activity to be both early and a set effect. Therefore, pre-SMA gamma 
activity increases with increasing contextual complexity on all trials prior to the presentation 
of the first go signal and does not differentiate later success or failure at stopping. Finally, 
recent fMRI studies have suggested that medial frontal activity is most parsimoniously 
related to ‘time on task’ rather than experimental manipulations of conflict or error-rate 
((Grinband et al., 2011) but see also (Yeung et al., 2011)). By using a convolution 
framework, we were able to estimate the effects of contextual complexity on pre-SMA 
activity after removing the effects of ‘time on task’ and corresponding reaction time drift – 
therefore our results are unlikely to be confounded by simple differences in reaction times.  
 
5.4.2 Global theta/alpha responses in a spatially diffuse ‘stopping 
network’  
Across all stop-signal trial variants, the most consistent response to the stop/change signal 
was a brief theta/alpha induced response which peaked around the same time as the SSRT. 
This response was relatively widespread - found in the pre-SMA, left and right IFG and SMA 
(but was not significant in the primary motor cortex itself). It is unlikely that the spatially 
diffuse nature of this response is due to methodological confounds such as volume 
conduction or correlated lead fields, because the maximal mean squared correlation 
coefficient of the beamformer filters between sources was minimal. We therefore believe that 
the stop/change signal causes parallel activation of multiple hubs of a stopping network, and 
that different cortical regions within this network may have different functions. Although 
similar medial frontal theta has been shown to be a marker of cognitive interference (Nigbur 
et al., 2011) and to predict error-monitoring (Cavanagh et al., 2009), in our experiment, the 
theta response was unaffected by the presence of an error (stop-fail or change-fail trial) 
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irrespective of the stop/change stimulus cue. This is in keeping with our behavioural data 
which showed no changes in the SSRT with our experimental modulations. So how can a 
ubiquitous theta/alpha response be causal to stopping? Unlike fMRI studies where the 
haemodynamic responses are delayed, we have been able to look at this issue by relating 
behavioural data directly to the induced electromagnetic responses seen. We suggest that 
all attended stop/change cues elicit a theta/alpha response – and that stop/change failures 
are trials where the primary task terminates earlier than average. In keeping with this, the 
median stop/change-fail reaction time is around the time that the theta/alpha response is 
starting, the median go only reaction time is just before the theta/alpha peaks, and 
successful change reaction times occur well after the peak theta response. Explaining 
successful and unsuccessful stopping behaviour in terms of a temporal relationship to the 
induced response negates the requirement to find changes in response amplitude causal to 
stopping. This is in keeping with fMRI studies which have consistently found a global 
network activation in response to a stop-signal, but have found it difficult to find amplitude 
differences between successful and unsuccessful trials (Aron and Poldrack, 2006; Aron et 
al., 2007a). 
 
5.4.3 Right IFG theta/alpha corresponds to stopping efficiency  
Different spatial or spectral elements of such a global network may operate different 
functions required for stopping an ongoing process. To isolate the region most closely 
related to executing the stop itself, we looked for the region which was most sensitive to 
stopping efficiency. At each cortical region, we modelled variation in the slope of the induced 
theta/alpha response as a function of the average time available to stop/change. We 
hypothesised that, in subjects and conditions where a longer than average time was 
available for stopping/changing, the cortical theta alpha response would be less efficient 
(less steep). This relationship was only significant in the right IFG, suggesting that this part 
of the cortical stopping network is most closely related to the actual stopping process. This is 
consistent with human lesion (Aron et al., 2003) and fMRI data (Aron and Poldrack, 2006) 
which have correlated right IFG damage and blood oxygenation with another measure of 
stopping efficiency - SSRT. Our results have also highlighted that right, as opposed to left, 
IFG activity is most closely related to stopping. It remains unclear why, but this asymmetry 
exists regardless of the hand being used to stop (Konishi et al., 1999), and whether a hand 
movement or verbal response is being stopped (Xue et al., 2008), supporting the idea the 
right IFG operates a fundamental operation in stopping.  
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5.4.4 Beta changes selective to stopping only 
We found a novel behavioural dissociation between the reaction time changes following 
stopping and changing – greater increases in primary task reaction time occurred after stop-
failures (rather than successes) and change-successes (rather than failures). Primary task 
reaction time during the stop-signal task has been reported to be lengthened after 
successfully inhibited trials (Emeric et al., 2007), after failed inhibited trials (Schachar et al., 
2004) and after both (Rieger and Gauggel, 1999; Bissett and Logan, 2011), suggesting that 
undefined variations in the task or subject group may lead to different behaviours. However 
the brain signals underlying these responses are not clear. We found significantly increased 
post-stop/change signal beta activity differentiated between successful and unsuccessful 
trials in the pre-SMA, and left and right IFG, but after the median go only reaction time. This 
response was significantly stronger for post-stop signal responses and almost absent in the 
change condition. This has two implications. Firstly, the relative absence of beta changes in 
successfully changed trials, suggest that it is not a necessary cortical response for stopping. 
Secondly, beta activity may play a specific role when the subject requires only a stop, and 
not a further response. So what role does cortical beta activity play in stopping? Stop-failures 
were associated with reduced beta and lengthened subsequent reaction times, suggesting 
that a drop in beta activity may be an error-monitoring signal or a signal to update the motor 
plan. If an error signal, there would be no change in beta after a successful stop - this is not 
the case, and therefore we favour the idea that after a successful stop, the current motor set 
is reinforced with a corresponding increase in beta. This is in keeping with the idea that 
increased beta activity maintains the current motor set (Engel and Fries, 2010; Jenkinson 
and Brown, 2011) after a correct response whilst reduced beta favours motor-
reprogramming after a failed stop response. However, we did not find similar cortical 
responses to explain the behaviour in the change paradigm, suggesting that post-change 
responses may be modulated by a different mechanism (e.g. locked to the motor response 
rather than the change-signal). 
 
5.5 Conclusion 
In this study we modulated the conditional complexity of stopping using 4 variants of the 
stop-signal task. We found that the left and right IFG and pre-SMA were all sensitive to the 
presence of a stop-signal, and that a theta/alpha synchronisation in these areas was early 
enough to be temporally causal to stopping. Of these areas, the right IFG was most closely 
associated with stopping efficiency.  Gamma activity in the pre-SMA was sensitive to 
modulations in contextual complexity, suggestive of local cortical processing. We additionally 
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found post-stop signal cortical responses that may explain primary task reaction time 
changes in the stop-signal task.  
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6. Dynamic cortico-basal ganglia connectivity during 
response inhibition in PD 
 
6.1 Introduction 
In chapters 3 and 4, we designed and tested an experimental model that allowed direct 
measurement of cortico-basal ganglia interactions in humans with PD. This approach relies 
on simultaneous MEG and depth electrode recordings and is able to segregate cortico-basal 
ganglia activity based on its spatial and spectral properties. But how does the activity of 
these resting networks relate to dynamic cognitive function and dysfunction in Parkinsonian 
patients? In chapter 5 we piloted novel experimental and analytical methods to examine 
dynamic network activity albeit restricted to cortical networks in healthy controls. In doing so, 
we disambiguated the specialised function of two key cortical areas involved in the act of 
stopping.  Directly following on from this work, we now apply the same analysis procedures 
to understanding the cortico- basal ganglia dynamics associated with stopping in PD.   
Converging evidence suggests that cortico-basal ganglia interactions play a key role in 
response inhibition (Aron and Poldrack, 2006; Aron et al., 2007a). PD offers a human model 
where the effects of a dopaminergic lesion on these cortico-basal ganglia interactions can be 
studied. Behavioural data in PD subjects suggest that stopping efficiency, as indexed by the 
SSRT during a stop-signal paradigm, is worsened (i.e. SSRT is lengthened) compared to 
controls, and that this does not improve after administration of levodopa (Gauggel et al., 
2004; Obeso et al., 2011b).  However, the classical stop-signal task and standard 
assessment of the SSRT may not be optimal in peri-operative PD subjects.  This is because 
PD patients, due to unclear reasons, miss more trials and/or guess on more trials than 
control groups.  This is especially important in the stop-signal task, where lapses in 
concentration where the subject does not make a response, would be categorised as 
successfully inhibited trials unless due care is taken with the analysis. Additionally, 
assumptions of SSRT stationarity may not hold in PD patients, or may be affected by the 
administration of dopaminergic medication (Mirabella et al., 2011).  
Neural connections thought to be of particular importance during stopping include those 
between the pre-SMA and the STN and those between the right-IFG and STN (Aron and 
Poldrack, 2006; Aron et al., 2007a) and are postulated to be monosynaptic – the so called 
hyperdirect pathway (Nambu et al., 2002). Although dynamic connectivity between these 
regions has not been convincingly characterised, studies have demonstrated individual roles 
for the cortical structures (see chapter 5) and also for the STN during response inhibition 
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(Kuhn et al., 2004; Ray et al., 2011). An increase in beta frequency activity in the STN has 
been reported after a successful stop-signal (Ray et al., 2011) and also after a successful 
no-go response (Kuhn et al., 2004), although the classical event-related averaging analysis 
techniques from both studies make it unclear whether this increase is due to response 
inhibition, or reaction time confounds inherent in the study. 
In this chapter, we address the limitations of previous studies by optimising three features. 
Firstly, we use an adapted version of the stop-signal paradigm - the change-of-plan 
paradigm (Logan and Burkell, 1986; Husain et al., 2003). This paradigm has the same visual 
cues as the stop-signal paradigm, but instead of inhibiting a button press in response to the 
stop-signal, the subject is required to additionally press the opposite button. This ensures 
that trials where there is a lapse in concentration can be excluded because they have no 
output. We combine this with previously demonstrated methodology to account for non-
stationarity in SSRT measurement and to ensure that the task is performed correctly (see 
chapter 5). Secondly, we simultaneously record whole-head MEG data and STN LFP data 
during the performance of the paradigm. This allows us to, not only look at the activity of 
individual regions, but also to characterise the connectivity between them at a high temporal 
resolution. Finally, we use a novel method of analysing continuous electromagnetic data 
within a General Linear Model (GLM) framework, which allows us to disambiguate induced 
responses to closely overlapping events (also see chapter 5).   
However, as we shall see, combing the electrophysiological, behavioural and statistical 
analysis techniques from previous chapters is difficult in this cohort and still needs future 
validation. Therefore, rather than providing a definitive account of biological findings, this 
chapter seeks to present a ‘proof-of-principle’ careful provisional analysis of the data 
highlighting its current limitations and suggesting some potential solutions. 
 
6.2 Methods 
 
6.2.1 Participants and surgery 
We studied a total of 16 subjects (10 in London, 6 in Oxford) who had undergone bilateral 
STN DBS electrode implantation prior to DBS therapy for PD. All subjects were diagnosed 
with PD according the Queen Square Brain bank criteria (Gibb and Lees, 1988). Clinical 
details of the subjects are summarised in Table 7 (also see section 6.2.2 for further details 
on UPDRS score calculation). The indications, operative procedure, targeting and beneficial 
clinical effects of STN stimulation have been described previously [see chapters 1.2.8, 2.1.2 
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and (Foltynie et al., 2010)]. However, the imaging modality used during the targeting 
procedure varied across sites as follows. In London preoperative stereotactic imaging was 
performed with stereotactic proton density weighted MRI, whilst stereotactic CT fused with 
T2 weighted MRI was used in Oxford. To confirm correct placement, electrodes were 
visualised on immediate post-operative imaging with the surgical frame in situ (proton 
density weighted MRI in London and CT (1mm slice thickness) fused with pre-operative T2 
weighted MRI in Oxford). Although electrodes were considered to lie within or abutting STN, 
we cannot assume that all contacts on each electrode shared this localisation; indeed, this 
would seem highly unlikely given the size and orientation of the nucleus in relation to 
electrode trajectory. Given this, and to avoid any selection bias, we entered data from all 
three bipolar electrode pairs into our statistical analyses (except where explicitly mentioned), 
and considered these to lie in the STN region.  
Case Age 
(years)/ 
sex 
Disease 
duration 
(years) 
Predominant 
symptoms (in 
addition to 
bradykinesia) 
UPDRS 
OFF/ON 
medication 
Pre-operative medication 
(total daily dose) 
LN01 53/F 12 Tremor, freezing, foot 
dystonias, restless 
legs. 
19/14 Stalevo 750mg 
Amantadine 200mg 
Pramipexole 3.375mg 
Rescue apomorphine 
LN02 60/F 32 Tremor, dyskinesias, 
leg dystonias. 
34/14 Rasagiline 1mg  
Stalevo 300mg 
Co-careldopa 562.5mg  
Co-careldopa CR 200mg 
LN03 53/M 17 Motor fluctuations, 
dyskinesias, freezing. 
29/21 Co-careldopa 1350mg 
Trihexyphenidyl 6mg 
Pramipexole 
375micrograms 
Rasagiline 1mg 
OX01 54/M 6 Tremor, dyskinesias, 
freezing 
28/28 Co-careldopa 1325mg 
Pramipexole 1.5mg 
Pramipexole XL 2.25mg 
OX02 63/F 11 Tremor, freezing, 
dyskinesias. 
57/40 Co-careldopa 1000mg  
Co-beneldopa 125mg 
Ropinirole XL 20mg 
Entacapone 1200mg 
LN05 55/M 11 Tremor, dopamine 
dysregulation 
*/40 (31/8) Selegiline 10mg  
Tolcapone 300mg  
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syndrome, motor 
fluctuations, 
depression, freezing, 
falls. 
Co-careldopa 1125mg  
Co-careldopa CR 600mg 
OX04 64/F 15 Dyskinesias, dystonia, 
freezing 
25/16 Apomorphine 6mg  
Co-beneldopa 750mg 
Amantadine 200mg 
Rotigotine16mg  
Selegiline (as Zelapar) 
1.25mg 
OX06 53/M 13 Tremor, freezing, 
dyskinesia. 
37/30  Co-careldopa 800mg 
Amantadine 200mg 
LN06 57/F 3 Depression, falls, 
dyskinesia, tremor.  
60/* (41/26) Co-careldopa 187.5mg  
Previously on 
apomorphine 
(discontinued prior to DBS 
procedure) 
OX09 64/M 13 Tremor, dyskinesia. 
 
26/* (33/6) Rasagiline 1mg 
Ropinirole 16mg 
Pergolide 3mg 
Co-careldopa 500mg  
LN07 47/M 10 Tremor, motor 
fluctuations. 
 
52/28  Rasagiline 1mg, 
Pramipexole XL 3mg  
Co-beneldopa 700mg 
Co-beneldopa CR 100mg  
Entacapone 800mg 
LN08 56/M 9 Dystonia, motor 
fluctuations, freezing, 
depression, urinary 
urgency.  
29/* 
(41/20) 
Ropinirole 24mg 
Trihexyphenidyl 12m,  
Co-beneldopa 62.5mg  
Co-careldopa 375mg 
Co-careldopa CR 200mg 
LN09 59/M 17 Tremor, dopamine 
dysregulation 
syndrome, 
hallucinations, REM 
sleep disorder, 
dyskinesias. 
56/19  Co-beneldopa 600mg 
Co-beneldopa CR 650mg  
Stalevo 525mg 
Trihexyphenidyl 2mg 
LN11 59/M 14 Tremor, dyskinesias, 
freezing, eyelid 
apraxia.  
34/* (29/6) Co-careldopa 1125mg 
Entacapone 800mg  
Co-careldopa CR 100mg 
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Ropinirole XL 16mg 
OX13 64/M 16 Dyskinesias, motor 
fluctuations 
34/26 Co-beneldopa 187.5mg 
Stalevo 400mg 
Amantadine 100mg 
 
LN13 58/M 11 Dyskinesias, motor 
fluctuations 
*/11 (22/7) Stalevo 750 
Cabergoline 8mg 
Amantadine 300mg 
Table 7: Clinical details of the study participants. All subjects have been anonymised 
using a study code. *UPDRS scores reported are at the time of recording. Because not all 
subjects completed both ON and OFF medication conditions, not all subjects have both ON 
and OFF UPDRS scores. In these cases a pre-operative OFF/ON UPDRS score is also 
provided in brackets – although the scores are not directly comparable (due to e.g. ‘stun 
effect’, see section 6.2.2). Stalevo is a proprietary combination of levodopa, carbidopa and 
entacapone for which the dose of levodopa is given. Pramipexole doses are given as a salt. 
REM = rapid eye movement. 
 
6.2.2 Experimental Paradigm 
Experiments were performed between 2-6 days post-operatively. Subjects were asked to 
perform up to 8 blocks (about 4 minutes each) of the task, interleaved by rest periods. 
Recording sessions did not last more than one hour and were performed whilst the patient 
was seated inside the MEG scanner. Visual stimuli were back-projected onto a screen in 
front of the subjects and were controlled using Presentation software (Neurobiological 
Systems). During each trial, the subject was presented with a fixation cross (lasting 1.3 – 
1.5s, the duration was drawn from a uniform distribution) which, after a 200ms pause with a 
blank screen, was followed by a green left- or right- pointing arrow (the primary task 
stimulus, or ‘go signal’). The subject was asked to make a button-press with the thumb of the 
corresponding hand as quickly as possible. In a randomly selected 50% of trials, a further 
red arrow, pointing in the opposite direction to the first arrow, was presented at a variable 
latency (SOA) after the primary task stimulus. In response to this second signal, the subject 
was asked to change to pressing the opposite button.  The SOA was varied trial-by-trial – 
increasing by 50ms after a successful change but decreasing by 50ms after a failure to 
change (Levitt, 1971). This tracking procedure aims to fix the probability of successfully 
changing at ~0.5 so that successful- and unsuccessful-change conditions were equally 
sampled. The SOA was randomly drawn from 2 independent staircases.  
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As part of the experimental protocol, each subject was asked to repeat the experimental 
paradigm twice – once after omitting all dopaminergic medication overnight (OFF medication 
condition) and once following administration of 200mg of levodopa (ON medication 
condition), the order counterbalanced across subjects. To assess the severity of motor 
impairment in this cohort, all patients were evaluated using part III of the Unified Parkinson’s 
Disease Rating Scale (UPDRS) during each experimental condition (ON and OFF), i.e. at 
the time of the electrophysiological recordings.  However, of the 16 subjects, only 9 
completed both ON and OFF sessions. In addition 5 were recorded OFF medication only 
and 2 were recorded ON medication only. In these cases, we also retrospectively recorded a 
pre-operative UPDRS score performed up to 6 months prior to surgery. Although the 
patients underwent a similar procedure to record OFF and ON UPDRS scores, there is 
expected variance between pre-operative and post-operative UPDRS scores because of 
many factors including post-op fatigue, variation in medications and the ‘stun effect’ (see 
chapter 7 for further discussion). A neurologist was present in the magnetically shielded 
room during the experiment to monitor the patient’s well-being.  
 
6.2.3 Behavioural analysis 
Behavioural analysis was similar to that performed in chapter 5. The aims of the behavioural 
analysis were threefold: to determine whether experimental modulations were evident in 
behaviour; to identify and exclude experimental runs where behaviour was anomalous; and 
to provide behavioural summary measures which could be used as predictor variables in the 
electrophysiological analysis.  Stimuli and response timings were recorded and analysed 
offline using custom Matlab scripts (The Mathworks, Inc, Natick, MA), the Psignifit 
toolbox(Fründ, I, Haenel, NV, Wichmann, 2011) and IBM SPSS version 20.   
Three key trial-types were considered: go only trials (where the change-signal is not 
presented), successful-change trials and unsuccessful-change trials. Other trials, such as 
non-change signal trials where the left button was pressed in response to the right arrow 
were considered unclassified errors and discarded.  
We performed two analyses to check that subjects had engaged in the task appropriately. 
Firstly, we calculated the proportion of unsuccessful change trials (error fraction) per 
condition.  Secondly, we modelled the inhibition function of each data run whilst trying to 
protect against non-stationarities in the data (e.g. reaction time drift) and behavioural 
confounds (guessing and lapses in concentration). The inhibition function models the 
proportion of correct responses, i.e. successful changes, as a function of the SOA, or the 
191 
 
SOA corrected for reaction time (primary task RT – SOA)(Logan and Cowan, 1984; Band et 
al., 2003).  Subjects tended to wait for the change-signal, presumably to increase their 
success-rate. To adjust for the resulting non-stationarity in primary task reaction time we 
fitted cubic splines to the SOA and the go only reaction time data. This provides a predicted 
go reaction time for stop/change trials – an estimate of how the subject would have 
responded on stop/change trials if they had been go only trials, based on the reaction times 
of neighbouring trials (Nachev P, unpublished, http://ukpmc.ac.uk/theses/ETH/445162).  On 
change trials we subtracted the SOA from the predicted go spline to estimate the decision 
time per trial - the post-stop/change signal latency required to make a correct or incorrect 
decision on that trial, correcting for reaction time drift in the data. The ratio of successful:total 
stop/change trials was calculated as a function of decision time in 100ms bins. We fitted a 
sigmoid inhibition function to this data using a Bayesian MCMC procedure, which is superior 
to other methods such as bootstrapping (Kuss et al., 2005; Fründ, I, Haenel, NV, Wichmann, 
2011). The function was defined by four parameters (with standard prior distributions): the 
upper limit of the function or ‘lapse rate’ (prior: gamma(2,400)), the 50% point of the function 
(prior: beta(1.5,10)), the ‘slope’ at 50% of the function (prior: beta(1.5,10)), and the lower 
limit or ‘guess rate’ (prior: gamma(2,400)). Calculating the Bayesian posterior for such a 
model is analytically intractable, but it can be approximated by the MCMC procedure, which 
generates many samples of the posterior according to a particular algorithm (Kuss et al., 
2005). We generated 4000 samples, discarding the first 2000 samples, to estimate an 
approximation to the posterior of the inhibition function. In this scenario the decision time at 
the mid-point of the inhibition function is equivalent to the SSRT. We assessed the 
goodness-of-fit of the model by calculating the deviance, which is a generalisation of the 
sum-of-squares metric that applies to binomial data (Fründ, I, Haenel, NV, Wichmann, 
2011). Trial numbers, behavioural summary measures and discarded data runs are shown in 
Table 8. 
To look for behavioural evidence of experimental modulations, median reaction time was 
estimated per condition.  We were able to fully remove the effects of reaction time drift when 
only analysing post change trials by calculating a corrected post-change signal reaction time 
(current trial go only reaction time - previous go only trial reaction time). To increase trial 
numbers, we included trials where a go only trial was preceded by several change trials, as 
long as the outcome for all stop/change trials was the same (similarly to Bissett and Logan 
(Bissett and Logan, 2011)). All behavioural measures including SSRT, slope, reaction time 
and adjusted reaction time data were subjected to mixed hierarchical general linear models 
with fixed-factors as previously described, and subject as a random factor.  
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6.2.4 Simultaneous STN-LFP and MEG recordings 
MEG recordings were performed in London with the 275 channel CTF (VSM MedTech Ltd., 
Vancouver, Canada) or in Oxford with the 306 channel Neuromag (Elekta Neuromag Oy, 
Helsinki, Finland) systems. Simultaneous to the MEG recording, both right and left first 
dorsal interosseus (FDI) electromyographic (EMG) signals, and four intracranial LFP 
channels were recorded per electrode.  All EMG recordings (across both sites), and LFP 
recordings from the first 4 London subjects were acquired using the integrated EEG 
systems. The London LFP acquisition system was then updated to a BrainAmp (Brain 
Products GmbH, Munich, Germany) monopolar recording system for the remainder of the 
subjects. All monopolar LFP and EMG recordings were referenced to the right mastoid. In 
Oxford, LFP signals in the STN were acquired in a bipolar configuration via a Digitimer D360 
amplifier (Digitimer Ltd, Hertfordshire, UK), and high-pass filtered at 0.5 Hz. All data were 
sampled at 2400 Hz and stored to disk for subsequent off-line analysis.  MEG, LFP and 
EMG data were hardware high-pass filtered at 0.03Hz (Oxford MEG and EMG) or 1Hz 
(London EMG and LFP; Oxford LFP only) and low-pass filtered at 600Hz (all signals). 
London LFP recordings were converted off-line to a bipolar montage between adjacent 
contacts (3 bipolar channels per side) to limit the effects of volume conduction from distant 
sources (Oxford LFP recordings were already recorded in this format).  
6.2.5 Data pre-processing, artefact rejection, and head localisation 
The data were analysed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) and Fieldtrip 
(http://www.ru.nl/neuroimaging/fieldtrip/), (Litvak et al., 2011b; Oostenveld et al., 2011).  The 
continuous recording was down-sampled to 300 Hz, high-pass filtered above 1 Hz and the 
line noise artefacts at 50 Hz and 100 Hz were removed using notch filters (5th order zero-
phase Butterworth filters). Head position was recorded continuously within the MEG, and in 
London was recomputed to correspond to the mean of the trials used for the analysis.  
Similar head movement compensation could not be made for Oxford subjects as the 
proprietary software had difficulty extracting the head location signal in the presence of 
metallic artefact from DBS extension leads. We therefore used the starting head location in 
these cases. Unlike the CTF system, the Neuromag MEG system contains magnetometers 
(a type of sensor) which, due to their greater sensitivity to distant sources and environmental 
noise, are more contaminated by metal artefacts. We, therefore, only based our analysis on 
planar gradiometers similarly to Hirschmann et al. (2011) who also used the Neuromag 
system.  
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6.2.6 Beamformer source extraction 
We extracted time-series data from cortical regions of interest using an LCMV beamformer 
(Van Veen et al., 1997).  The MNI co-ordinates (x,y,z) of locations of interest were taken 
from the literature and included the pre-SMA (2,30,48 taken from (Nachev et al., 2007)), the 
right and left IFG (±42,26,14 from (Aron et al., 2007a)), the SMA (-2,-10,59 adapted from 
(Mayka et al., 2006)) and both the primary motor cortices (±37,-25,62 adapted (Mayka et al., 
2006)).  Locations obtained from Mayka et al. were converted from Talaraich to MNI space 
using a transform devised by Mathew Brett (http://imaging.mrc-
bu.cam.ac.uk/imaging/MniTalairach).   The beamforming method involves linearly projecting 
the MEG sensor data using a spatial filter computed from the lead field of the source of 
interest and the data covariance (Van Veen et al., 1997). The spatial filter is designed to 
extract activity from the region of interest, whilst suppressing activity from other sources. 
Lead fields were computed using a single-shell head model (Nolte et al., 2004) based on an 
inner skull mesh derived by inverse-normalizing a canonical mesh to the subject's individual 
pre-operative MRI  image (Mattout et al., 2007). Co-registration between the MRI and MEG 
coordinate systems used 3 fiducial points: nasion, left and right pre-auricular; see (Litvak et 
al., 2010) for further details. Data covariance matrices were computed using all the data from 
a recording block, for each block separately. We specified 0.01% regularization and defined 
the orientation of each source to be in a fixed direction. Medial frontal sources (the SMA and 
pre-SMA) were oriented horizontally, whilst all other more lateral cortical sources (primary 
motor cortex and IFG) were oriented vertically. To determine whether data from these 
sources were adequately separated we correlated the beamformer filters (weights applied to 
the sensor data) of each source with all other sources per data run. These correlation 
coefficients (equivalent to Pearson’s r2) values were then averaged across conditions and 
subjects.  
Time-series data from the LCMV extracted cortical sources and each bipolar STN-LFP 
channel were then standardised by subtracting the mean and dividing by the standard 
deviation. To make standardization robust to possible artefacts, medians of the raw and 
squared signals were computed for non-overlapping 10 s segments and averaged yielding 
first and second moment estimates.   
6.2.7 Time-frequency analysis and epoching 
A time-frequency representation of the data was generated using multitaper spectral 
analysis (Thomson, 1982), in time windows of 0.4s shifted in steps of 0.05s over a frequency 
range of 2.5 to 90 Hz in steps of 2.5 Hz. The frequency resolution was set to the inverse of 
the time window (2.5 Hz) for up to 25 Hz, then 0.1 times the frequency for 25 to 50 Hz and 
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then to a constant 5 Hz. The resultant continuous power data were transformed with the 
square root transform to obtain RMS amplitude which better conforms to the linearity 
assumption of the convolution method (Litvak et al., 2012b). RMS amplitude data were then 
analysed using both standard epoching techniques and the novel convolution technique. 
The aim of the epoching analysis was to ensure that individual data in our cohort 
(contaminated by the presence of ferromagnetic wires) looked comparable to previously 
published data at the individual level, and that there were no gross differences between 
electromagnetic activity recorded by both CTF and Elekta systems. The aim of the 
convolution analysis was to provide a basis on which meaningful group level statistical tests 
could be performed.  
For the epoching analysis, RMS amplitude data were epoched into 5s trials centred around 
all go signals and all button presses.  The resulting time–frequency images were then 
averaged using robust averaging (Holland and Welsch, 1977; Wager et al., 2005; Litvak et 
al., 2012a) , and percentage change time–frequency responses were obtained relative to the 
baseline (1.8 to 1 s) before the trigger. Robust averaging is a special case of the robust 
general linear model (Holland and Welsch, 1977; Wager et al., 2005; Litvak et al., 2012a) . In 
this framework, outliers are down-weighted when computing the average, making it possible 
to suppress artefacts restricted to narrow time and frequency ranges without rejecting whole 
trials.  
Cortico-subthalamic coherence was also computed over a 5 second epoch using a robust 
averaging technique as follows. The complex cross-spectral density (CSD) between the two 
sources of interest (e.g. the motor cortex and the STN) was calculated for each trial. The 
complex CSDs were then weighted according to the absolute value of CSDs, before being 
averaged to obtain coherence. Percentage changes in cross-spectral responses were 
computed as above (Oswal et al., 2012). 
 
6.2.8 The convolution model for magnetoencephalographic data 
In the convolution framework, RMS amplitude data were analysed hierarchically: summary 
measures of induced responses were obtained with a first-level convolution model, then 
transformed into time-frequency images and finally subjected to a standard general linear 
model at the second level. To characterise and disambiguate induced responses to the 
events of interest, regressors were generated for each event-type, and assembled as 
predictors of continuous frequency-specific amplitude in a general linear model (GLM). Each 
event was modelled as a delta function (an impulse) and then convolved with a set of Fourier 
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basis functions spanning -0.5 to +1.5s relative to each event (the peri-stimulus time-window).  
GLM coefficients were estimated using ordinary least squares treating the different 
frequencies separately in mass-univariate fashion. The induced response for a particular 
event-type was reconstructed by multiplying the basis functions with a matrix of parameter 
estimates corresponding to the event-type in question (Litvak et al., 2012b). In the simplest 
case, with non-overlapping events, this would be equivalent to averaging time-frequency 
images centred on an event of interest. However, because our data contains multiple 
temporally overlapping responses, the convolution model was superior to event-locked 
routine averaging. Because, multiple predictors (different events) are included in the same 
GLM, the induced responses to different event-types can be disambiguated from each other, 
if they do not always occur together. Individual regressors were specified for the fixation 
cross, the primary task stimulus, the button press responses (separately for left and right 
responses) and the change signal (separately for successful and failed change conditions).  
Previous studies have suggest that the medial frontal cortex is sensitive to reaction time 
changes (Grinband et al., 2011; Yeung et al., 2011), therefore we sought to include this 
confound in our model by using the predicted go spline as a parametric modulator of the go 
signal induced response. After modelling the mean go event, and variation due to go-
reaction time drift, we then estimated induced responses separately for all combinations of 
the current trial (left or right cue) and previous trial-type (go only trial, successful-change 
trial, failed-change trial). The resulting induced responses are independent of reaction time 
drift. In addition, we modelled variation of the stationary measure of decision time (primary 
task go only reaction time – SOA spline) as a confounding parametric modulator of the 
change signal. The data and the design were filtered below 0.25 Hz.  
 
After eliminating reaction-time confounds, we generated time-frequency images for each 
event-type and entered these into within-subject ANOVAs for each cortical source. We 
studied responses to two event-types statistically: the change signal - with success 
(successful or failed), and dopamine (OFF or ON) as factors, and the go signal – with the 
current trial (left or right cue) and dopamine (OFF or ON) as factors. Two tailed t-tests were 
performed for each main effect and interaction and were thresholded at p=0.05 FWE (peak-
level), taking error non-sphericity into account using standard procedures (Litvak et al., 
2011b). Currently, coherence cannot be analysed using the convolution model because it is 
computed across trials. 
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6.3 Results 
 
6.3.1 Subject behavioural data 
It was apparent that, as predicted, not all subjects optimally engaged in the task. Therefore 
we excluded sessions in which the subject’s behaviour did not conform to the assumptions 
of the task. Sessions were discarded if the error fraction (the number of failed change trials 
divided by the number of successful change trials) was less than 0.1 of if the deviance of the 
inhibition function was greater than 13. Using these arbitrary criteria, seven sessions were 
discarded, leaving a total of 43 sessions (subjects x dopamine x side; see Table 8 and 
Figure 42). 
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Number of 
Trials  
Change 
Fraction  
Error 
Fraction  Go RT  
 
Fail 
RT  
 
Succ 
RT  
 
Fail 
SOA  
 
Succ 
SOA  
 Subject  Dopamine  L  R  L  R  L  R  L  R  L  R  L  R  L  R  L  R  
'LN01'  1  133  135  0.47  0.39  0.27  0.38  0.742  0.672  0.687  0.802  0.947  0.997  0.353  0.348  0.273  0.300  
 
2  111  118  0.46  0.46  0.25  0.56  0.550  0.518  0.527  0.480  0.868  0.925  0.250  0.225  0.200  0.150  
'LN02'  1  96  98  0.47  0.53  0.07  0.27  1.040  1.112  0.813  0.995  1.615  1.487  0.747  0.800  0.723  0.650  
 
2  101  110  0.49  0.53  0.14  0.31  0.755  0.740  0.817  0.538  1.225  1.128  0.500  0.398  0.398  0.398  
'LN03'  1  51  61  0.61  0.46  0.32  0.50  0.662  0.430  0.397  0.462  0.437  0.437  0.200  0.275  0.100  0.125  
 
2  78  76  0.59  0.62  0.39  0.36  0.785  0.713  0.767  0.537  0.907  0.743  0.300  0.300  0.200  0.150  
'OX01'  1  142  137  0.50  0.49  0.30  0.33  0.861  0.875  0.779  0.744  1.207  1.197  0.550  0.600  0.499  0.449  
 
2  143  145  0.52  0.50  0.38  0.26  0.836  0.822  0.762  0.734  1.049  1.033  0.599  0.551  0.476  0.500  
'OX02'  1  39  45  0.51  0.47  0.15  0.52  0.775  0.740  0.694  0.992  1.138  1.000  0.350  0.249  0.200  0.152  
'OX04'  1  141  138  0.48  0.49  0.19  0.21  0.962  1.027  0.887  0.966  1.090  1.110  0.750  0.750  0.550  0.550  
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2  49  55  0.49  0.47  0.25  0.23  1.007  0.892  0.767  0.824  0.977  1.024  0.675  0.650  0.550  0.575  
'LN05'  2  64  60  0.45  0.45  0.10  0.07  1.018  1.023  1.343  1.010  1.029  0.977  0.948  0.701  0.725  0.599  
'OX06'  1  133  141  0.53  0.50  0.30  0.31  0.705  0.725  0.601  0.611  0.835  0.749  0.450  0.400  0.350  0.300  
 
2  122  135  0.53  0.54  0.31  0.36  0.770  0.706  0.664  0.616  0.845  0.839  0.425  0.449  0.350  0.400  
'LN06'  1  66  56  0.52  0.50  0.26  0.36  0.699  0.508  0.561  0.517  1.129  1.240  0.300  0.349  0.300  0.326  
'OX09'  1  118  131  0.47  0.50  0.21  0.42  0.608  0.614  0.546  0.508  0.730  0.706  0.350  0.350  0.251  0.224  
'LN07'  1  102  105  0.57  0.54  0.28  0.30  0.773  0.726  0.771  0.682  0.873  0.882  0.600  0.499  0.449  0.499  
 
2  108  100  0.56  0.47  0.23  0.32  0.672  0.678  0.633  0.562  0.813  0.882  0.474  0.450  0.399  0.376  
'LN08'  1  115  128  0.57  0.48  0.28  0.49  0.626  0.525  0.611  0.550  0.791  0.930  0.275  0.251  0.199  0.151  
'LN09'  1  111  123  0.55  0.50  0.10  0.15  1.563  1.546  1.410  1.411  1.469  1.562  0.974  0.951  0.701  0.700  
 
2  119  132  0.56  0.49  0.13  0.09  1.343  1.215  0.996  1.296  1.396  1.491  0.849  0.974  0.700  0.699  
'LN11'  1  69  65  0.57  0.49  0.36  0.50  0.520  0.473  0.463  0.483  0.698  0.715  0.275  0.299  0.249  0.200  
'OX13'  1  141  145  0.49  0.48  0.09  0.19  1.164  1.086  0.909  0.974  1.445  1.296  0.850  0.899  0.798  0.600  
 
2  71  67  0.54  0.55  0.32  0.49  0.777  0.726  0.757  0.703  0.980  1.084  0.450  0.451  0.400  0.400  
199 
 
'LN13'  2  150  144  0.48  0.48  0.32  0.58  0.541  0.485  0.481  0.493  0.768  0.818  0.249  0.252  0.151  0.200  
MEAN  
 
103 106 0.52 0.50 0.24 0.34 0.830 0.783 0.746 0.740 1.010 1.010 0.510 0.497 0.408 0.387 
Table 8: Descriptive statistics of change-of-plan task in patients. Each row represents data from one subject (coded with an anonymous 
study code e.g. LN01) whilst on (dopamine=2) or off (dopamine=1) dopaminergic medication. Note that not all subjects were recorded in both 
conditions. Data is separated into left (L) and right (R) sides for each value.   As well as the total number of trials used, the change fraction (the 
number of change trials divided by the total number of trials) and the error fraction (the number of error change trials divided by the total 
number of change trials) is shown. Median reaction times for the go trials (Go RT), failed change trials (Fail RT) and successfully changed trials 
(Succ RT) are presented with their corresponding median stimulus onset asynchrony values (SOAs). All values are in seconds. Conditions with 
an arbitrary error fraction of less than 0.1 are highlighted in red and were excluded from further analysis. Mean group values (excluding all 
excluded runs) are presented on the bottom row.  
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Figure 42: Inhibition functions for each subject and condition. Each plot shows the proportion of correct changes as a function of the SOA, 
normalised by subtracting the predicted go reaction time. The trial data is binned in 100ms bins and plotted as blue circles – a larger circle 
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corresponding to more trials. The Bayesian MCMC fit is plotted in darker blue, and 20 samples from the posterior are plotted in lighter blue in 
order to aid visualisation of the posterior distribution. The threshold (equivalent to the SSRT) is highlighted by a red circle. The deviance (Dev) 
of the data is also shown - data runs with deviance greater than 13 were excluded and are highlighted by a red cross. Data runs with an error 
fraction lower than 0.1 were also excluded and are highlighted by a green cross. A p value, reflecting the Bayesian probability of the fit being 
part of the initial data distribution is also presented, but this value was redundant in calculations and not used further. 
  
 6.3.2 Beamforming adequately separates cortical sources involved in the 
change process 
Similarly to our healthy control data (chapter 5), source activity was extracted from six a 
priori cortical locations: the pre-SMA, the SMA, and the left and right primary motor cortex 
and inferior frontal gyri. Because of the increased artefact in the MEG data from these 
subjects – due to both increased head movement and the presence of ferromagnetic wires – 
the beamformer may potentially not be able to adequately separate the cortical sources of 
interest. To determine whether data from these sources were adequately separated we 
correlated the beamformer filters (weights applied to the sensor data) of each source with all 
other sources per data run. This was done separately for ON and OFF medication conditions 
(see Figure 43 and Figure 44). These coefficients (Pearson’s r2) were then averaged across 
conditions and subjects. The maximal mean correlation was low at 0.15 (between left M1 
and the pre-SMA) confirming that cortical sources were adequately separated (i.e. on 
average only 15% of the variance shared between these two sources can be attributed to 
non-physiological factors). To illustrate these correlations, we correlated the source filter at 
the locations of interest with the filter of every other voxel in the image and then averaged 
these images over runs and subjects. This image shows the spatial specificity of the 
beamformer in terms of the region of interest from which our source data come from (see 
Figure 43 and Figure 44).   
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Figure 43: Regions of interest in the OFF medication condition. A: Beamformer filters 
for each location of interest were correlated with filters for the rest of the brain. These 
correlation images were averaged across subjects and then thresholded at r2=0.2. Each 
resulting image represents a maximal region of interest. Locations are the left (red) and right 
(yellow) inferior frontal gyrus, the pre-SMA (blue), the SMA (purple), and the left (green) and 
right (cyan) primary motor cortices. The colour scale represents r2. B: Individual correlations 
of filters between point source locations are presented. Values represent r2. Locations are 
left (M1l) and right (M1r) primary motor cortex, SMA, pre-SMA, right (rIFG) and left (lIFG) 
inferior frontal gyri.  
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Figure 44: Regions of interest in the ON medication condition. The figure details are 
identical to Figure 43. 
 
6.3.3 Epoched data shows that event-related oscillatory responses can 
be visualised individually in the majority of subjects 
Prior to performing group analysis, we examined single subject data to ensure that 
reasonable and comparable event-related signals could be extracted from the MEG and LFP 
data, in spite of prominent artefact and the use of varied recording systems. In this section 
we use classically analysed robustly averaged data of left M1 (Figure 45 and Figure 46) 
and left STN (Figure 47 and Figure 48) activity during the presentation of a right go signal 
and right button press. We found that there was a consistent beta RMS amplitude decrease 
and subsequent rebound that occurred after the go signal and during the button press in 
both M1 and the STN. During the button press further gamma activity was demonstrated 
most clearly in the STN but also in primary motor cortex.  There were no significant 
differences in the pattern of activity between subjects recorded in Oxford and London. 
Therefore the data we have collected is reassuring in that classical averaging of the raw 
signal reveals event-related modulations that can be visualised at the individual subject level 
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in different frequency bands. However the same analysis highlights the problem if we were 
to use this as a basis for group analysis. Namely that it remains ambiguous whether the beta 
depression, for example, is locked to the go signal or to the button press. As previously 
shown (see chapter 5), if individual event-related responses cannot be disambiguated, then 
it is difficult to make a meaningful inference from the data. Therefore further analysis of the 
amplitude is performed using the continuous GLM (see section 6.3.4).  
 
Figure 45: Individual time-frequency images of left M1 activity during a right go signal. 
Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x axis, s). The go 
signal is presented at t=0. Neural activity is presented as a percentage change in RMS 
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amplitude relative to the baseline (-1.8s to 1s). The title of each image identifies the subject 
(e.g. LN07) and the medication condition. These images demonstrate a clear decrease in 
beta activity in the motor cortex after presentation of a go signal. There is no clear difference 
in pattern between subjects recorded in Oxford (‘OX’) and London (‘LN’). Subject OX04 may 
have spike artefact during the button press – seen as a broad band increase in amplitude 
around the time of the button press. 
 
Figure 46: Individual time-frequency images of left M1 activity during a right button 
press. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x axis, s). 
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The button press is at t=0. Neural activity is presented as a percentage change in RMS 
amplitude relative to the baseline (-1.8s to 1s). The title of each image identifies the subject 
(e.g. LN07) and the medication condition. These images demonstrate a clear decrease in 
beta activity in the motor cortex during the button press, immediately followed by a beta 
increase. There is no clear difference in pattern between subjects recorded in Oxford (‘OX’) 
and London (‘LN’). Subject OX04 may have spike artefact during the button press – seen as 
a broad band increase in amplitude triggered to the button press. 
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Figure 47: Individual time-frequency images of left STN activity during a right go 
signal. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x axis, s). 
The go signal is presented at t=0. Neural activity is presented as a percentage change in 
RMS amplitude relative to the baseline (-1.8s to 1s). For visualisation purposes, a single 
STN bipolar channel is shown per subject – selected as the one with highest gamma (60-
90Hz) variance. The title of each image identifies the subject (e.g. LN07) and the medication 
condition. These images demonstrate a clear decrease in beta activity in the motor cortex 
after presentation of a go signal. There is no clear difference in pattern between subjects 
recorded in Oxford (‘OX’) and London (‘LN’).  
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Figure 48: Individual time-frequency images of left STN activity during a right button 
press. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x axis, s). 
The button press is at t=0. For visualisation purposes, a single STN bipolar channel is shown 
per subject – selected as the one with highest gamma (60-90Hz) variance. Neural activity is 
presented as a percentage change in RMS amplitude relative to the baseline (-1.8s to 1s). 
The title of each image identifies the subject (e.g. LN07) and the medication condition. 
These images demonstrate a clear decrease in beta activity and increase in gamma activity 
in the STN during the button press, immediately followed by a beta increase. There is no 
clear difference in pattern between subjects recorded in Oxford (‘OX’) and London (‘LN’). 
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6.3.4 Group level theta and beta dynamics in the contralateral STN 
during a change signal 
We further analysed RMS amplitude in the STN and the M1 by means of a novel continuous 
analysis GLM. In this model, the induced response to all individual events such as the go 
signal, change signal and button press can be estimated and disambiguated. Although 
cortical regions such as the rIFG and pre-SMA are implicated in changing and stopping 
behaviour, we focused on the STN and M1 in this provisional analysis to provide a 
demonstration of the principle of this technique, rather than definitive conclusions about local 
power changes novel to the task at hand. We used data from all available bipolar STN 
channels in each subject (usually 3). After estimating the individual induced responses for 
event type and source location we collapsed together all data from source locations 
contralateral to the original go signal (i.e. we collapsed left STN power during a right arrow 
instruction with right STN power during a left arrow instruction). We than selected the 
induced responses to the change signal and entered them into an ANOVA with dopamine 
(ON and OFF) and success (successful versus unsuccessful change) as factors. The mean 
response, the main effects of the experimental conditions and their interaction can be seen 
in Figure 49Error! Reference source not found.  Although a transient theta response 
followed by a decrease in beta can be seen in the STN, there is no significant response in 
M1.  Dopamine reduces theta activity prior to the presentation of the change signal in the 
STN, but has no effect on M1. 
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Figure 49: Experimental effects on the induced response to the change signal in STN 
and M1. Induced responses to the change signal were converted to time-frequency images 
and entered into a within-subject ANOVA with success (successful v unsuccessful changing) 
and medication (ON or OFF levodopa) as factors. Each subimage displays frequency (y 
axis, Hz) against peri-stimulus time (x axis, s, t=0 is the time of the change signal) for a 
single source [top 2 rows are contralateral STN (cSTN), bottom 2 rows are contralateral M1 
(cM1)], and a single experimental contrast. Each contrast image is labelled with a 
neighbouring statistical mask (green = no effect, blue= significant decrease in amplitude, 
red=significant increase in amplitude). The most marked finding is a transient theta increase 
during the presentation of the change signal, followed by a beta decrease. Experimental 
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interventions had little effect of RMS amplitude. This demonstrates the principle of the 
convolution approach to RMS amplitude analysis in our cohort. 
 
6.3.5 Coherence between the motor cortex and STN cannot be seen 
consistently in individual subjects. 
Previous studies in a similar cohort have shown that coherence changes are rarely seen in 
individual subjects, and better demonstrated across the group (Litvak et al., 2012a). We 
examined single subject data to ensure that reasonable and comparable event-related 
signals could be extracted from the MEG and LFP data, in spite of prominent artefact and 
the use of varied recording systems. In this section we looked at coherence between left M1 
and left STN during a right button press. We found that there was a detectable increase in 
cortico-subthalamic gamma coherence at the time of movement in only a few subjects (see 
Figure 50).  
 
6.3.6 Group level network coherence dynamics during the change task 
Although, using robust averaging, coherence between the motor cortex and  STN could not 
be seen at the individual level, we went on to calculate the group average of cortico-
subthalamic and cortico-cortical coherence in three selected example cases. Events such as 
the button press and change signal may be close, but not predictably separated, in time. 
Therefore coherence changes cannot be definitively attributed to any particular event. 
Acknowledging this, in this demonstration, we have focused our interpretation of the data on 
coherence changes close to the triggered event (t=0), which are most likely (but not 
definitively) to be related to the event in question. Firstly we looked at coherence between 
the left motor cortex and left STN during various events in the change task (see Figure 51). 
Because we were looking at the left STN, we only included trials where the go arrow was 
presented to the right initially to allow ease of interpretation. The data are not all that clear, 
but the clearest finding triggered to an event is a relative increase in gamma coherence 
locked to the go signal in the ON medication condition. This is consistent with recent 
evidence linking increased cortico-subthalamic gamma coherence with increased motor 
responsiveness to dopamine in PD subjects (Litvak et al., 2012a). Next we looked at 
coherence between the pre-SMA and STN during the same trials and events (see Figure 
52). Here, the most striking feature was a gamma coherence burst locked to the change 
signal, but only on failed change trials. Again, the significance of this is difficult to determine 
(see discussion). Finally, we looked at coherence between two cortical sites – the right IFG 
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and the pre-SMA (see Figure 53). Again, we found striking gamma coherence locked to 
both the change signal and button press. However we are unable to disambiguate whether 
this activity is in fact locked to one or both of these events.
 
Figure 50: Coherence between the left M1 and left STN during a right button press. 
Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x axis, s) for a 
single subject per medication condition. The button press is at t=0. Coherence is presented 
relative to the mean of the entire time window (-2.5s to 2.5s). The title of each image 
identifies the subject (e.g. LN07) and the medication condition. Only some of these images 
suggest that there is increased gamma coherence during the button press, otherwise there 
are no clear signals at the individual subject level. There is no clear difference in pattern 
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between subjects recorded in Oxford (‘OX’) and London (‘LN’). Note that although subject 
OX04 had prominent spike artefact in the cortical amplitude signal, this artefact does not 
dominate the coherence signal. 
 
 
Figure 51: Average group-level coherence between the left M1 and left STN during the 
change task. Only trials following presentation of a right go arrow are included for ease of 
interpretation. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x 
axis, s) for the group OFF medication (top row) and ON medication (bottom row). Individual 
columns represent the average of trials locked to the go signal (GO, go signal at t=0) the 
button press (PRESS, button press at t=0), the change signal during failed change trials (Ch-
F, change signal at t=0) and change signal during successful change trials (Ch-S, change 
signal at t=0). The most striking feature locked to any of the trial events is a gamma increase 
at around the time of the go signal (black arrow) seen in the ON medication condition. 
Coherence is presented relative to the mean of the entire time window (-2.5s to 2.5s), and 
has been smoothed to aid visualisation. 
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Figure 52: Average group-level coherence between the pre-SMA and left STN during 
the change task. Only trials following presentation of a right go arrow are included for ease 
of interpretation. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x 
axis, s) for the group OFF medication (top row) and ON medication (bottom row). Individual 
columns represent the average of trials locked to the go signal (GO, go signal at t=0) the 
button press (PRESS, button press at t=0), the change signal during failed change trials (Ch-
F, change signal at t=0) and change signal during successful change trials (Ch-S, change 
signal at t=0). The most striking feature is a gamma increase at around the time of the 
change signal – but only in the failed change condition (see black arrows). Coherence is 
presented relative to the mean of the entire time window (-2.5s to 2.5s), and has been 
smoothed to aid visualisation. 
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Figure 53: Average group-level coherence between the right IFG and pre-SMA during 
the change task. Only trials following presentation of a right go arrow are included for ease 
of interpretation. Each subimage displays frequency (y axis, Hz) against peri-stimulus time (x 
axis, s) for the group OFF medication (top row) and ON medication (bottom row). Individual 
columns represent the average of trials locked to the go signal (GO, go signal at t=0) the 
button press (PRESS, button press at t=0), the change signal during failed change trials (Ch-
F, change signal at t=0) and change signal during successful change trials (Ch-S, change 
signal at t=0). A clear gamma increase can be seen in most conditions, but it is unclear if this 
is locked to the change signal or button press (black arrows). Coherence is presented 
relative to the mean of the entire time window (-2.5s to 2.5s), and has been smoothed to aid 
visualisation. 
 
6.4 Discussion 
 
This chapter provides proof-of-principle that dynamic cortico-basal ganglia activity can be 
measured with combined MEG and simultaneous STN-LFP recording. We demonstrated a 
change-signal locked theta response in the STN, similar to the cortical theta network seen in 
healthy controls. We have also found preliminary evidence for the role of cortico-subthalamic 
and cortico-cortical gamma coherence during the change task. However, although the raw 
data and initial analyses look promising, further more sophisticated analysis techniques are 
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required to make definitive biological inferences from these data – especially with regards to 
dynamic connectivity. In this discussion, we will therefore focus on both methodological 
aspects and the limited demonstration results we have presented. 
 
6.4.1 Signal Fidelity 
Standard robust averaging techniques are well suited to our data, and with minimal pre-
processing, are able to provide clear induced responses to events that can even be seen 
individually in most subjects. This supports the notion that signal-to-noise ratio of the MEG 
recording is adequate in spite of the ferromagnetic artefact from the extension wires. In 
addition, reassuringly no systematic differences in the pattern of induced responses can be 
seen between subjects recorded with different MEG systems (i.e. between Oxford and 
London). Finally, low filter correlation coefficients suggest that source activity can be 
confidently extracted from the MEG data with enough resolution to separate the a priori 
regions of interest. 
 
6.4.2 Amplitude responses of cortical and subthalamic regions during 
the change-of-plan task 
We focused on a preliminary analysis. We found that robust averaging of induced responses 
confirmed a beta decrease and rebound increase, but it was unclear whether this was locked 
to the go signal, or also partly the button press itself. A similar pattern was found in the STN 
with additional gamma activity more clearly locked to the button press itself. Reassuringly 
these movement-related amplitude changes are similar to power changes previously 
reported during simple movements in other studies(Litvak et al., 2012a). However in our 
case, because of the nature of our cognitive task, we cannot make any further substantial 
inferences regarding the relationship between particular task events and brain activity 
changes. This is because standard averaging techniques (including robust averaging) 
cannot disambiguate the brain responses to closely overlapping experimental events. One 
approach to this problem, exemplified in chapter 5, is to use a convolution model to perform 
group analysis. Here, all individual events are modelled in the same GLM and therefore it is 
possible to disambiguate the response to different experimental events. Because of the 
increased within and between-subject variability in our patient cohort as compared to our 
healthy control cohort, it also becomes important to include factors such as age and UPDRS 
in our hierarchical model. However, due to time-constraints, we present only a provisional 
demonstration of the model (without including important confounds). Convolution model 
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analysis of the change signal revealed that, on average, there was a theta increase followed 
by a beta depression in the contralateral STN during a change signal. This is similar to the 
widespread cortical theta responses seen during a similar task in healthy controls (chapter 
5). However, in this patient cohort, no such activity was seen in the motor cortex itself. There 
was additionally a marginal effect of dopamine on contralateral STN theta activity just before 
the presentation of the change signal. However more clearly defined effects may become 
apparent after relevant confounds are modelled out. 
 
6.4.3 Dynamic coherence responses during the change-of-plan task 
Coherence between the motor cortex and STN could not be seen clearly at the individual 
level, as has been noted before (Litvak et al., 2012a). In addition, coherence was derived in 
a fashion analogous to classical averaging, and therefore suffers from the same inferential 
limitations previously mentioned. However, acknowledging this, clear bursts of gamma 
coherence are locked to various events during the change task suggesting that gamma 
coherence is a fundamental message passing mechanism between pre-SMA, right IFG, 
primary motor cortex and the STN during the change task. Group average figures suggest 
that gamma coherence between the motor cortex and STN is locked to the signal to start 
moving, whereas gamma coherence between the pre-SMA and STN is locked to the signal 
to change. This is in keeping with our original hypothesis, that the pre-SMA is specifically 
involved in change behaviour. However, if this is the case, why then is pre-SMA to STN 
gamma coherence limited to failed change trials? This could be a genuine finding, but could 
also be due to unaccounted experimental confounds. Specifically, failed change trials require 
a different button to be pressed, than successful change trials. Therefore because the timing 
and nature of the motor response to the button press is different in both trials, the 
electromagnetic activity underlying the motor response will differentially interfere (by 
increasing or decreasing the change-locked coherence) with a failed and successful change 
event. We also demonstrated that this technique could also uncover dynamic cortico-cortical 
coherence between the pre-SMA and right IFG. This was in the form of a gamma coherence 
response which, although striking, was difficult to assign to either the button press or change 
signal. Cortico-cortical coherence measurement has been traditionally hampered by the 
presence of volume confounds. However, we have showed that the cortical sources looked 
at in this study are adequately separable (see section 6.3.2) using beamforming. Also, the 
nature of the gamma oscillatory responses are transient in time and therefore less likely to 
be a result of volume conduction. One way to potentially confirm this would be to ensure that 
the phase delay between the sources was not zero. .  
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So although gamma coherence may index information exchange between cortico-
subthalamic and cortico-cortical hubs during dynamic motor behaviour, with our current 
methodology, it is difficult to disentangle what this information might mean. One approach to 
the inference problem is to again use a convolution model as we demonstrated with 
amplitude responses. This would be able to disambiguate the responses to different events 
and additionally account for reaction time confounds that are magnified in the patient group. 
However, the convolution model requires a continuous estimate of the dependent variable 
and unfortunately, coherence cannot be estimated continuously currently in the SPM 
framework.  Additionally, coherence is a non-linear measure and further validation would be 
required before this can be modelled adequately using a GLM. However, in principle, with a 
continuous estimate of coherence, similar procedures found in fMRI analysis could be 
applied to our MEG data, to allow us to make more substantial biological inferences.  
 
Finally we should note that there are a wide variety of other techniques that we could use to 
perform further analysis of these data which might enrich inferences in different ways. Firstly, 
coherence is only one metric of coupling between two regions. Other metrics including 
phase-locking value, multivariate connectivity and imaginary coherence may provide 
additional insight into different mechanisms of communication. Secondly, in previous 
chapters we have calculated directional connectivity using Granger-based techniques. The 
same method could be applied to this data in order to determine if activity in one region 
temporally precedes another during this task. 
 
6.4.4 Conclusions and further directions 
In conclusion, this chapter provides evidence that combined measurement of MEG and 
basal ganglia LFPs is a technique that is, in principle, able to test predictions about dynamic 
cortico-basal ganglia connectivity during cognitive tasks. Secondly, although the patients in 
our cohort did not perform as consistently as healthy controls, using an adapted paradigm – 
the change-of-plan task – and robust behavioural analysis techniques, we were able to get 
consistent behavioural results from this cohort. Finally, although reassuring, the analyses we 
have performed remain provisional. Critically, this is because currently there exists no 
marriage of the appropriate electrophysiological analysis techniques (continuous coherence) 
with the appropriate statistical techniques designed for cognitive tasks (the convolution 
model). Therefore, although we can demonstrate local amplitude changes in the STN and 
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cortex during the change-of-plan task, we cannot yet robustly infer the meaning of the 
changes in gamma connectivity between regions. 
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7. Discussion 
Prior to summarising and discussing the research undertaken, we will briefly remind 
ourselves of the objectives of this thesis that were set out in the introduction: 
1) To develop a study model and methodology to measure cortico-basal ganglia 
connectivity, based on simultaneous magnetoencephalographic and basal - ganglia 
recordings in Parkinsonian patients. 
2) To determine if the cortical and subcortical spatial distribution of cortical-basal ganglia 
connectivity is frequency and dopamine dependent at rest. 
3) To characterise the role and spectral signature of different cortical areas during the stop- 
signal task.  
4) To characterise how activity in cortico-basal ganglia circuits changes during the 
performance of the stop-signal paradigm, and how these changes relate to behaviour in PD 
patients.  
 
7.1 Simultaneous MEG and basal ganglia LFP recording – a new 
model for studying cortico-basal ganglia oscillations 
 
The first aim of this thesis was to develop a study model by which cortico-basal ganglia 
interactions could be studied in humans with PD. Previous work in humans had either relied 
on functional MRI (fMRI) studies (e.g. (Di Martino et al., 2008)) or combined EEG and deep 
electrode LFP recording (e.g. (Lalo et al., 2008)). Although combined EEG and LFP 
recordings had sufficiently high temporal resolution to capture the spectral characteristics 
and directionality of cortico-basal ganglia interactions, they lacked spatial resolution at the 
cortex. This is primarily for two reasons. Firstly post-operative neurosurgical patients have 
limited access to the scalp because of the need to avoid the wounds, meaning that head 
coverage is not consistent. Secondly, the EEG signal is distorted by bone and scalp layers, 
making the accurate modelling of these distortions (i.e. a head model) particularly important. 
This is hampered, in this group of subjects, by the presence of burr holes, and post-
operative scalp swelling. On the other hand, although fMRI studies had sufficient spatial 
resolution to identify distinct cortical nodes of interest, they had difficulty isolating activity 
from small but crucial structures such as the STN and, of course, they had poor temporal 
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resolution.  Another approach, employed by this thesis, is to replace EEG recording with 
MEG recordings. In addition to increasing the number of cortical sensors (from 32 or less to 
over 275), the MEG signal is not distorted by bone and skin, and is therefore less sensitive 
to the presence of burr holes, and is less sensitive to inaccuracies in the head model.  
Combined with simultaneously recorded intracranial (LFPs), MEG is a promising solution but 
still has potential limitations – such recordings are hampered by the presence of high-
amplitude artefacts in the MEG due to the presence of percutaneous extension wires made 
of stainless steel close to the MEG sensors. However, Litvak et al described these artefacts 
and showed that despite their presence, topographical mapping of coherence between 
bipolar LFP channels and the MEG sensors could disclose physiological patterns (Litvak et 
al., 2010). Furthermore, they demonstrated that beamforming effectively suppresses 
artefacts and thereby enables both localization of cortical sources coherent with the STN 
and the extraction of artefact-free virtual electrode data from these sources. In this study, we 
built-upon these technical advances to characterise cortico-subthalamic and cortico-
pedunculopontine coherence in a cohort of PD patients. Although we have used sensor-level 
noise modelling (see chapter 5) to internally validate our approaches, most reassuring is that 
a similar study (of combined MEG and STN LFP recordings in PD patients) that used MEG 
compatible extension wires presented almost identical results to ours (Hirschmann et al., 
2011). With increasing availability of MEG-compatible wires in the future the approaches 
developed in this thesis will possibly yield even better data quality. 
 
7.1.1 Limitations 
However, a couple of limitations remain. Firstly, healthy control data are necessarily limited 
because it would be unethical to implant electrodes into human brains for research purposes 
only. To militate this we have, in this thesis, limited our inferences to comparisons between 
conditions in the same set of subjects, rather than comparisons across different groups such 
as patients and controls. Additionally, as the range of indications for DBS increases, non-
parkinsonian patients with STN electrodes may be used as controls (e.g. see (Neumann et 
al., 2012)). Secondly our cohort is immediately post-operative, and therefore may not be 
physiologically similar to typical PD patients. Perhaps the most striking demonstration of this 
is the so called ‘stun’ effect, where the symptoms of PD are dramatically reduced post-
operatively by peri-lesional oedema from the electrode insertion (Lalo et al., 2008). However, 
although clinically the stun-effect may subside within days, initial STN LFP findings probably 
remain stable over time - even up to 7 years later (Giannicola et al., 2012).  
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7.2 Cortico-basal ganglia networks at rest 
In chapters 3 and 4, we studied resting cortico-subthalamic and cortico-pedunculopontine 
networks at rest. We used coherence, a frequency dependent measure of coupling, to 
assess the strength of cortico-basal ganglia interactions. Remarkably we found that in both 
cases networks at distinct frequencies were also spatially distinct, supporting the idea that 
different brain regions may have different ‘default’ frequencies at which they synchronize 
together at rest (Eusebio et al., 2009). Our resting results focus on two frequency-specific 
networks – alpha (7-12Hz) and beta (15-35Hz). The anatomical basis for these networks is 
supported by recent DTI data that demonstrated connectivity between the STN and 
temporoparietal and medial frontal cortical hubs in PD subjects (Lambert et al., 2011). 
 
7.2.1 The cortico-basal ganglia alpha network 
Both the STN and PPNR demonstrated increased alpha frequency connectivity with other 
brain regions. The STN was coherent with the temporo-parietal cortex bilaterally and the 
brainstem, whilst the PPNR was coupled to the ipsilateral cerebellum. Additionally, a central 
portion of the PPNR was preferentially coupled to the inferior frontal gyrus in the alpha band. 
We must acknowledge that some of these structures are deep inside the brain, where MEG 
sensitivity is poor. However, Parkkonen et al have recorded brainstem early auditory evoked 
responses with MEG (Parkkonen et al., 2009) and Schnitzler et al have suggested MEG can 
detect signals from the thalamus, brainstem and cerebellum (Schnitzler et al., 2009).  
 
7.2.1.1 Potential functions of the alpha network 
So can we speculate on the potential functions of the alpha network? One candidate is that 
the network may, in part, overlap with the previously described alpha network coherent with 
Parkinsonian rest tremor (Timmermann et al., 2003; Pollok et al., 2009). Although this 
network included brainstem areas and the cerebellum, we would not favour this explanation, 
because the minority of our subjects had tremor as a presenting symptom and very few had 
significant episodes of tremor during our recordings, as demonstrated by simultaneous EMG 
recordings. Changes in alpha activity in the subthalamic region have also been reported in 
response to emotional stimuli (Brucke et al., 2007), however, our study did not present any 
emotional stimuli to the patients.  
We favour the hypothesis that the alpha network subserves attentional/arousal functions. 
Arousal can be regarded as the general state of physiological reactivity of a subject, ranging 
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from asleep to panicked (Coull, 1998). Such physiological states were thought to be heavily 
influenced by brainstem activity, particularly the activity of the reticular formation. Early 
neuropsychological models suggested that higher cortical and thalamic areas mediating 
attention were dependent on the activity of such brainstem arousal mechanisms. Attention 
itself, can be thought to be the allocation of awareness, or brain resources, to a particular 
behavioural process or thought. Indeed, attention can be described in temporal, spatial or 
capacity terms. Early influential models suggested that arousal and low-level attentional 
mechanisms (such as orienting to a stimulus) were mediated by noradrenergic and 
cholinergic brainstem, thalamic and parietal mechanisms, whilst higher-level functions, such 
as set-shifting and other executive functions, were mediated by dopamine mechanisms 
involving the frontal cortex (Coull, 1998).  
So what is the evidence that the alpha network described here may represent an arousal 
and low-level attentional network? Firstly, the alpha frequency itself has been associated 
with modulating attention within different brain regions (Palva and Palva, 2007).  Secondly, 
the brain structures involved in this network – temporo-parietal regions, STN, PPNR, 
cerebellum and brainstem – have all been implicated in studies of attention. In particular, 
temporo-parietal alpha/low beta (10-20Hz) has been implicated in visual attention studies 
and is sensitive to the levels of acetylcholine present (Bauer et al., 2012). However, the 
strongest support to the idea of an alpha attentional network comes from the studies on the 
PPNR. The PPN is considered a component of the ‘reticular activating system’ and may 
modulate states of arousal and attention (Winn, 2006). In line with such a role, PPN 
stimulation in patients with Parkinson's disease (PD) may increase rapid eye movement 
sleep (Romigi et al., 2008; Lim et al., 2009) and diurnal vigilance (Ferraye et al., 2010), and 
there is PPNR-cortical coherence in the alpha band during wakefulness (Androulidakis et al., 
2008). In fact the brainstem region identified by the STN network may be the PPNR, which is 
directly connected with the STN (Androulidakis et al., 2007).  
7.2.1.2 Clinical correlation with alpha activity 
In chapter 3, we performed multiple post hoc correlations between local and inter-regional 
electrophysiological parameters and multiple clinical symptoms. After a stringent correction 
for multiple comparisons, no correlations remained significant. However, recent papers using 
a more targeted approach have correlated local alpha activity in the STN with maximal effort 
responses in patients with PD. Maximal effort has been linked to attention and arousal most 
strikingly by a phenomenon termed paradoxical kinesis. In such episodes, PD subjects 
undergoing intense stimuli (e.g. escaping from a burning house) report temporary but 
dramatic resolution of their motor impairment (Souques, 1921). Although the relationship 
226 
 
between such arousing stimuli and electrophysiological parameters is difficult to study in the 
laboratory, the brain responses underlying maximal effort may be related. In a study of 10 
PD patients undergoing DBS surgery to the STN, Anzak et al found that both theta/alpha (5-
12Hz) and broad band gamma (55- 375Hz) activity in the STN predicted approximately 70% 
of the inter-subject variance in maximal grip responses. This effect was relatively 
independent of dopamine, although the authors were unable to conclude if this effect was 
due to variation in arousal, attention, or the motor activity itself (Anzak et al., 2012). 
Furthermore, in a similar carefully parameterised motor performance study, Tan et al 
confirmed these findings and showed that increased STN theta/alpha activity was also 
associated with an ability to sustain a motor grip. Again this effect was independent of 
dopamine.  
Previous literature has also shown attention may be especially important in those with PD 
and gait dysfunction, particularly freezing. A relationship between attentional control and gait 
performance is increasingly recognised (Yarnall et al., 2011). Gait speed reduces in healthy 
subjects, elderly fallers and in Parkinson’s disease during the performance of a second, 
unrelated task (‘dual tasking’) (Hausdorff et al., 2003; Springer et al., 2006; Lamoth et al., 
2011). Dual tasking and other processes that divert attention away from walking can all also 
precipitate gait freezing (Giladi and Hausdorff, 2006). In PD, attentional deficits are 
increased in patients that fall (Allcock et al., 2009) and freeze during gait (Amboni et al., 
2008; Yogev-Seligmann et al., 2008).   
Alpha networks preferentially involving the middle PPNR (including the caudal PPN), 
between 2 to 6mm below the pontomesencephalic line, may be particularly important in 
supporting a possible role in gait control through attentional modulation. This region 
demonstrates both the greatest local alpha synchrony, a marker that correlates with gait 
performance (Thevathasan et al., 2012) and clinical response to stimulation, as well as the 
greatest alpha synchrony with distant brain regions. Furthermore, just as cortical hubs of the 
alpha attentional network may be modulated by acetylcholine levels, acetylcholine may also 
have a special role in the PPNR. The middle section of the PPNR may include the caudal 
part of the ‘pars dissipata’ of the PPN (Thevathasan et al., 2012). The pars dissipata of the 
PPN, as defined by immunohistochemical labelling of choline-acetyltransferase in humans, 
extends both rostrally and caudally from the central pars compacta (Mesulam et al., 1989; 
Manaye et al., 1999), and has been implicated in gait and its dysfunction (Karachi et al., 
2010). It should, however, be acknowledged that the pars dissipata of the PPN has indistinct 
boundaries, and of note, just medial to its caudal boundary is the laterodorsal tegmental 
nucleus which is also rich in cholinergic neurons (Manaye et al., 1999). 
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Can we say anything further about inter-regional alpha coupling?  Oswal et al have re-
analysed task data on the same cohort of subjects as presented in chapter 3. Using 
combined MEG and STN-LFP recordings they looked at activity in the temporoparietal 
region – a hub in the alpha network described in chapter 3 – during a button press (Oswal et 
al., 2012). They found that temporoparietal alpha power decreased up to 2 seconds prior to 
a button press, and that this remained unaffected by levodopa administration. This effect 
was prolonged for sequential button pressing as opposed to simultaneous pressing, 
suggesting that it may be related to either the increased motor activity or attentional 
engagement required by the more complex sequential condition. They also found a drop in 
temporoparietal-STN coherence immediately after a button press regardless of its 
complexity, but related to levodopa administration and the level of clinical impairment. The 
authors argue that the absence of a relationship with task complexity supports the notion 
that such coherence represents arousal or attentional modulation, as opposed to motor 
processing. In essence, the alpha cortico-STN network has to ‘disengage’ during a task to 
allow other (e.g. gamma) networks to be activated (Oswal et al., 2012).  This is an attractive 
hypothesis, but further experimental studies are required to confirm whether disengagement 
of the alpha network represents attentional allocation, or whether it represents a different 
feature of motor preparation or executive function such as working memory. 
In summary, although speculative, our results support the notion of an alpha cortico-basal 
ganglia resting network that influences attention and arousal, some components of which 
may also be particularly important for gait dysfunction in PD, and some for recruitment of 
maximal force. We would suggest that most parts of this network are sensitive to 
acetylcholine levels, rather than dopamine, (although see (Oswal et al., 2012)) and that 
future studies that extrinsically modulating acetylcholine levels may provide useful data on 
the role of this network.  
 
7.2.2 The cortico-basal ganglia beta network 
The second pattern of coupling was evident in the beta frequency band in which both the 
STN and the PPNR were coupled to medial frontal motor areas (including the primary motor 
cortex, sensorimotor cortex, SMA and cingulate). Overall, the STN had a larger cortical 
network, extending anteriorly to medial prefrontal areas and laterally to premotor areas and 
the lateral frontal cortex. The areas of cortical involvement suggest that this network, 
recorded at rest, might be engaged in setting the level of preparedness for executive 
functions. This would be compatible with the emerging view that beta activity may promote 
the status quo at the expense of action (Hammond et al., 2007; Engel and Fries, 2010; 
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Jenkinson and Brown, 2011). However, this remains speculative with regards to beta 
coherence between distant regions, rather than local beta synchronisation within a region.    
 
7.2.2.1 Are beta networks pathological? 
Do these beta networks represent physiological or pathological activity? Without the 
opportunity to record from the subthalamic area in healthy subjects, or at least non-
Parkinsonian patients, we cannot answer this question directly. A common approach under 
these circumstances is to determine whether dopaminergic therapy alters the pattern of 
activity noted in the untreated state. The approach is based on the premise that the core 
deficit in PD is partially reversed by exogenous dopaminergic input, although the homology 
between brain states in treated PD and the healthy subject is only likely to be approximate at 
best. Relying on studies using this approach, it has been proposed that local beta 
synchronisation is a normal phenomenon in certain basal ganglia structures, but that this 
may be pathologically exaggerated in PD (Jenkinson and Brown, 2011). Hence levodopa 
administration reduces local beta synchronisation. But how may this apply to beta 
synchronisation across structures? 
We found that levodopa increased beta coupling between the STN and a limited part of the 
anterior medial frontal cortex. Without a direct clinical or cognitive correlate to this change, 
the inference remains unclear. In fact, the limited effect of dopamine on the beta network 
was surprising given its consistent effect on local beta synchronisation. Similarly, Lalo et al. 
(2008) found little effect of medication with levodopa on the STN-cortex DTF below 35 Hz, 
although there was an increase in the gamma band. Williams et al. (2002) did find a 
suppression of beta band STN-cortex coherence at rest following medication, but this was in 
a much smaller sample of patients.  It may be that some of the negative findings relate to 
stun effects in the immediate post-operative period (Lalo et al. 2008).  However, the limited 
changes in the distributed (rather than local) networks following dopaminergic therapy might 
also suggest that synchronisation across structures may be at least partly physiological 
phenomena in patients.  Further support for this is provided by recent studies of cortico – 
basal ganglia functional connectivity based on functional magnetic resonance imaging and 
positron emission tomography. Both healthy subjects (Postuma and Dagher, 2006) and PD 
patients (Helmich et al., 2010; Hirschmann et al., 2011) show resting connectivity between 
the basal ganglia and the supplementary motor area, the temporo-parietal area and parts of 
the prefrontal cortex.   
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7.2.2.2 Is there more than one beta network? 
Another reason for the minimal effect of dopamine may be that local synchronisation in the 
STN tends to be low beta (12-20Hz), whereas we found distant synchronisation tended to be 
maximal around 30Hz (high beta). The implications are twofold. First, the difference in 
frequencies between peak subthalamic power and peak subthalamo-cortical coherence 
reinforces the notion that subcortico-cortical coherence is not a simple passive phenomenon, 
but that its pattern is dictated by the transfer characteristics of the pathways involved. 
Second, the difference in frequencies adds weight to the argument that subthalamic 
activities in the lower and upper ranges of the beta frequency band may have somewhat 
different functional significance (Williams et al., 2002; Priori et al., 2004; Fogelson et al., 
2006). Activity in the upper beta band seems to be more strongly coupled with cortical 
activity, and relatively less modulated by dopaminergic therapy. 
 
7.2.3 Directionality within the resting networks 
In both resting studies, we used variants of Granger causality to explore the direction of 
coupling between either the STN or PPNR and other brain structures identified within either 
the alpha or beta networks. Such techniques identify which signal leads in time, in so far as 
one signal is able to predict the other over time. The most parsimonious explanation for such 
a relationship between two coherent population activities is that the leading population drives 
the lagging population. However, this may not be the only explanation. Driving may be direct 
or indirect, via one or more unrecorded structures, or activity in both recorded structures may 
be driven by a third unrecorded structure (Sharott et al., 2005a). Given this, we use the term 
‘effective direction of coupling’ (distinct from effective connectivity (Friston et al., 2012)) to 
describe a pattern of temporal relationships rather than a measure of direct coupling. 
 
7.2.3.1 The STN 
The clearest finding was that cortical regions temporally led the activity of the STN in the 
alpha and beta bands, regardless of the frequency of the network or the dopaminergic state 
of the patient. Similar apparent driving of LFP activity in the STN  region in the beta band by 
cortex in PD patients has been noted using linear regression of phase (P Brown et al. 2001; 
Noa Fogelson et al. 2006; D Williams et al. 2002b) and the DTF (Elodie Lalo et al. 2008). 
This has been further replicated in animal models of PD (N. Mallet et al. 2008b; Andrew 
Sharott et al. 2005). These observations are compatible with the recent demonstration in a 
rodent model of PD that it is sufficient to stimulate the afferents to the subthalamic nucleus at 
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high frequency, rather than the local neurons themselves, to overcome Parkinsonism 
(Gradinaru et al., 2009). However, although the direction of information flow is relatively clear 
from our data, further modelling would be required to determine whether the cortico-
subthalamic coupling identified reflects a mono-(hyperdirect) or polysynaptic (direct and 
indirect) pathway, or a mixture of the two. 
 
7.2.3.2 The PPNR 
Conversely, the PPNR showed no clear overall directionality with other brain structures it 
was coupled to. The most interesting feature in this cohort was the effect of levodopa: to 
increase beta outflow from the middle PPNR to the cortex. Again, without a direct 
behavioural correlate, we can only speculate upon the role of this. Basal ganglia 
pathophysiology in PD is classically modelled as a relative overactivity of the polysynaptic 
indirect pathway. This potentially upregulates two sets of competing inputs to the 
downstream PPN:  inhibitory GABAergic influences from the GPi and SNr and excitatory 
glutamatergic influences from the STN. Although still debated, several lines of evidence 
suggest that the inhibitory inputs dominate, resulting in an overall pathological inhibition of 
the PPN in PD (but on the other hand, see Teo 1997 & 1998). Hence acetylcholine synthesis 
is suppressed in the PPN in the Parkinsonian state (Gomez-Gallego et al., 2007). Reducing 
PPN activity, as occurs with destructive lesions, leads to a Parkinsonian-like state (Aziz et 
al., 1998), and there is a relationship between the loss of cholinergic neurones in the PPN 
pars compacta and the severity of Parkinson's disease (Zweig et al., 1989). Furthermore, 
akinesia in MPTP treated monkeys may be reversed by the microinjection of the GABA 
antagonist, bicuculline, into the PPN (Nandi et al., 2002). Therefore if there is overall 
inhibition of the PPN in PD, one may hypothesise that treatment by levodopa may ‘release’ 
the PPN outflow. Indeed this is what we found – increased beta outflow from the middle 
PPNR to the cortex. However, the clinical associations of this remain unclear. 
 
7.3 Dynamic cortico-basal ganglia activity during executive 
function 
To understand how these spectrally and spatially distinct resting cortico-basal ganglia 
networks relate to function and dysfunction in PD, we assessed the behaviour of these 
networks during dynamic experimental paradigms. Patients with PD have slower reaction 
times than average, and also have difficulty with alternating and repeated motor tasks (Lees 
et al., 2009). In addition, they are disproportionately slow during tasks demanding greater 
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executive control such as changing or stopping pre-prepared movements (Gauggel et al., 
2004).  We decided to test the hypothesis that the beta cortico-subthalamic network was 
involved in executive motor processing – in particular response inhibition, which is 
specifically impaired in PD (Gauggel et al., 2004).  In order to do this, we used variants of 
the stop-signal paradigm, which requires contextual motor control – to be precise, it requires 
the participant to stop a pre-planned movement based on the occurrence of a visual stop-
signal. This task has previously been shown to activate specific prefrontal regions and the 
STN (see introductory review).  However, the distinct roles of different prefrontal areas 
during response inhibition remain unknown. We investigated this in two stages: first we used 
MEG in healthy controls to clarify the specialised roles of different cortical areas during 
stopping; second we performed a simplified variant of the task in post-operative PD patients 
undergoing combined MEG and STN LFP recording to examine the behaviour of the cortico-
subthalamic network during stopping. However, we found that analysis of event-related 
electromagnetic responses required a more sophisticated analysis approach. This was 
developed in parallel with this thesis (Litvak et al., 2012b), but unfortunately has not yet been 
extended to include network analysis (i.e. coherence). Therefore we can make biological 
inferences only about the healthy control group (chapter 5), and in chapter 6 have performed 
a provisional ‘proof-of-principle’ technically motivated analysis of network behaviour. 
 
7.3.1 Theta activity and the cortical response to a stop-signal 
In chapter 5, we performed 4 variants of the stop-signal task that dissociated the effect of 
conditional complexity – i.e. the initial requirement to cognitively ‘set-up the rules of the 
experimental task’ – from the later possible requirement to inhibit an ongoing movement. 
Because some variants of the task required motor inhibition (a stop), and others required an 
opposite movement (i.e. a change-of-plan), the signal was termed the stop/change signal. 
In order to study the neural basis for the second component (the activity associated with 
stopping a movement) we looked at brain signals locked to the stop/change-signal. The most 
consistent response to the stop/change signal was a brief theta/alpha induced response 
which peaked around the same time as the average time taken to stop a response – the stop 
signal reaction time (SSRT). This response was relatively widespread - found in the pre-
SMA, left and right IFG and SMA (but was not significant in the primary motor cortex itself) – 
suggesting that it causes parallel activation of multiple hubs of a stopping network. Although 
similar medial frontal theta has been shown to be a marker of cognitive interference (Nigbur 
et al., 2011) and to predict error-monitoring (Cavanagh et al., 2009), in our experiment, the 
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theta response was unaffected by the presence of an error (stop-fail or change-fail trial) 
irrespective of the stop/change stimulus cue.  
So what are the specialised functions of different cortical areas during stopping? To isolate 
the region most closely related to executing the stop itself, we looked for the region which 
was most sensitive to stopping efficiency. At each cortical region, we modelled variation in 
the slope of the induced theta/alpha response as a function of the average time available to 
stop/change. We hypothesised that, in subjects and conditions where a longer than average 
time was available for stopping/changing, the cortical theta alpha response would be less 
efficient (less steep). This relationship was only significant in the right IFG, suggesting that 
this part of the cortical stopping network is most closely related to the actual stopping 
process. This is consistent with human lesion (Aron et al. 2003) and fMRI data (Aron and 
Poldrack 2006) which have correlated right IFG damage and blood oxygenation with another 
measure of stopping efficiency - SSRT. Our results have also highlighted that right, as 
opposed to left, IFG activity is most closely related to stopping. It remains unclear why, but 
this asymmetry exists regardless of the hand being used to stop (Konishi et al., 1999), and 
whether a hand movement or verbal response is being stopped (Xue et al., 2008), 
supporting the idea the right IFG operates a fundamental operation in stopping. 
 
7.3.2 Pre-SMA gamma activity and the modulation of context 
Our experiment was also able to dissociate the effect of contextual complexity from the 
requirement to stop during the stop-signal task variants. The neural correlate of contextual 
complexity was identified as an early and persistent gamma response found in the pre-SMA.  
Crucially, pre-SMA gamma activity increases with increasing contextual complexity on all 
trials prior to the presentation of instructional signals and does not differentiate later success 
or failure at stopping. This is consistent with the idea that this activity is coincident with the 
‘setting-up of the rules/context of the task’. This feature is also interesting because gamma 
responses generally represent local cortical processing (e.g. (Swettenham et al., 2009)) 
rather than network processing, and early gamma activity in the pre-SMA has been seen in a 
conditional variant of the stop-signal task in a single subject with subdural electrodes over 
the medial frontal wall (Swann et al., 2012). Finally, in one of the few cases of gamma 
synchrony between regions that have been described, the gamma coherence between the 
primary motor cortex and STN has been shown to correlate with bradykinesia in PD patients 
(Litvak et al., 2012a). Therefore the role of gamma coherence in our patient cohort would be 
particularly interesting. One would predict that increased gamma coherence between the 
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motor cortex and STN would correlate with reaction time, whereas increased coherence 
between the pre-SMA and STN would correlate with SSRT. 
 
7.3.3 Beta changes selective to stopping only 
So what differentiated between successful and unsuccessful stopping? We found 
significantly increased post-stop/change signal beta activity during successful stopping in the 
pre-SMA, and left and right IFG, but after the median go reaction time. This response was 
significantly stronger for post-stop signal responses and almost absent in the change 
condition. This has two implications. Firstly, the relative absence of beta changes in 
successfully changed trials, suggests that it is not a necessary cortical response for 
stopping. Secondly, beta activity may play a specific role when the subject requires only a 
stop, and not a further response. So what role does cortical beta activity play in stopping? 
Stop-failures were associated with reduced beta and lengthened subsequent reaction times, 
suggesting that a drop in beta activity may be an error-monitoring signal or a signal to 
update the motor plan. If an error signal, there would be no change in beta after a successful 
stop - this is not the case, and therefore we favour the idea that after a successful stop, the 
current motor set is reinforced with a corresponding increase in beta. This is in keeping with 
the idea that increased beta activity maintains the current motor set (Engel and Fries, 2010; 
Jenkinson and Brown, 2011) after a correct response whilst reduced beta favours motor-
reprogramming after a failed stop response. However, we did not find similar cortical 
responses to explain the behaviour in the change paradigm, suggesting that post-change 
responses may be modulated by a different mechanism (e.g. locked to the motor response 
rather than the change-signal). 
 
7.3.4 Cortico-subcortical interactions during stopping – a ‘proof-of-
principle’ 
Our secondary aim was to characterise event-related network activity in patients with PD 
during a variant of the stop-signal task: the change-of-plan task. We were unable to include 
the complete analysis in the present thesis because of technical limitations; however our 
provisional analysis suggests that the analysis could be performed on the dataset we 
acquired. Using standard robust averaging techniques we were able to see dynamic 
changes in local alpha, beta and gamma synchronisation during the change-of-plan task. 
These responses were visible in the primary motor cortex and the STN itself. Prefrontal 
regions were not examined in this technical analysis, so that no a priori bias exists when 
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they are analysed in the future. Importantly we found that the signal-to-noise ratio of the 
MEG recording is adequate in spite of the ferromagnetic artefact from the extension wires. In 
addition, reassuringly no systematic differences in the pattern of induced responses can be 
seen between subjects recorded with different MEG systems (i.e. between Oxford and 
London). Finally, a spatial sensitivity analysis (filter correlation coefficients) suggested that 
source activity can be confidently extracted from the MEG data with enough resolution to 
separate the a priori regions of interest. 
However, although induced responses were clear enough to be visible on an individual 
subject basis, their relationship to experimental triggers remains debatable without a more 
formal analysis. Such an analysis can be performed using the convolution model used in 
chapter 5 – this model is able to disambiguate responses to distinct experimental events. We 
demonstrated this in principle in chapter 6, where we discovered a change-signal locked 
theta response in the STN, similar to the cortical theta network seen in healthy controls. 
However, in this clinically and behaviourally heterogeneous cohort, further careful dissection 
of the data must be performed before any robust inferences can be made.   
Finally, we were unable to perform adequate analysis of dynamic cortico-subthalamic 
coherence in this context because a convolution model for coherence does not yet exist. We 
hope to perform such analysis in the future after the appropriate methodology is developed 
and tested. 
 
7.4 Summary 
In summary we have developed a novel methodology for measuring cortico-basal ganglia 
activity in humans with PD (Litvak et al., 2010, 2011a). Such measurements are critical to 
understanding the pathophysiological basis of symptoms in PD. Resting data have 
demonstrated that two spatially and spectrally segregated networks exist between both the 
cortex and STN and the cortex and PPNR. We speculated that the alpha network is 
attentional, whilst the beta network is related to motor executive processing (Litvak et al., 
2011a). In order to test the second of these speculations, in parallel with this thesis, we 
developed further analytical tools to characterise brain responses during dynamic executive 
motor tasks (Litvak et al., 2012b). Using these new techniques, in healthy controls, we 
detected a global, widespread theta/alpha cortical network related to the executive ability to 
stop an ongoing movement. We were further able to find specialised roles for both the right 
IFG and pre-SMA during stopping and were able to characterise the spectral properties and 
temporal profiles of local cortical synchronisation within these regions. However, a complete 
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analysis of similar behaviour in PD, and the cortico-subcortical interactions that underlie it, 
remains outstanding.  
So what are the potential benefits of such research? The critical advance is that we have 
seen some evidence of segregation of functional systems – both according to frequency and 
topography. Future research will continue to interrogate these systems more closely to try to 
understand the precise functional roles that they subserve. This is important because 
currently, electrical interfaces with the brain such as DBS presumably have side-effects 
partially because they interfere with multiple functioning and malfunctioning systems. In the 
future, by varying different stimulation parameters, such as stimulation frequency and 
electrode location, one may be able to target isolated malfunctioning systems without 
interfering with functioning ones – in essence to be able to optimise the efficacy of treatment 
without causing side-effects. 
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